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Abstract 
 
Improving measurement in perimetry for glaucoma 
Ciara Bergin (City University London) 
 
Glaucoma is a leading cause of visual impairment and, if untreated, irreversible blindness. Perimetry 
is the clinical tool for assessing the functional ‘seeing’ part of the field of view (visual field) and is 
widely used in the detection and clinical monitoring of glaucoma. These measurements rely on a 
psychophysical response making them inherently variable. This measurement noise can disguise both 
disease pathology and progression. 
The work described in this thesis aims to improve the quality of perimetric measurements. The 
platform for this is the Moorfields Motion Displacement Test (MMDT), a perimetric test that uses 
unconventional test stimuli and can be delivered on an ordinary computer monitor. Specifically, this 
thesis describes efforts to develop novel, mathematically derived, test algorithms, designed to be 
used with the MMDT. The performance of these new testing methods is assessed using pilot studies 
involving patients and visually healthy people, computer simulation and interim results from a large 
prospective clinical study. One of these test algorithms, the Enhanced Suprathreshold Testing 
Algorithm [ESTA] provides shorter test duration, making it attractive for case-finding and screening 
for glaucoma, without seemingly negatively affecting diagnostic precision, and has become patented 
technology. Another bespoke test algorithm (Weighted Binary Search; WEBS) provides a threshold 
test for the MMDT.  
The thesis also describes a study examining the resistance of several newer clinical perimetric 
instruments to the optical artefact of stray light that might be caused by media opacity. This is 
clinically important because cataract and degraded optical media is a leading cause of false-referral 
for glaucoma. This work, being the first of its kind, indicates that the MMDT has greater resilience to 
simulated effects of media opacity compared with other clinically used devices. 
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HoV  Hill of Vision 
HRT  Heidelberg Retinal Tomograph 
IOP  Intraocular pressure 
IOS  Intraocular Straylight 
MD  Mean Defect 
MMDT  Moorfields Motion Displacement Test 
MS 2/2  Multisampling Suprathreshold two out of two criterion  
MS 2/3  Multisampling Suprathreshold two out of three criterion 
MOBS  Modified Binary Search 
MOCS  Method of Constant Stimuli 
NTG  Normal Tension Glaucoma 
ONH  Optic Nerve Head 
ORS  Observer Response Simulator 
PACG  Primary Angle Closure Glaucoma 
PD  Pattern Deviation 
PDF  Probability Density Function 
PICS  Perimetry Instrument Comparison Study 
POAG  Primary Open Angle Glaucoma 
PP  Pulsar Perimetry 
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PSD  Pattern Standard Deviation 
ROC  Receiver Operator Characteristic 
RNFL  Retinal Nerve Fibre Layer 
SAP   Standard Automated Perimetry 
SITA  Swedish Interactive Threshold Algortihm 
SLv  Standard Local Variance 
ST  Suprathreshold  
SWAP  Shortwave Automated Perimetry 
TD  Total Deviation 
TOP  Tendency Oriented Perimetry 
VF  Visual Field 
WEBS  Weighted Binary Search 
WOF  White Opacity Filter 
YAAP  Yet Another Adaptive Procedure 
ZEST  Zippy Estimation of Sequential Testing 
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1 Introduction 
 
1.1 Overview of thesis 
 
In short, this thesis describes the development of two novel test strategies to improve visual field 
assessment in glaucoma and a novel experiment examining the resistance of four clinical perimetric 
instruments to the simulated effects of cataract. The test strategies developed within this thesis are 
designed to be applicable to any perimetric instrument but were initially motivated by the practical 
requirements of the Moorfields Motion Displacement Test (MMDT).  
The MMDT is a software program which provides a test of the field of vision. It was developed from  
the principles of a single-location MMDT (Fitzke et al., 1987). The test was refined and expanded to a 
multi-location format prior to the start of this thesis (Verdon-Roe, 2006, Moosavi, In submission; MD 
Thesis) (www.moorfieldsmdt.co.uk).   
Chapter one provides an introduction to glaucoma diagnosis and management. A brief overview of 
the risk factors and epidemiology of the disease is given, followed by an outline of the instruments 
used for detection and monitoring of the disease. This leads to a discussion on the role of 
measurement error, which causes misclassification errors, increases test variability and lowers 
repeatability. This in turn leads to a discussion of the importance of reducing noise in perimetry 
measures for glaucoma management. The chapter is concluded with an overview of newer 
perimetric instruments. 
Chapter two describes the development of a computer based ‘patient simulator’ via the collection of 
so called Frequency of Seeing data on the MMDT, for perimetric testing which is used in chapters 
three and four. Chapter three of the thesis outlines threshold testing algorithms used in perimetry 
and discusses which of these provides a suitable method for the MMDT. Several clinical search 
methods have been previously depicted in the literature; primarily these have the disadvantage of 
being significantly slower, in terms of test time, for glaucoma patients than for subjects with healthy 
vision.  This chapter reports on the development of an alternative search method (threshold 
algorithm), adapting a previously reported algorithm. 
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Chapter four describes the development of a completely novel fast suprathreshold strategy which 
implements spatial information contained within the visual field. The aim of this testing method is to 
provide a quick test of the visual field making it potentially suitable in screening and case finding.  
Chapter 5 illustrates how the two test strategies, as implemented on the Moorfields MMDT, were 
used in a prospective study comparing different perimetric instruments. Also the outcome of a 
screening type study implementing the MMDT suprathreshold test is reported. 
The presence of cataract is an additional difficulty in glaucoma management for detection and 
follow-up. In the screening or case-finding scenario, false referrals contribute a large proportion of 
the referred cases (Bowling et al., 2005). When truly trying to identify glaucoma, especially in an 
elderly population, the effect of cataract is a serious confounder to glaucoma patient care, which 
underlines the importance of the estimation of effect of cataract on newer types of perimetric 
stimuli. Chapter 6 of this thesis consists of a novel investigative study which was undertaken to 
examine the resistance of several newer clinical perimetric instruments to the effects of induced 
increases in stray light by comparison with standard automated perimetry (SAP), which is a measure 
of differential light sensitivity. From a clinical perspective, this may be regarded as a simulation of the 
effects of cataract on clinical perimetric measures. Chapter 7 concludes with a brief summary of the 
prospective projects arising from discoveries made within this PhD.  
 
1.2 Classification of Glaucoma 
 
Glaucoma is a collective term for a complex group of conditions that have a common end point of 
progressive optic neuropathy. Glaucomatous optic neuropathy (GON) is characterized by distinctive 
patterns of structural changes at the optic nerve head (ONH) and of the retinal nerve fibre layer 
(RNFL) with associated loss of visual function.  
The conventional classification of primary glaucoma is by the anatomical configuration of the 
drainage system of the eye: primary open angle glaucoma (POAG), where the drainage angle is non-
occludable, and primary angle closure (PACG), where the drainage angle is occluded.  Secondary 
glaucoma may be due to a variety of processes, which include, for example, steroid induction, 
pseudoexfoliation, pigment dispersion, uveitis, diabetes (neovascular), central retinal vein occlusion 
(neovascular), significant hyphema or trauma.  
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The modern concept of glaucoma is that it is a primary neurodegenerative disease of the optic nerve, 
with complex ocular and systemic contributions, which may be influenced by genetic and 
environmental factors. 
 
1.2.1 Presentation of Glaucoma 
 
Within the UK there is no systematic screening program for glaucoma. Case finding usually occurs 
during routine eye care examination. Therefore, optometrists initiate more than 96% of glaucoma 
case referrals (Sheldrick et al., 1994, Bell and O'Brien, 1997). However, it has been estimated that up 
to 63% of referrals are false positive (Lockwood et al., Sheldrick et al., 1994, Bowling et al., 2005), 
which results in wastage of resources and unnecessary anxiety and inconvenience to the patient. 
Training can reduce the false positive rate (Henson et al., 2003, Patel et al., 2005), but this has not 
been implemented on a large scale. A recent Health Technology Assessment report by Burr and 
colleagues (Burr et al., 2007) states that up to 67% of glaucoma in the UK is  undiagnosed, the 
insidious nature of the disease being a major confounder to its detection.  
POAG has a gradual and painless progression. Due to the sensory adaptation to the gradual loss of 
visual field the patient is often unaware of disease presence until an advanced stage has been 
reached (Bunce and Wormald, 2006, Fraser et al., 1999). If glaucoma is detected early the prognosis 
is good and the probability of bilateral blindness is low (Quigley and Broman, 2006, Chen, 2003, 
Munoz et al., 2000, Quigley, 1999, Blomdahl et al., 1997).  
 
1.2.2 Epidemiology and risk factors 
 
Approximately 2.7% of the global population is affected by glaucoma (Table 1-1); there are large 
differences in reported rates of prevalence with respect to sex, ethnicity and age (Figure 1-1). Two 
per cent of the population is affected by PAOG and 0.7% by PACG. Those of African racial origin are 
more than twice as likely to develop PAOG as Europeans. Chinese and South East Asians are 5 times 
as likely to develop PACG as Europeans. 
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Table 1-1 Prevalence of open angle glaucoma (OAG) and closed angle glaucoma (ACG), as reported by Quigley and 
colleagues (Quigley and Broman, 2006). 
The prevalence of glaucoma  has been shown to increase with age across the dominant ethnicities  
(Quigley and Broman, 2006), (Figure 1-1). With an increasingly ageing population in western 
countries alongside a dramatic increase in life expectancy there is an unprecedented increase 
forecast in the number of glaucoma patients (Quigley and Broman, 2006).  
 
Figure 1-1 The glaucoma prevalence model for age specific prevalence of open angle glaucoma (OAG) for the six major 
ethnic groups (Quigley and Broman, 2006). 
Elevated intraocular pressure (IOP) (> 21 mm Hg) is a major risk factor for the development of POAG 
but is not in itself a diagnosis of glaucoma (Sommer and Tielsch, 1996, Sommer et al., 1991, Sommer, 
1989). The prevalence of POAG with elevated IOP varies with ethnicity and ranges from 2.3% to 4.6% 
(Quigley and Broman, 2006). Glaucoma can be further defined as normal tension glaucoma (NTG), 
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where IOP is < 21 mm Hg. From the Rotterdam 10 year follow-up study it is estimated that with every 
1mmHg increase in IOP there is an 11% increase in risk of developing glaucomatous vision loss 
(Czudowska et al., 2010).   
Family history of glaucoma is a recognised risk factor for glaucoma. However, the assessment of 
family history is subject to error where it is reliant on patient self-reporting (Craig et al., 2001, Tielsch 
et al., 1994, Mitchell et al., 2002). Since the prevalence of POAG in first-degree relatives is low, this 
suggests that not a single-gene but rather a multi-gene combination is responsible for the disease 
(Garway-Heath, 2000). Several large family gene studies are currently being conducted to explore 
this further, the results of which may have large ramifications for the screening and treatment of 
glaucoma. Systemic factors such as hypertension (Sommer and Tielsch, 2008, Langman et al., 2005) 
and diabetes (Frank and Dieckert, 1996, Tan et al., 2009) have also been shown to be associated with 
glaucoma and more recently ocular biometry (Bourne et al., 2008, Kuzin et al., 2010, Perera et al., 
2010). 
 
1.3 Detection and monitoring of Glaucoma  
 
Different measurements are acquired during clinical examination for the detection and monitoring of 
glaucoma, namely IOP measurement and gonioscopy for the assessment of the related structures 
with respect to drainage or blockage, the health of the optic nerve head (referred to as structural 
measures) and assessment of the visual field (functional measures). No single measure provides 
conclusive evidence of presence or absence of glaucoma, nor is one measure sufficient for the 
monitoring of the disease. Instead, the combination of evidence from all three groups of measures is 
used to determine the presence and to monitor the progression of the glaucomatous damage. 
Conventional IOP measures are taken with the current reference standard test, Goldmann 
applanation tonometry (GAT) (Kotecha et al., 2010). The measure is then assessed as to whether it is 
within or outside normal limits. 95% of the healthy European population has IOP≤21mmHg (95.4% of 
the population had pressure below 22mmHg).  Evidence of iridocorneal angle narrowing (including 
evidence of previous apposition (peripheral anterior synechiae)), closure or blockage to the 
trabecular mesh work (e.g. pigment dispersion) should also be investigated during routine 
examination using the current gold standard of gonioscopic inspection in dark adaptation. 
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 A high IOP reading (>21mmHg; ocular hypertension) can be an indicator of glaucoma. The higher the 
IOP reading the greater the probability of the disease (Davanger et al., 1991, Klein et al., 
1992).Tracking the level of IOP when following a patient provides important clinical information. An 
increase in the IOP reading can indicate that medication is no longer yielding the desired efficacy. 
However, all IOP measures are subject to inter/intra observer variability and diurnal changes or 
associated measurement error (Kotecha et al., 2005, Sudesh et al., 1993, Kotecha et al., 2010). 
The ONH (or optic disc) contains the neuro-retinal rim and the optic cup. The neuro-retinal rim is the 
gathered retinal nerve bundles leaving the eye and is delimited peripherally by the edge of the RPE 
and internally by the cup. The cup is the depression at the centre of the disc. As nerve fibres are lost 
the amount of space taken up by the neuro-retinal rim reduces. The health of the ONH is assessed 
clinically under slit lamp examination within routine glaucoma care. This is often summarised with 
the parameter of cup to disc ratio, where a high ratio would represent an unhealthy disc (Armaly, 
1969). Since this is a subjective measure there are associated variability issues.  When monitoring for 
glaucomatous change, a subjective measure such as cup to disc ratio is not sensitive to subtle 
changes, instead large changes to the shape of the ONH, such as significant cupping, notching or 
other changes such as haemorrhage must be noted. Most likely lesser but significant changes/losses 
e.g. the cup to disc ratio changes from 0.70 to 0.80 will be disregarded as inter/intra-observer 
differences. 
Imaging devices using different optical techniques can also be used to assess the ONH and RNFL 
thickness such as scanning laser ophthalmoscope (SLO) as in the commercially available Heidelberg 
Retinal Tomograph (HRT)(Heidelberg engineering, Heidelberg Germany), scanning laser polarimetry 
(SLP) as is implemented in the GDx (Carl Zeiss Meditec, Dublin, CA, USA), and ocular coherence 
tomography (OCT) as with the Cirrus (Carl Zeiss Meditec, Dublin, CA, USA) or the RT-VUE (Optovue, 
Fremont, CA, USA)(Greenfield and Weinreb, 2008, Townsend et al., 2009). 
 The HRT is an example of SLO technology and is used in the assessment and management of 
glaucoma (Chauhan, 1996, Mikelberg et al., 1995, Zangwill et al., 2004, Zinser et al., 1989). In the 
case of the HRT the neuroretinal rim area of the ONH can be assessed (statistically) to be within or 
outside normal limits; this can be done within the software of the instrument, using the Moorfields 
multivariate regression analysis (MRA)(Wollstein et al., 1998). The HRT is also useful for monitoring 
for progression (Chauhan et al., 2000, Patterson et al., 2005). Another advantage that imaging 
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methods such as these have is that little patient co-operation is required. This is a less subjective 
measure. 
Functional measures are unappealing clinically as they are time consuming and sometimes difficult 
for patients (Gardiner et al., 2008). Despite these disadvantages, in terms of glaucoma management 
visual field assessment is very important. This is because the classification of the ONH or the level at 
which the IOP stands cannot provide any functional information and maintaining functional health is 
the primary aim of glaucoma treatment (European glaucoma society guidelines, 2009). 
Visual function loss is the lessening of ability to perceive/process visual information from the full 
healthy visual function profile. The healthy visual function profile can be established from the normal 
population. Comparison between the measured profile and the healthy profile is performed to 
detect loss, this may be diffuse or local or a combination of both. ‘Progression’ or further visual 
function loss is deterministic in treatment changes.  
Treatment of glaucoma currently involves controlling IOP levels. This is achieved medically or 
surgically or using a combination of both. The method is determined based on patient dependent 
factors such as compliancy (Robin et al., 2007), IOP control needed, and/or whether maximal 
tolerated treatment is reached. A moderate drop in IOP has been shown to change the course of 
progression of visual field loss (Chauhan et al., 2010). 
 
1.4 Measurement error in glaucoma assessment 
 
All the clinical measures in glaucoma are subject to inter and intra test measurement noise. The 
following provides a short overview. 
 
1.4.1 IOP measurements 
 
Apart from the large inter-observer and inter-visit variability inherent to this method of assessment 
there are some less obvious sources of measurement error, where careful consideration has yielded 
positive results with respect to reducing measurement noise. 
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The normative cut off changes with age and with race are as previously described in Figure 1-1. 
However less obvious was the different increment of IOP with age with respect to race (Klein et al., 
1992). Generally this was understood to be approximately 0.03mmHg per year as these limits were 
originally established for a mixed population (Qureshi, 1995). With the introduction of race specific 
normative cut offs and functions of change with respect to age, classification was significantly 
improved. In Japanese populations for example, on switching to race specific database, significant 
differences in the classification were made. In this population there is a much lower average IOP 
(11.5mmHg) and a lower increase with age of 0.02mmHg per year (Nuramuro et al, 1999).   
The GAT method of measuring IOP assumes a constant central corneal thickness (CCT) of 
approximately 520 microns. The recent introduction of calibrating IOP according to CCT provides a 
means of adjustment for the related measurement error. Previously, no allowance was made for 
CCT, resulting in subjects with thicker CCT (> 600 microns) being more likely to be classified as having 
raised IOP. Conversely, subjects with thin CCT were more likely to be wrongly classified as NTG 
(Brusini et al., 2000, Brandt et al., 2001, Copt et al., 1999, Shah et al., 1999). The newly introduced 
DCT (Pascal dynamic contour tonometer DCT; Swiss Microtechnology AG, Port, Switzerland) employs 
a correction for CCT. On examination it shows similar reproducibility to GAT, however the inter 
observer noise is significantly reduced (Kotecha et al., 2010).  
In terms of assessing the structure of health/effectiveness of aqueous drainage pathways the large 
inter-observer variability in the standard clinical setting associated with the current gold standard 
method of clinical assessment (gonioscopy) is clear as it currently remains a purely subjective 
measure (e.g. estimate of iridiocorneal angle in degrees (0⁰-40⁰). New measurement techniques such 
as that provided by the anterior segment optical coherence tomography (Visante;  Carl Zeiss 
Meditec, Dublin, CA, USA) may offer automation of this assessment, providing objective 
measurements in years to come (Kim et al., 2009). 
 
1.4.2 Structural measurements 
 
The ability of clinicians to detect glaucomatous eyes using subjective evaluation of ONH appearance 
is limited with the direct ophthalmoscope, fundus photography and other similar tools. The use of 
imaging systems to aid diagnosis and follow-up of POAG is becoming more widespread. Examples of 
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these are the HRT (Heidelberg engineering, Heidelberg Germany), GDx (Carl Zeiss Meditec, Dublin 
CA, USA) and RT-VUE (Optovue, Fremont, CA, USA). Studies have shown that whilst none of these 
systems are likely to perform better than a glaucoma specialist clinician viewing stereo-photographs, 
they can all perform at a similar level and have the potential to aid detection and monitoring of 
POAG (e.g. Reus et al., 2007). 
Measurement error plays a significant role in the ability to detect change using an optical imaging 
device.  Much of the responsible noise stems from image acquisition, which takes two forms: inter-
image misalignment due to pulse, head movements, cataract/media opacity etc. (Orgul et al., 1996, 
Chauhan and McCormick, 1995, Kremmer et al., 2003) and poor instrument to eye alignment which 
results in poorly illuminated images or magnification errors (Garway-Heath et al., 1998).  
Imaging techniques have quickly gained high resolution and continue to reduce noise; the large 
strides undertaken have resulted in a common misconception that they will lead to next to perfect 
images and measures of the optic nerve head and thus a gold standard classification. However, the 
images obtained will always be far less than perfect, since some measurement noise will likely 
remain. Auto calibration and alignment algorithms have succeeded in significantly reducing image 
acquisition noise but it remains difficult to remove this noise completely (for example see section 
1.5). Detecting change between images will also remain difficult as any change or loss will have to be 
greater than expected measurement noise and aging effects (Chang and Budenz, 2008a, Chang and 
Budenz, 2008b). 
Structural measures are heavily reliant on normative databases for classification, which is a 
disadvantage in the detection of early damage. Early damage is likely to be on the less depressed end 
of the measurement scale where the normal population will share the same measures. Therefore 
with the current statistical cut-off values of 95%, 98%, 99% and 99.5% employed within most clinical 
instruments this “loss” is easily overlooked. Until classification no longer relies on normative 
populations, there will likely be considerable misclassification error. 
 
1.4.3 Function 
 
A single visual function assessment can produce an unreliable measure, because of its dependency 
on the patient responses. In a visually healthy patient, responses will fluctuate according to fatigue, 
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attention and understanding of the test as well as true retinal sensitivity (Henson and Emuh, 2009, 
Anderson and McKendrick, 2007, Marra and Flammer, 1991, Johnson et al., 1988). In a glaucomatous  
patient these fluctuations are likely to be much greater, and will increase with depth and/or extent of 
loss (Artes et al., 2005, Spry et al., 2001), with additional variability along the edges of deficits (Wyatt 
et al., 2007). 
The presence of ocular media opacity (e.g. cataract) can mimic visual function loss (Superstein et al., 
1999, Moss et al., 1995, Siddiqui et al., 2007, Carrillo et al., 2005, Siddiqui et al., 2005, Matsumoto et 
al., 1997). Depending on the type of ocular media opacity present e.g. different types of cataract 
(Chylack Jr et al., 1993) focal or diffuse loss can be observed in visual functional assessments. Unlike 
glaucoma, the visual functional loss associated with cataract is reversible with phacoemulsification; 
therefore it is important to be able to differentiate between them. Efforts have been made to 
achieve this (Åsman and Heijl, 1994).  
Since both glaucoma and cataract are age related, it is not uncommon for them to occur in tandem. 
The advance of cataract development in a glaucomatous patient can mask glaucomatous visual loss 
progression, which confounds glaucoma monitoring (Siddiqui et al., 2007, Carrillo et al., 2005, 
Siddiqui et al., 2005, Matsumoto et al., 1997). For example, in advanced glaucoma where surgical 
interventions are more common, secondary cataract is an associated risk (Hylton et al., 2003, Gedde 
et al., 2007b, Gedde et al., 2007a, Borisuth et al., 1999) and can confound the assessment of the 
efficacy of the intervention in these high risk patients.    
Clinical threshold search methods in functional testing are designed to find the point of subjective 
equivalence, at which the subject is equally likely to provide a seen or unseen response, otherwise 
known as threshold. The method used to search for threshold introduces bias and variability in 
measures of both visually healthy subjects and glaucomatous patients (Turpin et al., 2003, Turpin et 
al., 2002b, Bengtsson and Heijl, 2003, Bengtsson and Heijl, 1999b, Bengtsson and Heijl, 1999a).  
The depth of the deficit is strongly associated with the amount of variability in a given measure of 
retinal sensitivity (Henson et al., 2000, Chauhan et al., 1993, Spenceley and Henson, 1996). Therefore 
given a threshold estimated by a clinical search method there is a distribution of thresholds which we 
could reasonably expect this threshold estimate to originate from (interpretation error)(King-Smith 
et al., 1994, Treutwein, 1995, Wichmann and Hill, 2001a). For change in a threshold measure to be 
significant the underlying distributions associated with interpretation error should not overlap, 
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however in clinical perimetry these distributions are so wide, that this is unlikely to occur until a large 
degree of damage has occurred. 
According to Swanson and colleagues, a true reduction in sensitivity from 33dB to 31dB, which is a 
loss of 2dB, would equate to the loss of over 50% of ganglion cells (Swanson et al., 2004).  However 
this measure of 31dB would remain well inside the normative range of a young visually healthy eye at 
a central location and thus with the current methodologies would not be isolated as a damaged 
location. Considering the test retest variability at this end of the range (SD~±2dB, (Artes et al., 
2002b)), it is clear that a true reduction of 2dB would be indistinguishable from measurement noise. 
The difference between two assessments of a given visual field must be greater than sources of 
measurement noise, in addition to the possible depression in retinal sensitivity associated with aging 
over follow-up, before any further depression in sensitivity is detectable. Depending on the innate 
measure of function or structure in any given patient (thick RNFL versus thin RNFL, high sensitivity 
versus low sensitivity), functional assessment or structural assessment likely will detect loss in 
different orders to one another. This is a major confounder when dealing with individual patients as 
the category to which they belong is unknown. One category of patients encompasses those with 
innate lower sensitivities and thinner RNFL, when disease presence/progression is detected it is likely 
to detected on both functional and structural measures. Conversely, loss in those subjects with 
glaucoma but with innate high retinal sensitivity and thick RNFL are unlikely to be detected as 
glaucoma sufferers until significant reductions have occurred.  This idea could also explain the lack of 
agreement between functional and structural measures;  those with innate lower sensitivity and 
thick RNFL are likely to be detected on functional loss, while those with innate higher sensitivity and 
thinner RNFL are likely to be detected with structural loss first.  
The lack of uniformity in the measurement scales is another large contributor to measurement noise. 
With an ideal device the complete scale of vision, from full vision to blindness should be covered, 
with uniformity. In typical structural and functional tests there has been no calibrating of 
measurement scales, so there is no reason to expect uniformity or high correlations between 
measures.  Most likely adjacent increments of visual loss will sometimes fall far apart (c and d), while 
others far within a small range (a and b) on the measurement scale (see Figure 1-2). This would in 
part explain the large variability at the lower end of SAP estimates (<15dB)(Henson et al., 2000). 
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Figure 1-2 Disparity in measurement scales for an ideal device compared to a typical device. The orange dashed line 
represents the normative range. Measures falling to the right of the normative range make detection possible. The 
dotted grey lines demonstrate the non-uniformity present in a typical device. The distance between a and b is less than 
that between c and d on measurement scale (x-axis) whereas these are equidistant with the ideal device. 
In structural tests, the idea of “scaffolding” was proposed by Hood and Kardon (2007), which in 
theory masks detection of further RNFL loss in moderate to advanced glaucoma. It hypothesises this 
is due to a “minimum” height of the RNFL attributed to presence of non-neural cells (e.g. blood 
vessels and connective tissues) (Hood and Kardon, 2007, Hood et al., 2007). This suggests that the 
changes in the lower end of the range of vision are not estimable with imaging.  
 
1.5 An example of handling measurement error in glaucoma assessment  
 
A brief description of a study examining measurement error in one type of imaging device follows. 
The work formed a paper published by Acta Ophthalmologica ((Bergin et al., 2008); See ‘List of 
supporting publications’). The joint authors of this work are Ciara Bergin [CB], David Crabb [DC] and 
David Garway-Heath [DGH]. The work was supervised by DC and DGH. Everything else described in 
this section was completed by CB. 
Changes in structure, such as the thinning of RNFL or progressive damage of the ONH indicate 
glaucomatous progression. The HRT as outlined above is established SLO technology used for the 
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examination of the ONH and surrounding RNFL (Chauhan, 1996, Mikelberg et al., 1995, Zangwill et 
al., 2004, Zinser et al., 1989); HRT is a useful tool for diagnosis and valuable in patient follow up by 
assessing structural change of the ONH by using series of images acquired over time. Analysis of a 
series of HRT images is done clinically to help distinguish between progressing glaucomatous patients 
and non-progressing patients. However, these images are not identically scaled versions of the true 
ONH and are affected by measurement variability during image acquisition (intra-scan noise) and 
between the visits in follow-up (inter-scan noise). For example, scan-resolution is limited by the 
optics of the human eye; the scanning laser must past through the tear film, cornea, lens and 
vitreous humour to reach the ONH; these media produce wave aberrations that degrade the 
resulting image (Artal et al., 2001) and add measurement noise. A number of other factors also 
contribute to the measurement noise including eye movements, pupil size (Artal et al., 2001, Zangwill 
et al., 1997), optic disc size (Iester et al., 1997), changes in intra-ocular pressure, placement of the 
contour line (Orgül S et al., 1995) and the use of a reference plane in generating stereometric 
parameters (Strouthidis et al., 2005a, Burk et al., 2000) and even the cardiac cycle (Chauhan and 
McCormick, 1995). 
The new image alignment algorithm was introduced as part of the HRT3 software (version 3.0.2.0) 
and the exact detail is proprietary. The aim of this study was to examine the impact of this new 
alignment algorithm on the inter-scan variability in series of HRT images, focusing on the 
improvements in repeatability of global stereometric parameters (such as neuroretinal rim area 
measurements) and also on the variability in the estimated height measurements at each pixel in a 
series of images.   
HRT image series from 124 patients with glaucoma or ocular hypertension were made available 
from previously reported studies (Strouthidis et al., 2003, Strouthidis et al., 2005b, Strouthidis et al., 
2006a) and were re-processed with the old and new image alignment algorithms. Improvements 
afforded by the new alignment algorithm were examined by considering statistically significant 
improvement in repeatability of specific stereometric parameters (SP), namely Rim Area (RA), Rim 
Volume (RV), Cup Volume (CV) and Cup Shape Measure (CSM). A further comparison was made by 
examining reduction in the variability of pixel-by-pixel height measures within image series. 
In some HRT image series the new algorithm automatically corrected obvious misalignment events 
that occurred with the previous algorithm.  However, average improvement in repeatability of the 
SPs in HRTI image series was not statistically significant (p=0.13) and there was no statistically 
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significant reduction in pixel-by-pixel height measurement variability (p=0.73). In HRTII image series, 
there was evidence of improvement, on average, in the repeatability of some parameters (RA; 
p=0.01, RV; p=0.02, CSM; p=0.05), but not in CV (p=0.22). There was, however, a large reduction in 
pixel-by-pixel variability in HRT II image series (p<0.001). Therefore this study, only briefly described 
here, revealed some evidence to show that the new algorithm improved repeatability.  
 
1.6 Impact of glaucoma 
 
The loss of nerve fibre layer caused by glaucoma, manifests in structural damage at the optic nerve 
head. Considerable RNFL loss results in repeatable measurable visual function loss, manifesting as 
depression of sensitivity locally and/or globally. In a glaucomatous eye this loss can progress to 
severe visual impairment over time, including the possibility of blindness. As visual function is lost, 
the quality of life is negatively affected. 
Glaucoma has a major impact on quality of life. According to the European Glaucoma Society, the 
goal of glaucoma treatment is to “maintain the patient’s visual function and related quality of life at a 
sustainable cost”… “Quality of life is closely linked with visual function and overall patients with early 
to moderate glaucomatous damage have good visual function and modest reduction in quality of 
life”. To ensure that the functional loss remains early to moderate for the duration of life expectancy, 
it is important to detect glaucoma as early as possible.  With expected increase in prevalence the 
balance between cost effectiveness and early detection and treatment is under review (Burr et al., 
2007).  
A reference standard for automated glaucoma detection has not yet been established, but will be 
required to facilitate the possibility of glaucoma screening (Hernandez et al., 2008). Currently, 
significant damage of structure or function must be present, with the additional requirement of 
disease progression detection before diagnosis confirmation (in early glaucomatous cases) 
(Guidelines of European Glaucoma Society (EGS) 3rd edition). Due to the innate structures of the 
population, as outlined above, it is unlikely that structural measures alone will achieve the 
appropriate levels of sensitivity or specificity required for automated case detection. Ideally 
detection of damage to both structure and function should determine disease presence; however the 
weak relationship between structural measures and functional measures in early glaucomatous cases 
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continues to impede a combined approach (Hood and Kardon, 2007, Gardiner et al., 2005, Bowd et 
al., 2006). Significant reductions to error in both measures would be required to allow this. 
Since a reduction in visual function is deterministic in treatment changes it will continue to serve as 
an endpoint for clinical trials. The guidelines for treatment of glaucoma aim at preserving visual 
function and avoiding visual impairment – it is reasonable that visual function assessment will remain 
paramount in glaucoma care. Furthermore, if glaucoma screening is to be viable, more efficient and 
reliable visual functional assessment will be required.  Therefore, it is clear that all possible 
reductions in measurement noise of functional measures should be pursued as vigorously as those in 
structural measures. 
 
 
 
1.7 Perimetry 
 
The visual field (VF) was defined by Tate and Lynn (Tate and Lynn, 1977) ‘as all the space that one eye 
can see in an instant’. Perimetry is defined as the study of the visual field (VF). Vision is most 
sensitive in the line of sight (Henson, 1993). As field of view extends to the periphery, the sensitivity 
reduces. From the line of sight the field of view extends 60˚ upwards, 75˚ downwards, 100˚ 
temporally and 60˚ nasally. The shape and sensitivity of the visual field can be described 
geometrically by what is known as the hill of vision. In Figure 1-3 the height of the hill is 
demonstrated by the luminance level, with the dark sections representing areas of no vision and the 
brightest areas corresponding to the areas of best vision. In healthy eyes there are additional 
components affecting the assessment of the hill of vision, the position of the blind spot and the 
horizontal streak. This is due to the changes in the underlying ganglion cell mosaic (Dacey, 1993, 
Curcio et al., 1991, Thibos, 1998). Furthermore, in eyes with pathology, any number of changes can 
be made to the shape of the hill of vision (Weber and Rau, 1992, Chauhan et al., 1993)(Figure 1-4). 
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Figure 1-3 A schematic showing the line of sight and sensitivity of the hill of vision with respect to eccentricity, where the 
brightest white represents the most sensitive area and sensitivity reduces with eccentricity. 
 
Figure 1-4 Normal hill of vision for contrast sensitivity (white stimulus on a white background) on the z-axis. Respective 
luminance values are given for the mean stimulus perceived by the healthy subject from 0˚-90˚. Beneath there is a 
diagrammatic example of a patient with pathology (Image courtesy of M. Monhart). 
Visual field assessment techniques are designed to assess how well an individual eye is able to detect 
movement or changes in contrast or colour. The measure is typically referred to as sensitivity. To 
measure the different types of sensitivity, stimuli vary in form between devices. The scale on which 
sensitivity is measured has been established by modulating the stimulus along one domain e.g. 
temporal or spatial.  In perimetry the ability to detect stimuli at different levels of intensities 
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(size/brightness/contrast) is measured. To be able to determine differences between patients (or to 
monitor patients) standardised methods of assessing the visual field were needed. 
The existence of the visual field was known to Hippocrates but the modern tangent screen was 
introduced by Bjerrum in 1889. With this screen it is possible to assess the extent of the field and 
localised defects in the central field. This method remains the standard in campimetry. Perimetry, 
which refers to the assessment of the field on a curved screen, has largely replaced campimetry. The 
first perimeters were arc perimeters. They used light projection and were introduced in the 1930’s, 
followed by the bowl perimeter in 1945. Computer technology was combined with the light 
projection bowl perimeter in the 1970’s. In the subsequent years many bowl perimeters were 
manufactured. Globally few manufactures remain, examples of which are Octopus perimeters (Haag 
Streit, Koeniz, Switzerland) or Humphrey Visual Field Analyzer (Carl Zeiss Meditec, Dublin, CA, USA). 
 The repetitive nature of static perimetry made it an ideal test for adaptation by computer 
automation (Koch et al., 1972). Furthermore with computer controlled presentation duration each 
presentation remained above the critical presentation duration time (obeying Bloch’s law) and below 
a duration which would allow fixation change to affect sensitivity (200ms). Therefore, Goldmann 
static perimetry was modified from size modulation to contrast modulation and with the aid of 
computer automation the current gold standard in perimetry was created. Automated static 
perimetry employs static stimuli which are presented at set visual angles in the bowl perimeter. The 
intensity of the stimulus is changed an encoded number of times based on patient responses. Since 
more parameters of this perimetric method are preset before testing, it is not operator dependent 
and is relatively fast to perform in comparison to manual perimetry. 
  
1.7.1 How is automated perimetry used in glaucoma management?  
 
As outlined above, measureable functional loss occurs in most cases of glaucomatous patients in the 
periphery (outside the central 10 degrees). Automated static perimetry is the most popular clinical 
tool for measuring visual function outside the fovea. Threshold perimetry offers an estimate of visual 
function on a sensitivity scale derived from the perceptible intensity level. Based on the measure of 
this level, sensitivity (or sensitivities) can range from those observed in the healthy eye to those in 
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the defective eye. Suprathreshold perimetry provides an estimate as to whether sensitivity at a given 
test location is within normal limits. 
Perimetric measures are summarised, to aid interpretation of the health of a patient’s vision. This is 
represented by indices for diffuse loss (Flammer et al., 1985, Airaksinen et al., 1985, Chauhan et al., 
1990), focal loss (Chauhan et al., 1989, Bebie et al., 1989), likelihood of glaucoma (Asman and Heijl, 
1992) and inter-eye difference (Asman et al., 1992). 
 
1.7.2 Standard automated perimetry (SAP) 
 
One of the main clinical instruments employed in the UK is the Humphrey Field Analyser II (HFA II) 
(Myint et al., 2010, Myint et al., 2011). Within the HFA II, the stimulus is an intensity-modulated 
Goldman III achromatic white stimulus on a 10cd/m2 achromatic white background, presentation 
time is 200ms (Figure 1-5 A) (Heijl, 1985b). This is conventionally known as white on white.  The 24-2 
standard test pattern comprises 54 test locations (Figure 1-5 B). Threshold is the lowest luminance at 
which the stimulus is detectable 50% of the times it is presented. Suprathreshold testing was the 
original testing method with SAP (Heijl, 1976, Johnson et al., 1979, Heijl and Krakau, 1975b, Heijl and 
Krakau, 1975a)  only with the addition of testing methods (Heijl, 1977, Bebie et al., 1976, Enoch and 
Campos, 1980) could threshold perimetry be elevated to its current status. Threshold perimetry 
alongside the introduction of numerical analysis quickly became an important clinical tool (Heijl and 
Drance, 1980, Enger and Sommer, 1987, Heijl and Patella, 2002).  The threshold search method used 
to obtain the most reliable measure of threshold is Full-Threshold (Schaumberger et al., 1995, 
Spenceley and Henson, 1996). Clinically the most used threshold search method is SITA-Standard 
(Bengtsson et al., 1997) which has been shown to have comparable reliability to full-threshold (Wild 
et al., 1999, Bengtsson and Heijl, 1999b, Bengtsson and Heijl, 1999a). Despite SAP originating with 
suprathreshold methodologies (Johnson et al., 1979, Heijl, 1976) these have been largely neglected 
since in favour of threshold methods. The current suprathreshold HFA SAP tool is the 64-point 
screener, the test pattern is larger than threshold perimetry (52 points) and differently spaced 
(Figure 1-5 (C)).  
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Figure 1-5 (A) Goldman type III stimulus (B) the central 24-2 threshold test pattern (right eye) (C) Suprathreshold testing 
pattern (right eye). 
There are several issues with the HFA SAP instrument which have an effect on the clinical usefulness 
of SAP. The large effect of optical defocus due to the small stimulus size employed requires that 
optical correction be worn (Araie et al., 1995, Herse, 1992) which introduces several further 
complications to assessment and clinical practicability (Heijl and Patella, 2002) pg133. There is also a 
large negative effect with respect to reduced quality of the optical media (Stewart et al., 1995, Lam 
et al., 1991, Verdon-Roe et al., 2009, Anderson et al., 2009, Bigger and Becker, 1994, Siddiqui et al., 
2007) which confounds clinical interpretation and management in glaucoma (Stewart et al., 1995, 
Katz, 2000, Chauhan et al., 2008). Interpretation of threshold estimates are further complicated by 
the measurement scale used (Malik et al., 2006) and the threshold search methods employed 
(Spenceley and Henson, 1996).  Added to this, there is a large learning effect associated with SAP 
threshold testing (Autzen and Work, 1990, Wild et al., 1989) and fatigue effect (Marra and Flammer, 
1991, Wild et al., 1991) both of which increase test variability (Henson and Emuh, 2010, Henson et 
al., 1997). As a case-finding tool, the suprathreshold test is time consuming (approximately 3.5 
minutes) and overly specific. Lastly, the size and cost of the instrument make it less portable and 
affordable, reducing the overall value of this instrument. Many of these issues with SAP perimetry 
lead to it being impractical in routine eye care, which may be a large contributor to the proportion of 
undetected cases of glaucoma (Burr et al., 2007). 
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1.7.3 Novel Perimetry 
 
As previously discussed, structural loss is often observed at a retinal level before functional loss is 
identified, and in particular of SAP, with the original white-on-white stimulus type and vice versa 
(Quigley et al., 1982, Harwerth et al., 1999, Fraser and Manvikar, 2005). In an effort to detect 
glaucoma earlier the search for newer perimetric techniques began. This was prompted by 
histological studies undertaken in the late eighties and the early nineties  (Glovinsky et al., 1993, 
Quigley et al., 1987, Quigley et al., 1988), which suggested that in early glaucoma there may be 
preferential damage to the M pathway (Weber et al., 2000, Chaturvedi et al., 1993). Recent work by 
Yucel and colleagues has contradicted these findings, determining that no such preferential damage 
occurs in glaucoma (Yücel et al., 2003, Ly et al., 2011, McKendrick et al., 2004). However, in the 20 
year interim several new perimetric stimulus types were developed with the intention of exploiting 
this phenomenon, mostly with stimulus types directed toward the M-pathway. While the 
underpinning logic for development of the stimulus types has been eroded, potentially any of these 
new perimetric instruments may offer improvements in value over the gold standard. This 
improvement may manifest itself in simple things like the improvement of overall workflow of the 
instrument, portability or affordability, or with a more stimulus based improvement such as 
resilience to optical blur or media opacity or alternatively a simpler test may be more robust to 
learning to fatigue effects. Here follows an overview of the some of these perimeters which are 
commercially available or shortly will be. 
 
1.7.3.1 Short Wavelength Automated Perimetry (SWAP) 
 
 SWAP has been implement within the HFA II, the stimulus is an intensity-modulated Goldman V blue 
stimulus on a 100cd/m2 yellow background, presentation time is 200ms (Figure 1-6) (Johnson et al., 
1995). The standard test pattern remains the same as SAP, namely the 24-2 pattern (Figure 1-5 B). 
Threshold is the lowest luminance at which the stimulus is detectable 50% of the times it is 
presented. Similarly to SAP, the most used search method is SITA-Standard. Comparison in reliability 
to full threshold has not been completed in the clinical instrument. SWAP has been shown to have 
higher variability and there is a longer adaptation time than SAP (Moss et al., 1995). It has also been 
shown to be more affected by lens opacity (Moss et al., 1995), and in particular with increases in 
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intraocular stray light associated with lens opacity, than white on white perimetry (Anderson et al., 
2009). In a recent study by van der Schoot and colleagues it has been shown that SWAP defects do 
not present earlier than SAP defects (van der Schoot et al., 2010). 
 
Figure 1-6 Short Wave Automated Perimetry stimulus. 
 
1.7.3.2 Frequency Doubling Technology (FDT) 
 
FDT Matrix is a new instrument designed to be more portable and user friendly than the HFA. The 
doubling illusion described by Kelly and colleagues (1966), from which the FDT inherited the name, is 
not the discrimination task implemented in the clinical instrument (Kelly, 1966, Kelly, 1981, 
McKendrick et al., 2003). FDT perimetry is a contrast dependent task, where threshold is estimated 
as the contrast at which the stimulus is detected for 50% of the presentations made.  The threshold 
method used is the ZEST program (Anderson et al., 2005).  The stimulus used is a contrast-modulated 
5o sinusoidal grating (0.5cycles/degree) stimulus (encased in a square envelope) with a fixed counter-
phase flicker of 18Hz displayed on a screen of background luminance of 100cd/m2 (Anderson, 2006, 
Anderson et al., 2005, Johnson et al., 2004), the total stimulus presentation time is 720ms 
(McKendrick et al., 2003). The threshold test pattern has 55 test locations similar in format to the 24-
2 pattern but modified in stimulus location (Figure 1-7) (personal communication Chris Johnson; Feb 
2011). There is a significant learning effect reported with the FDT MATRIX threshold test (de T Pierre-
Filho et al., 2009, Clement et al., 2009, Centofanti et al., 2008). The suprathreshold FDT test is run on 
an older model of the FDT, namely the FDT1. Here the stimulus sizes are larger (10˚), the sinusoidal 
grating is of lower spatial frequency (0.25cycles/degree) and higher temporal flicker frequency 
(25Hz). The rest of the test parameters remain the same. On this device the spatial resolution is also 
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reduced from 55 locations to 17. Here the C-20-5 suprathreshold method is used. There is no 
published material outlining the methodology for this testing method.   
 
Figure 1-7 (A) Frequency Doubling Technology stimulus (B) Frequency Doubling Technology test pattern location 0-54 
indicate left eye test locations, while locations 2-56 indicate right eye test locations (courtesy of C. Johnson) (C) 
Suprathreshold screening pattern used in the FDT 1 C-20-5 strategy. 
 
1.7.3.3 Moorfields Motion Displacement Test (MMDT) 
 
The MMDT is a laptop based perimetry test, designed for portability and affordability. All lines used 
to form the stimuli are displayed concurrently on the laptop screen. A stimulus consists of the 
displacement of a vertical bar from starting position, an increment of pixels towards the fixation 
target, where it is displayed for 100ms followed by a return displacement to the starting point also 
held for 100ms. This oscillation is repeated three times, resulting in presentation duration of 600ms. 
The amplitude of displacement increment is modulated. Stimuli are presented at 85% Michelson 
contrast on a 10cd/m2 achromatic background (Verdon-Roe et al., 2006b). There are 32 test 
locations, the line stimuli have been scaled with respect to age and eccentricity (Figure 1-8). The test 
pattern consists of a subset of test locations from the standard 24-2 test pattern. The missing 
locations were removed to address the over sampling at the poles of the ONH associated with the 
standard 24-2 test pattern. This pattern was designed as a part of the creation of the multi-location 
MDT format (Verdon-Roe, 2006). Threshold is the smallest discernable displacement (Verdon-Roe et 
al., 2006a). Currently a 1-1 staircase threshold search method is used. There is no suprathreshold test 
available. 
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Figure 1-8 Motion Displacement Test stimulus presentation and test pattern for the right eye. 
 
 
1.7.3.4 Frequency Defined Form (FDF) 
 
FDF is implemented on the new Heidelberg Edge Perimeter (HEP). This open platform perimetric 
device controlled by a Windows based operating system has resolved old issues with operator 
interfaces. The FDF stimulus uses contrast-modulated 5° patches of 0.34o (diameter) dots flickering in 
counter phase to a background of identical dots with a mean luminance of 50cd/m2 .The random dot 
background had a density of 3.5 dots per degree.  There are 55 test locations which are matched 
directly to the 54 test locations of 24-2 test pattern, with an additional measure at the fovea. The 
threshold is the lowest contrast for which an illusionary “edge” of a grey circle is perceived (Quaid 
and Flanagan, 2005) and the illusion is termed Flicker Defined Form (Figure 1-9). The ASTA1 program 
is the threshold search method currently employed. There is no suprathreshold test in the current 
HEP instrument. A significant learning effect has been reported with the FDF stimulus type 
(Lamparter et al., 2011). As of yet the resilience to poor optics quality (refractive blur/media opacity) 
has not been examined with this stimulus type. 
                                                          
http://www.heidelbergengineering.com/international/products/hep/ 
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Figure 1-9 Schematic showing Frequency Defined Form stimuli http://www.optech.net.au/optech_net_HEP.html.  
 
1.8 Summary 
 
Overall reduction of measurement noise in perimetry is pursued through two avenues within this 
PhD, the exploration and refinement of testing strategies and the classification and quantification of 
noise associated with lens opacity. 
Here follows a short description of each chapter. 
Chapter 2 outlines a study which investigated frequency of seeing curves in healthy subjects and 
patients with mild to moderate glaucoma. These functions are then used to build a patient simulator 
which helped to test each of the testing strategies in developmental stages. 
Chapter 3 contains a description of parametric and non-parametric methods for adaptive threshold 
testing. These tests allow for quicker perimetric assessment. Study data from a small cohort of 
patients tested is included here. This work is further supported by the data derived from the patient 
simulator, which was used to explore associated measurement error. 
Chapter 4 contains a description of a novel suprathreshold testing algorithm which uses the spatial 
information contained within a visual field. Results of a pilot study of the new algorithm’s 
performance compared to conventional suprathreshold tests are reported. 
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Chapter 5 describes studies that have used the test methods developed in the preceding chapters 
and provides evidence for their utility and comparable performance with other perimetric methods 
and devices. 
Chapter 6 presents a study which investigates perimetric measurement error associated with lens 
opacity. Lens opacity induces an increase in intraocular stray light, which in conventional perimetry is 
often perceived as a lowering of the retinal sensitivity. In perimetric measures this is a major 
confounder to correct interpretation. In this study the level of intraocular stray light is systematically 
increased in visually healthy observers to examine the effect on retinal sensitivity measures.  
Chapter 7 summaries the main findings from the work described in this thesis and offers some future 
projects associated with the work. 
2 Frequency of seeing and the observer response simulator 
 
The work described in this chapter leads to the development of an observer response simulator 
(ORS). This ORS was used to test potential testing strategies in chapter 3.  The results in this chapter 
have been presented, in part, as a read paper at the 18th International Symposium of the Imaging and 
Perimetry Society Meeting in Nara, Japan in May 2008 (See ‘List of supporting publications’).  Data 
collected in this study were collected by CB and Reza Moosavi MD at Moorfields Eye Hospital. 
In chapter 1 the sources of measurement noise with instruments in glaucoma diagnosis and 
monitoring were discussed, in particular those associated with perimetric measures. Measurement 
noise in perimetry may be due to the testing algorithm or other factors, for example, where retinal 
sensitivity was underestimated due to the reduced quality of the optics. However, the most 
convoluted source of measurement noise in perimetry originates from the subjective nature of the 
test (dependence on observer response). In this case the false positive (FP) (or guess) rate  and false 
negative (FN) (or lapse) rate will significantly influence the test results, as will the response 
confidence of the observer (Wichmann and Hill, 2001a) (Figure 2-1). FP rate is the proportion of 
responses which were unseen but the observer provided a seen response. This is sometimes referred 
to as ‘trigger happiness’. FN rate is the proportion of responses which were easily visible but the 
observer provided an unseen response or in lapse in concentration.  High confidence of an observer 
in comparison to an observer with lower confidence (even with matching sensitivity), would equate 
to a smaller interval of intensities which cover the range from where the stimulus is easily visible to 
where it is not visible.  
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Figure 2-1 An example of a Frequency of seeing curve for a reference threshold of 27decibels (dB) in 
differential light perimetry (SAP). The observer should see 0.95 or 95% of all presentations (or 19 
presentations out of 20 presentations) at 20dB or below, decreasing slowly to 0.05 or 5% seen (1 
presentation out of 20) for presentations at or above 35dB. The observer has a 50% chance of seeing 
a presentation of 27dB.In yes-no paradigms, such as those used in clinical perimetry, threshold is 
defined as the intensity level where a stimulus presented at this level would produce a seen response 
in exactly 50% of the times it was presented. Where there is high confidence, there is less doubt as to 
where threshold lies. Intra-observer deviations in the confidence levels, FN rate and FP rates skew 
threshold search methods, in terms of bias, precision and accuracy (Treutwein, 1995). Precision is the 
amount of variance in repeated measures; bias is the average difference between true threshold and 
measured threshold.  Accuracy is a combination of precision and bias, and can be defined as the 
amount of variance between true threshold and measured threshold. A more detailed overview of 
these is given in chapter 3.   
A threshold measurement of any psychophysical stimulus can only be estimated, because it is based 
on a probability of stimulus perception. One technique that has been proposed as a reference 
standard for estimating threshold employs the idea of frequency of seeing (FOS) curves. A threshold 
is defined as the point on the FOS curve where the patient has 50% chance of seeing or missing the 
presentation. The FOS is estimated by sampling along the measurement scale, as the number of 
presentations increases, estimation of reference threshold theoretically becomes closer to true 
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threshold. The slope of the FOS curve can be interpreted as the amount of ‘doubt’ around threshold 
or confidence of the observer and therefore is directly related to precision.  
FOS curves are designed to describe the signal strength required by an observer to accomplish a 
given perceptual task. The method of constant stimuli (MOCS) refers to the data collection procedure 
where an equivalent number of presentations are displayed at each intensity level and the order of 
displaying intensity levels is randomised. These data are then used to construct the associated 
frequency of seeing curve (Wichmann and Hill, 2001a, Treutwein and Strasburger, 1999). Despite 
being time consuming (Watson and Fitzhugh, 1990), MOCS is a standard method in psychophysics 
(Treutwein, 1995) for collecting FOS data.   
In clinical perimetry, full VF assessment takes from about 4 to 7 minutes per eye for 24-2 SITA 
standard but can take up to 15 minutes per eye for a full threshold 30-2 test. FOS data collection 
requires anything between 40-120+ presentations per location depending on the level of precision 
required and can last as long as 70 minutes for adaptive FOS at 52 locations (estimate using method 
described by Turpin (Turpin et al., 2010)). This type of FOS data collection is clearly not feasible in the 
clinical setting. Yet it is accepted that the estimated threshold measures from FOS data collection are 
superior (have greater accuracy) to those estimated using clinical search methods (Turpin et al., 
2000, Treutwein, 1995). When threshold is calculated from constructed FOS curves it is generally 
referred to as “reference” threshold (Treutwein, 1995). 
With the ‘ideal’ visually healthy observer, systematic bias in measures should only be expected to 
vary with eccentricity or with age. It has been shown that threshold and slope of the FOS curve will 
vary between locations in healthy observers (Wall et al., 1996, Henson et al., 2000, Spry et al., 2001, 
Gilmore et al., 2005, Verdon-Roe et al., 2006a, Olsson et al., 1993, Westcott et al., 1999): central 
locations will have higher sensitivity presented by upward shifted FOS curves with steep slopes (Wall 
et al., 1996). As the degree the stimulus is subtended from the fixation point (or eccentricity) 
increases, the FOS curve experiences a downward shift (lowering of sensitivity) in threshold and a 
decrease in slope.  
The shape and position of the curve also vary between subjects, especially with respect to age or 
glaucomatous field damage (Henson et al., 2000). In damaged test locations the shift will be 
significantly greater than that expected with age alone (Henson et al., 2000, Chauhan et al., 1993, 
Westcott et al., 1999). Thus to be able to simulate observer responses throughout the field, FOS data 
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should ideally be collected at a range of eccentricities and subjects presenting with a whole spectrum 
of disease stages and a wide age range.  
By using FOS curves it is possible to estimate bias and precision of clinical threshold search methods 
in two ways. Firstly, by constructing FOS curves and deriving a “reference threshold” in a cohort of 
subjects, then comparing this to threshold measures yielded from clinical search methods collected 
directly from the same cohort. Secondly by computer simulation; in this case the clinical search 
method utilises simulated observer responses from the underlying probability function of the 
respective FOS curve. The latter can be used to generate a series of ‘patient’ trials with each clinical 
search method, returning a distribution of possible threshold values. Bias and precision can be 
estimated from these data. 
 
2.1 Observer response simulator 
 
The aim of the work described in this chapter is to implement a series of FOS experiments to be used 
in the development of an observer response simulator (ORS). This in turn will be used as a reference 
standard and test-bed for the perimetry strategies developed in subsequent chapters. Simply put, an 
ORS uses the FOS curve to assign a probability to how a given observer would respond to a given 
“event” or stimulus presentation. An ORS acts like a ‘robot’ observer.  Variants of this method were 
previously described (Swanson and Birch, 1992, Spenceley and Henson, 1996) to assess variability.  
Artes and colleagues used this approach (Artes et al., 2002a) to assess the comparative performance 
of clinical suprathreshold methodologies and Turpin and colleagues (Turpin et al., 2002a) to assess 
the comparative performance of the perimetric clinical threshold search methods. In the subsequent 
chapters this patient simulated approach of assessing clinical perimetric testing methods will be 
utilized to obtain relevant comparative threshold search data and comparative suprathreshold data. 
The ORS is the simple idea of selecting a random value from a uniform distribution between 0 and 1. 
Then a presentation response is simulated by ORS with the logical question, ‘is this random value 
below the FOS curve at this presentation intensity level?’ If the answer is yes, then a seen response is 
recorded. Otherwise an unseen response is recorded. For example, if the presentation is set at an 
intensity which equates to an 88% probability of being seen (e.g. Figure 2-2, 4 pixel movement), then 
the ORS will return a seen answer for on average 88/100 trials simulated. 
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If an ORS is working in conjunction with a clinical threshold search method, then the stimulus 
intensity is going to change as the search progresses. In the example illustrated in Figure 2-1 if a seen 
response was returned after a presentation was made at a 28dB, then there will be a upwards shift in 
sensitivity values (reduction in stimulus intensity) to 30dB for the subsequent presentation. At this 
point the ORS assigns a 17% probability to seen response. In this way the ORS will give appropriate 
answers at each stage.  
By assessing clinical search methods with responses generated from ORS, it is possible to compile a 
large set of trials. Each threshold testing strategy can be assessed in terms of accuracy, bias and 
precision without requiring the test subject to return multiple times. Repeating the experiment 
under variants of various parameters, including for example step size, starting point and termination 
criteria, then the usefulness of this methodology quickly becomes apparent. Results are then used to 
compare accuracy, bias and precision with respect to many variants of each clinical search method. 
In this manner the most efficient parameters for each clinical search method can be found. This 
methodology has been used previously by Turpin and colleagues for the development of testing 
strategies for the FDT (Turpin et al., 2002a, Turpin et al., 2003). 
 
2.2 Frequency of seeing: methods and modelling 
 
FOS data has been collected in glaucomatous patients using the MMDT stimulus type once previously 
(Westcott et al., 1998), but the test has had marked changes in screen, viewing distance, stimulus 
and format. Previously a monochromatic monitor (Phillips green monochrome P31 monitor, model 
number 750205, pixilation 300x920, frame rate 50 Hz) was used. In this new experiment a LCD screen 
was used (Lenovo: Thinkpad W500, resolution 1920x1200 pixels, frame refresh rate of 60Hz). 
Previously the viewing distance was 1.24 m (resulting in a minimum angle subtended of 1.1 minutes 
of arc (+15⁰,+09⁰)), currently the test is performed at 30cm (resulting in a minimum angle subtended 
of 1.8 minutes of arc (+15⁰,+09⁰)). On the original MMDT test instrument the stimulus size subtended 
2.2 minutes of arc, however with the multi-location MMDT format the stimuli are scaled with ages 
and eccentricity and so vary in size.  Stimuli in the previous study had a background luminance of 7 
cd/m2 and the stimulus luminance was 27 cd/m2. In this new experiment the background is on 
average 10 cd/m2 (varying from 6cd/m2 to 14cd/m2 due to angular luminance) with a stimulus of 
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105cd/m2 (varying between 100cd/m2 to 112 cd/m2). Michelson contrast is maintained at between 
80% and 90% for all locations.  
The primary aim of the study described in this chapter was to collect FOS type data on the new 
MMDT stimuli in a group of glaucomatous patients and visually healthy subjects across a range of 
eccentricities to develop an ORS for MMDT stimuli. This has not been done before. This ORS will be 
used to assess the performance of the clinical threshold search methods for the MMDT invented in 
subsequent chapters. 
MOCS method was also used for the data collection within this study; however, some minor 
modifications have been made. At each test location an effort was made to assess at least the 5% to 
95% segment of the FOS curve of the MMDT stimulus type (section 1.4.3) as it was shown to be a 
sampling scheme with less bias and better precision than alternative schemes (Wichmann and Hill, 
2001a).  
An important restriction with the MMDT stimulus type, left unexpanded until this point, is pixel pitch. 
With MMDT the stimulus intensity is displacement size, the possible range of which is restricted by 
the pixel pitch of the monitor used. (Up until this point a Dell monitor of pixel pitch 0.26mm was 
used). In DLS the contrast can be reduced until the background and foreground are inseparable in all 
observers.  Unlike DLS where intensity levels are log units, the intensity levels of the MMDT are 
minutes of arc subtended. With the MMDT, the minimum possible movement in some young 
observers remains apparent, which means the lower end of the FOS curve is lower than that which is 
measureable. An example of the pixel pitch dividing the FOS curve is shown in Figure 2-2 with the 
green vertical lines (2.4 minutes of arc apart) representing the minimum step size available.  
A further complication with working on a scale depending on pixel pitch and minutes of arc is the 
inconsistency in intensity levels across the field. Pixel pitch is consistent across the screen, however 
as eccentricity increases, the distance from the eye to the screen increases and as a consequence the 
angle subtended decreases. Therefore, while a displacement of 9 pixels subtends 25.7 MoA at a 
location positioned 3 degrees temporally and 3 degrees inferiorly (+3⁰,-3⁰), the same displacement of 
9 pixels will subtend 20.5MoA at a location 27 degrees nasally and 3 degrees superiorly (-27⁰,+3⁰). 
2 Improving measurements in perimetry for glaucoma 2011 
 
49 
 
 
Figure 2-2 The FOS curve for a subject with reference threshold of 5.5 minutes of arc with the MMDT stimulus. The green 
values represent increments of pixels (step size).  These steps in intensity values can be read by tracing down the 
respective green vertical line. The blue values are the y-value/ proportion seen at the given intensity level (intersection 
of blue curve and green vertical line to the left of this value).  
For this study a finer resolution screen was acquired than that used previously with the MMDT (this 
monitor was the highest resolution available at the time, which was also within the budget 
restraints). The pixel pitch (0.17mm) decreased the minimum angle subtended to 1.9MoA at location 
(+03⁰,-03⁰) and 1.6 at location (-27⁰, +03⁰). Increments on an example FOS curve with a screen of this 
resolution, at location (+09⁰, +09⁰) are shown in Figure 2-3.  This did not resolve the issue of uneven 
number of intensity levels across eccentricities. A displacement of 13 pixels produced a 24.7MoA 
presentation at (+03⁰, +03⁰) but a 20.2 MoA at location (-27⁰, +03⁰). However, it did make it possible 
to measure many more, but not all of the lower ends of the FOS curves in this study. It also increased 
the number of increments of possible intensity levels to approximately 16 which is ’equivalent’ to the 
number of intensity levels used in SAP DLS testing. Since the measurement scale of the MMDT and 
SAP have not currently been matched, it is unlikely that these intensity levels will agree. A translation 
between these scales may be established in the future to allow comparison of threshold estimates, 
however currently there is not enough available information to achieve this. 
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Figure 2-3 The FOS curve for a subject with reference threshold of 5.5 minutes of arc with the MMDT stimulus. The green 
values represent increments of pixels (step size).  These steps in intensity values are easily interpreted by tracing down 
the respective green vertical line. The blue values are the y-value/ proportion seen at the given intensity level 
(intersection of blue curve and green vertical line to the left of this value).  
Like DLS, with inter-observer differences (threshold and confidence), the number of intensity levels 
required to straddle threshold and cover the 5% to 95% part of the FOS curve will not be uniform 
between observers. Also FOS curves change shape with eccentricity, therefore the number of 
intensity levels will not be uniform between locations within observers either.  However, at each 
intensity level possible between the 5% and 95% of the FOS curve, 15 presentations were made. 
An estimate of threshold from a clinical threshold search method was used to initiate the FOS MOCS 
data collection. The initial range of intensity levels (size of displacements presented) were chosen to 
straddle this estimate of threshold. The width of the range of intensity levels was adjusted according 
to the position of threshold on the whole range of possible stimulus intensities. Since thresholds of 
higher sensitivities were expected to have steeper slopes, it was estimated that lower MoA 
thresholds would require a narrow range of intensities to span the 5% to 95% part of the FOS curve. 
Similarly, it was estimated that higher MoA thresholds would require a wider range of intensities to 
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span the 5% to 95% part of the FOS curve, as a curve centred on higher MoA threshold should have a 
shallower slope.     
The number of locations, selected for interleaved (within the same session) testing was 12, seven 
test locations and five dummy locations (dummy locations are additional to test locations and were 
selected to help maintain fixation, approximation 15% of all presentation were made at dummy 
locations). This number of test locations was selected to reduce the effect that covert spatial 
attention could have on threshold estimates. Covert spatial attention is the ability to  grant priority 
(given a cue) in processing of visual information at a particular location away from fixation, without 
eye movements (Posner, 1980).  Many studies have shown that covert attention influences 
thresholds of  basic early visual processing e.g. contrast sensitivity tasks (Carrasco et al., 2000), 
spatial sensitivity tasks (Yeshurun and Carrasco, 1999) and hyperacuity tasks (Shiu and Pashler, 
1995). If a presentation location is known, this can be considered a cue, which may initiate covert 
spatial attention.  
 
It has been shown that the human brain is typically able to learn and retain seven (±two) pieces of 
information in working memory (Miller, 1956). By loading the working memory to the limit we inhibit 
the learning effect. Any new piece of information causes that previous piece of information to be 
discarded. Therefore selection of a large enough number of stimulus test locations will inhibit the 
ability of the observer to learn the selected stimulus locations. If the observer is unaware of the 
locations of test stimuli, it will be impossible to direct covert attention to the appropriate area of the 
VF. In this way the elevation in threshold associated with attention can be reduced.  
 
In the clinical scenario the number of perimetric test locations is far greater than in the typical FOS 
data collection study. Hence the effect of attention is likely to be negligible in comparison. Therefore, 
minimising the effect of attention is important in FOS data collection because it is the foundation for 
the ORS and we wish the ORS to mimic clinical perimetry. In this study, stimuli were presented at 
twelve locations in random order; seven test locations with five additional dummy stimuli Figure 2-4. 
This was thought to be adequate to inhibit the average observers’ ability to learn the position of test 
locations (Miller, 1956). Thus, the effect covert attention was theoretically reduced to levels more 
typical to those found in clinical perimetry. 
 
2 Improving measurements in perimetry for glaucoma 2011 
 
52 
 
FOS data collection at seven locations with 15 presentations at between five and ten intensities 
levels straddling the 5% to 95% probability of seeing part of the FOS curve required more than a 1000 
presentations as a minimum. At over two seconds per presentation this equates into more than 40 
minutes of uninterrupted testing. Thus collection of this FOS data was divided into shorter sessions 
to reduce fatigue. DLS and MDT FOS curves vary with eccentricity and direction in the VF (Wall et al., 
1996, Westcott et al., 1999). Therefore, an attempt was made to sample at enough locations in the 
VF to give good coverage at an acceptable level of precision (15 presentations per stimulus intensity 
– there is a balance to be maintained between accuracy and precision) while maintaining suitable 
test duration. If there are significantly more presentations appearing in one direction away from 
fixation, then learning effects may draw gaze in that direction. The position of the test locations 
chosen is shown in Figure 2-4. In this study presentations were slightly biased to occur nasally rather 
than the temporally of fixation (due to the uneven number of test locations employed). Left eyes 
tested used a vertically flipped set of stimulus locations to those shown in Figure 2-4. 
The rationale behind the number of test locations was based on acceptable test duration, adequate 
coverage of the FOS curve (5%-95% of the curve), sampling of a range of eccentricities, and 
attempting to reduce possible attention effects while aiming to maintain fixation. 
 
 
Figure 2-4 Frequency of seeing (FOS) data was collected at the indicated test locations (red markers). Dummy stimuli 
were located at blue markers and the fixation target was location at the central point. Remaining 32 line stimuli were 
displayed at the indicated locations, but remained stationary for the duration of the data collection. 
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Stimulus selection and queuing was all authored in Matlab based on previously obtained MMDT 
threshold results. The facility to provide location and stimulus intensity information were provided 
separately within the MMDT software and was coded by the software developers for the MMDT 
(Whitespace, Upper St Martins Lane, Covent Garden, London, UK). Analysis of collected data and 
subsequent updating of stimulus intensity and location information was authored again in Matlab 
and ‘passed back’ into the MMDT software. 
 
2.2.1 Fitting models (curves) to FOS data 
 
A bootstrapping method on the assumed underlying function as described by Wichmann and Hill was 
used (Wichmann and Hill, 2001a). The Psignifit module offers a choice of four distributions, namely 
the Gaussian, Lognormal, Gumbel or Weibull.  In this experiment the Psignifit function/tool was 
reduced to the appropriate to Y-N paradigm from the default two alternative forced choice 
paradigms.  This code was implemented in Matlab R2006a version 7.2.0.232 (The MathWorks Inc) to 
fit the FOS data collected within this study.  
The Psignifit Matlab module uses Monte Carlo simulations to derive confidence limits. In short, this is 
done by selecting subsets of each FOS data set, then fitting the curve multiple times. For this 
experiment the default 1999 Monte Carlo simulations were performed. From these simulations 
deviance distributions were derived; these are typically used to indicate if the incorrect choice of 
underlying function has been made. This is indicated by whether or not the deviance value 
associated with the fit is within the 95% confidence interval (CI) of Monte Carlo simulations (Figure 
2-5 B) and whether or not the correlation coefficient of the fit is within the 95% CI (Figure 2-5 C) of all 
Monte Carlo generated correlation coefficients from residuals of the raw data to the fit (Figure 2-5 
B). Furthermore there are facilities within this analysis package to examine learning effects. However 
these were not utilised here. The bootstrap (Efron, 1979, Efron, 1981, Efron and Gong, 1983, Efron 
and Tibshirani, 1991) was used to estimate the variability of parameters, thresholds, and slopes of 
psychometric functions, following the techniques described by Treutwein (1995) and Treutwein and 
Strasburger (1999) (Treutwein and Strasburger, 1999, Treutwein, 1995). In psychophysical testing, 
where CI are known to converge with data collection, these methods show increased accuracy over 
percentile-based methods and are less effected by sampling schemes and number of presentations. 
The confidence limits reported here are of this type.  
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Figure 2-5 Details of the Psignifit module analysis. Plot A shows the derived lognormal fit to MMDT data at a single 
location (+15⁰,+15⁰) for a visually healthy subject.  Plot B is the Monte Carlo generated deviance values of the model; 
here the fit is indicated with a blue line, and the 95% Confidence interval (CI) with a red line. Plot C shows the residuals 
of the fit to the raw data, plot D gives the Monte Carlo generated deviance values of the residuals of the data (green line) 
against the residuals fit is indicated with the green line and the 95% CI with red lines.  
Examples of MMDT FOS data collected during this experiment are shown above in Figure 2-5, and 
below in Figure 2-6 and Figure 2-8 to Figure 2-10. 
The fits described in this chapter were derived from the Psignifit module (Wichmann and Hill, 2001a, 
Wichmann and Hill, 2001b). In the subsequent plots the inter-quartile range represents the region in 
MoA units where 75% of all Monte Carlo simulated curves lie (the extent of the box). These are 
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shown at the 10% seen point, 50% seen point and 90% seen point. The 50% seen point is the 
‘reference’ threshold. 
 
Figure 2-6 An example fit using the Psignifit module on MMDT data (raw data points are represented with green dots). 
Data was collected at location (+03⁰, +03⁰) in a healthy observer. The fit returns a reference threshold of 5.8 minutes of 
arc (MoA), with a narrow 95% confidence interval of [5.0MoA, 6.9 MoA]. The 95% confidence limits for the 10% and 90% 
seen points of the curve are also denoted with boxplots. 
 
2.3 Methods 
 
In order to provide a range of  FOS curves  from subjects with different ages and/or extent of  
glaucomatous damage, fourteen mild to moderate glaucoma patients at early to moderate stage of 
the disease and fourteen age matched healthy observers were recruited from Moorfields Eye 
Hospital. The age range of the patients was 36 to 79 years with an average age of 65 years. Average 
MD and PSD was -3.82dB [range -8.24dB to 0.57dB] and 7.19 [range 2.78dB to 12.51dB] respectively. 
The age range of the healthy observers was 37 to 79 years with an average age of 65 years. Average 
MD and PSD for the visually healthy observers was -0.36dB [range -1.82dB to 1.39dB] and 1.41dB 
[range 1.05dB to 1.94dB] respectively. SAP greyscale plots and individual MD and PSD values are 
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given for all glaucomatous subjects in 
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Figure 2-7. Inclusion and exclusion criteria for the healthy observers and the glaucomatous patients 
recruited for this study were as follows. 
 
2.3.1 Standard testing procedures 
 
Inclusion criteria of visually healthy subjects included a “within normal limits” reading using MRA 
analysis from Heidelberg Retina Tomograph (HRT 3), IOP less than 22mmHg, and a full visual field 
with SAP SITA perimetry. Refractive error was required to be less than 6.00DS with astigmatism less 
than 1.25D, with a visual acuity of 6/9 or better in the test eye and absence of significant corneal or 
media opacities. Test subjects also were required to have no family history of glaucoma in a first 
degree relative (as FOS testing is more sensitive than SAP and may detect small changes which would 
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be undetectable with SAP) or ocular/systemic disease which is likely to affect visual performance (e.g. 
diabetes, thyroid disease). No history of previous ocular surgery (apart from uncomplicated cataract). 
 
Inclusion criteria of glaucomatous patients included an “outside normal limits” reading using MRA 
analysis from Heidelberg Retina Tomograph (HRT 3), IOP greater than 21mmHg before treatment, a 
full visual field with SAP SITA perimetry, and a gonioscopically open angle. Refractive error was 
required to be less than 6.00DS with astigmatism less than 1.25D, with a visual acuity of 6/12 or 
better in the test eye and absence of significant corneal or media opacities. Exclusion criteria were 
secondary causes of elevated IOP, other than pseudoexfoliation and pigment dispersion. No history of 
diabetic retinopathy or previous retinal vein occlusion or history of ocular surgery, previous stroke, 
ocular trauma or amblyopia. No history of previous ocular surgery (apart from uncomplicated 
cataract). 
 
All participant testing for this thesis was done at Moorfields Eye Hospital by CB and by Reza Moosavi 
[RM] MD. The study was approved by an ethics committee and conformed to the Declaration of 
Helsinki with all participants giving their informed written consent. All data was anonymised before 
being transferred to a secure computer database at the university. Data was collected at all seven 
test locations in the visually healthy subjects. In glaucomatous patients, data was collected at 
corresponding test locations with early to moderate visual field damage, but test locations which fell 
within deep focal defects were excluded from data collection. Presentations were made at a 
minimum of 9 test locations in all subjects. The number of sessions varied between subjects 
(between six and twelve sessions) due to the width of the range of intensities tested and number of 
locations where data collection was possible. There was an extended break after every three 
sessions.  No test session was greater than 7 minutes long. Observers could take a break at any stage. 
During session breaks, the probability of seeing at the chosen intensity levels was calculated. This 
information was then used to review the interim FOS curve. If it was determined that the 5% to the 
95% range of the FOS curve was not within the range of test intensities levels, then the range was 
expanded to accommodate These (with new bins added).  
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Figure 2-7 Greyscale plots from SAP SITA 24-2 threshold measures taken on 14 glaucomatous patients, including MD and 
PSD values (lower right corner). 
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Figure 2-8 Three FOS curves constructed from data collected at a single test location for three different test subjects 
(rows) at the location (+03
 o
,+03
 o
 ) an eccentricity of 4.2 degrees from fixation target. Row 1 is data collected  from a 
healthy subject, row 2 and 3 contain data collected from mild and moderate glaucomatous patients respectively. The 
stimulus intensity (different ranges for each curve) is given on the x-axis (minutes of arc), the probability of seeing the 
stimulus is given on the y-axis (probability). To the right hand side the associated SAP greyscale plot is given with the test 
location denoted with a red dot. The red vertical dashed line shows the healthy observers reference MMDT threshold at 
this location for comparison with reference threshold of mild and moderate patient examples. 
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Figure 2-9 Three FOS curves constructed from data collected at a single test location for three different test subjects 
(rows) at the location (-09
 o
,-09
 o
) an eccentricity of 12.1 degrees from fixation target. Row 1 is data collected from a 
healthy subject, row 2 and 3 contain data collected from mild and moderate glaucomatous patients respectively. The 
stimulus intensity (different ranges for each curve) is given on the x-axis (minutes of arc), the probability of seeing the 
stimulus is given on the y-axis (probability). To the right hand side the associated SAP greyscale plot is given with the test 
location denoted with a red dot. The red vertical dashed line shows the healthy observers reference MMDT threshold at 
this location for comparison with reference threshold of mild and moderate patient examples. 
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Figure 2-10 Three FOS curves constructed from data collected at a single test location for three different test subjects 
(rows) at the location (-27
o
, +03
 o
) an eccentricity of 27.1 degrees from fixation target. Row 1 is data collected from a 
healthy subject, row 2 and 3 contain data collected from mild and moderate glaucomatous patients respectively. The 
stimulus intensity (different ranges for each curve) is given on the x-axis (minutes of arc), the probability of seeing the 
stimulus is given on the y-axis (probability). To the right hand side the associated SAP greyscale plot is given with the test 
location denoted with a red dot. The red vertical dashed line shows the healthy observers reference MMDT threshold at 
this location for comparison with reference threshold of mild and moderate patient examples. 
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2.4 Results 
 
Satisfactory FOS data was collected at all 98 locations in healthy observers and at 75 of 98 locations 
in glaucomatous patients. Missing data coincided with focal defects. In Figures 2-8 to 2-10 the effect 
on threshold and slope of both the eccentricity and the extent of the disease is recognizable.    
There was a difference in average threshold recorded with glaucomatous patients (n=75) compared 
to visually healthy subjects (n=98) but the difference was not significant (p=0.07, two sample equal 
variance t-test).  The variation between the groups with respect to slope did not reach significance 
either (p=0.13, F-test). Despite the small sample size the disparity in measured threshold between 
glaucomatous patient and visually healthy subject was significantly different at 3 of the 7 locations, 
and also for slope at 3 of the 7 locations. Details for each location are given in Table 2-1. 
 
Location (-27o,+03 o) (+15 o,+15 o) (+15 o,-9 o) (-15 o,+03 o) (-09 o,-09 o) (-09 o,+03 o) (+03 o,+03 o) 
Average threshold 10.37 8.42 6.05 4.82 5.61 4.49 4.06 
STD 4.22 3.09 2.15 2.46 1.96 1.78 1.76 
Average threshold 19.68 9.77 7.34 6.77 9.13 5.19 4.04 
STD 8.74 3.97 3.78 2.63 7.00 1.74 2.05 
p-value 0.00 0.17 0.14 0.04 0.04 0.17 0.49 
Average slope 0.13 0.17 0.24 0.70 0.45 0.75 0.47 
STD 0.05 0.07 0.20 0.75 0.60 0.86 0.32 
Average slope 0.07 0.13 0.27 0.23 0.19 0.26 0.66 
STD 0.03 0.09 0.20 0.14 0.13 0.14 0.75 
p-value 0.00 0.15 0.35 0.04 0.08 0.04 0.20 
Table 2-1 A summary of average threshold and slope parameters across glaucoma patient (red) and visually healthy 
(green) groups, including standard deviation (STD) of threshold and slope estimates and the p-value derived using a two 
sample T-test (threshold) between the groups is also given. Significant p-values are highlighted in yellow. 
The effect of eccentricity is illustrated in Figure 2-11. In summary, thresholds measured in healthy 
subjects are clearly associated with eccentricity. The average slope recorded was 0.28MoA/degree, 
(ranging from 0.24 to 0.36 MoA/degree between subjects) (R2 value of 0.35). Thresholds measured in 
glaucomatous patients had a stronger association with eccentricity with an average slope of 0.54 
(ranging from 0.37 to 0.71 MoA/degree between subjects) and R2 value of 0.36. 
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Figure 2-11 Threshold with respect to eccentricity for glaucomatous patients (red circles) and visually healthy subjects 
(blue triangles). 
In visually healthy subjects the change in slope recorded with respect to eccentricity was                      
-0.023MoA/degree2, (ranging from -0.00MoA/degree2 to -0.6MoA/degree2 between subjects) and R2 
value of 0.08). Change in slope measured in glaucomatous patients had a weaker association with 
eccentricity with an average rate of change of -0.02 MoA/degree2 (ranging from -0.00 MoA/degree2 
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to -0.05 MoA/degree2 between subjects) and R2 value of 0.17 (
 
 
Figure 2-12). 
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Figure 2-12  Slope of each FOS collected with respect to eccentricity for glaucomatous patients (red squares) and visually 
healthy subjects (blue triangles). 
There is a curvilinear relationship between slope and threshold, where reduction in retinal sensitivity 
(increase in MoA threshold) will coincide with a reduction in slope (increase in variability) (Figure 
2-13). This relationship is not significantly different in glaucomatous eyes than visually healthy eyes. 
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The fitted model achieves a R2 value of 0.53 for glaucomatous patients and 0.74 for visually healthy 
subjects. 
 
Figure 2-13 The relationship between slope of the sensitivity profile as against reference threshold. The red 
(glaucomatous) and blue (visually healthy) solid lines represents a fitted curve to the respective dataset (of the form 
2.69*x^(-0.54)), the dotted lines on either side of the curve represent the prediction bounds.  
Often interquartile range is given as a surrogate measure of slope, as slope is inversely proportional 
to interquartile range. Therefore the relationship between inverse slope and reference threshold is 
given in Figure 2-14. The linear relationship is nearly exactly the same between visually healthy 
subjects and glaucomatous patients; the slope was 0.84 (RMSE=2.76) in visually healthy subjects 
against a slope of 0.89 (RMSE=3.06) in glaucomatous patients. This model explains 69% of the 
variability in the data (R2 =0.53 in visually healthy subjects, and R2 =0.75 in glaucomatous patients). 
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Figure 2-14 The relationship between inverse slope of the sensitivity profile as against reference threshold. The red 
(glaucomatous) and blue (visually healthy) solid lines represent a fitted line to the respective dataset, the dotted lines on 
either side of the line represent the prediction bounds. Equation of the red fitted line is 0.84x+0.76. For completeness the 
relationship between interquartile range and threshold is also given.  
Interquartile range, defined as the width of the range from the 25% seen point of the FOS curve to 
the 75% seen point of the FOS curve, is proportional to inverse slope. However some papers report 
interquartile range instead of slope. Figure 2-15 shows the relationship between interquartile range 
and threshold in study eyes. In visually healthy eyes the average interquartile range is 2.96 MoA with 
a standard deviation of 2.3 MoA, in glaucomatous eyes the change in slope is reflected in the wider 
interquartile range of,on average,4.76 MoA (standard deviation = 4.5 MoA). 
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Figure 2-15 The relationship between interquartile range (width in minutes of arc from the 25% seen to 75% seen points 
on the FOS curve) and threshold (minutes of arc) . 
 
2.5 Discussion  
 
The aim of the work described in this chapter is to implement a series of FOS experiments to be used 
in the development of an observer response simulator (ORS). This in turn will be used as a reference 
standard and test-bed for the perimetry strategies developed in subsequent chapters.  This study is 
the first FOS analysis of the effect of eccentricity on the MMDT MoA thresholds in glaucomatous 
patients. The difference between glaucomatous patients and visually healthy subjects in threshold 
agrees well with the literature on other perimetric stimuli types. The change in the strength of the 
relationship with eccentricity i.e. stronger peripherally than centrally ((-27⁰, +03⁰): p<0.01 vs 
(+03⁰,+03⁰): p=0.48) was unsurprising. The difference in the strength of this relationship between 
glaucomatous patients and visually healthy observers is probably due to the selected patients and 
locations.  
Since there is a three way relationship between threshold, slope and eccentricity, multivariate 
analysis should be undertaken with a larger dataset. Ideally this should be undertaken for a more 
varied degree of defect and with a greater number of locations. This is the focus of one future project 
stemming from this thesis.  
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 Despite the sizeable differences between the setup used by Westcott and colleagues (1998) and 
those implemented in this study, the results of this experiment agree well with those reported 
previously. Examining the location at 15 degrees eccentricity within this experiment with those 
collected previously (albeit in a different quadrant but with the same eccentricity), we find good 
agreement between the average thresholds (visually healthy subjects 4.8±2.5MoA vs. 5.9±1.7MoA 
glaucomatous patients 6.8 ± 2.6MoA vs. 8.7 ± 3.4MoA). Slopes are not reported by Westcott and 
colleagues but rather the inter-quartile ranges (3.39 ± 1.4 in visually healthy subjects vs. 5.39 ±2.3 in 
glaucomatous patients), again showing good agreement with the current study. 
The difference in slope between the patients and visually healthy subjects is not surprising and 
reflects conclusions from several studies that previously described the reduction in slope with 
decreased retinal sensitivity in DLS (Henson et al., 2000, Chauhan et al., 1993). The high correlation 
between slope and threshold shown here suggests that this is true also with the MMDT stimulus 
type. 
The thresholds and slopes vary considerably between subjects which is representative of the true 
population. Since the ORS will estimate for each subject (set of FOS curves) independently and since 
ideally we want to examine a wide range of subjects, this was not perceived as a disadvantage. It was 
concluded that FOS curves constructed would serve as an adequate estimate of observer responses 
and would provide reasonable estimates of true threshold for simulation work as described by others 
(Turpin et al., 2003). 
Using the Psignifit module provides an independent methodology for eliminating the underlying 
models which are less suitable for fitting the collected data. For example, the Gaussian was less 
suitable than the Weibull. Furthermore Psignifit  offers more reliable information on width of the 
confidence intervals around threshold with the addition of the ‘worst’ CI based on sensitivity analysis 
(Wichmann and Hill, 2001b). Finally Psignifit offers estimates on how well the turning points of the 
FOS curve were assessed. There are more conventional methods of fitting the psychometric function. 
One of these, Probit analysis, relies on an underlying Gaussian distribution in the model for the FOS 
curve. However the estimate of error (the standard deviation) is calculated directly from empirical 
data, which again would be fine if the data sets were large (and sampling scheme was correct). In 
most psychophysical settings this is not the case, and substantial errors have been reported in Probit 
estimates of variability (Foster & Bischof, 1987, 1991; McKee, Klein, & Teller, 1985).    
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Adaptive frequency of seeing data collection methodologies may have significant advantages to the 
standard MOCS approach, manifesting mostly in the reduction in required number of presentations 
and subsequent reduction in test duration. The adaptive probit estimation (APE) approach as 
described by Watt and Andrews (Watt and Andrews, 1981) or the Bayesian adaptive procedure of 
Kontsevich and Tyler (Kontsevich and Tyler 1999) ,for example, outlines two such methods. In each 
an adaptive approach to the choice of stimulus intensity presented is used, where presentations are 
focused at the level of threshold. Intermediate assessment of threshold and slope is derived during 
data acquisition and when variability falls within an acceptable level then testing is terminated. 
However, with the adaptive probit approach it has been shown that there is associated bias and the 
Probit fit used to calculate the variability may not be the correct model. Kaernbach and colleagues 
also suggested an adaptive approach which focused presentations on the turning points  of the 
curves achieving quicker more reliable estimates than that of the APE methodology (Kaernbach, 
2001). A more recent study by Turpin et al. (Turpin, McKendrick,  2010) has examined the Bayesian 
approach to FOS data collection but further examination of bias is required. The study described in 
this chapter did not aim to look at a ‘quick’ FOS method, but this is the subject of future work. But a 
comparison with such a method against sampling using MOCS would be useful, because there is no 
doubt that the latter is onerous even for people who are relatively experienced in psychophysics. The 
main objective of this study was to gather FOS responses on the multi-locational MMDT to ‘fuel’ the 
ORS, which in turn was used to develop the test strategies at the centre of this thesis. The idea was 
to follow that approach used by others to test performance of test strategies notably Turpin (Turpin 
et al., 2003) and accordingly to use this information on performance to iteratively test and improve 
new test strategies. There are limitations to every ORS even when based on FOS data. Some of the 
perceived limitations of the ORS originate from the assumption that the FOS curves do not change 
with fatigue and learning effects are negligible. In addition, the FOS data was collected at only seven 
locations and thus is not ideal for generation of a full field patient simulator. Still, the data gathered 
here is useful since it provides, at least, a direct method of isolating the threshold algorithm most 
likely to have highest efficiency for testing.  
3 Developing and evaluating clinically useful threshold search 
methods 
 
The work described in this chapter, outlines the performance of clinical threshold search method 
which was implemented on the MMDT.  The results here have been presented in part as a poster 
presentation at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, 
Florida, USA in May 2008 and, again in part, as a read paper at the 18th International Symposium of 
the Imaging and Perimetry Society Meeting in Nara, Japan in May 2008 (See ‘List of supporting 
publications’). 
Using real patients to examine testing strategies is time consuming and difficult. Moreover, it is 
impossible to know the true threshold because it is ever changing with respect to attention 
(Carrasco, 2006), alertness (Henson and Emuh, 2010), eye movement and other factors. Testing real 
observers and patients will be the ultimate aim of a clinical threshold search but should be reserved 
for final stage assessment. A good method to objectively examine the accuracy and bias of any 
threshold search method is with computer simulation. The sole limitation of this methodology is 
accepted (Treutwein, 1995), namely: Does the chosen observer model represent real observers 
behaviour? The previous chapter described how data was carefully collected to build an ORS used in 
some of the studies described in the following chapters. 
By using FOS curves derived in chapter 2 it is possible to measure error of clinical threshold search 
methods in two ways. One approach allows FOS curves to provide a “reference threshold” in a cohort 
of subjects, this reference standard can then be compared to threshold estimates yielded using 
clinical search methods collected directly from the same cohort. This will be referred to as the 
patient data approach. Alternatively the ORS approach utilises simulated observer responses directly 
from the underlying probability function of the respective FOS curve. The latter can be used to 
generate a series of patient trials with each clinical search method, returning a distribution of 
possible threshold values. Estimates of error and efficiency can be derived from this data. 
The methods and formulae used to calculate error and efficiency are provided below. Next, an 
overview of the possible testing strategies and details of the necessary adaptations to the MMDT are 
given. In the second half of this chapter reports the results of both methods, firstly the patient data 
approach followed by the ORS approach. 
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3.1 Estimating measurement error and efficiency 
 
To detect differences in the performance between clinical test methods and threshold search 
methods in particular, certain summary measures are helpful. In this chapter the reference threshold 
was derived from the constructed FOS curves outlined in chapter 2. Bias is the average difference 
between measured threshold and reference threshold. Equation 3-1 was used to calculate bias, 
denoted B. The total number of trials with one variant of a clinical search method completed 
(reaching termination) with ORS is denoted by n (in the patient data approach n is equal to 1).          
denotes reference threshold as estimated from the constructed FOS curve at location i.    is the 
threshold as estimated from a clinical threshold search method.  
Equation 3-1 Bias at one location 
  
∑          
 
 
 
 
Precision is a summary measure of the amount of variance in the estimate of threshold which is 
unaffected by bias, denoted by P in Equation 3-2. For example if a method returns an estimate of 
threshold which is consistently within a small range of values, this will have high precision even if 
these values are not close to reference threshold.  
Equation 3-2 Precision at one location 
  √
   
∑      ̅  
 
 
 
Accuracy is the average variance between estimated threshold and reference threshold. This 
combines bias and precision. 
Equation 3-3 Accuracy  
  √
   
∑ (          )
  
 
 
Test duration can be measured in two ways the test duration in seconds or the number of 
presentations required. In this chapter, in the patient data approach, average time per location as 
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recorded within the software, for the ORS approach the number of presentations will be used, in the 
latter case it is denoted TD and di denotes the total number of presentations during the i
th simulated 
threshold search. 
 
Equation 3-4 Test Duration 
   
∑   
 
 
 
 
 
Efficiency is a parameter which combines time and accuracy, and in short summaries the 
performance. Time and accuracy are weighted differently according to the requirements of the test; 
there is debate on ideal efficiency, however in this case the simplest option was chosen. 
 
Equation 3-5 Efficiency 
       
 
3.2 Review of established threshold search methods 
 
Method of constant stimuli (MOCS) can be thought of as a reference technique to obtain sensitivity 
data (Fechner, 1860). It is reliable, providing data for threshold estimation; however for frequent use 
it is impractical due to the long test duration. 
The method of limits (Fechner, 1860) uses an up-down method to reach threshold estimation. In 
predefined sized steps, the intensity is increased/decreased from one end of the range to the other 
and then reversed and decreased/increased back through the range of intensities.  
All threshold search methods including those employed in clinical use are really variants of these 
basic approaches. Three questions determine the signatory attributes of a threshold search method: 
what intensity level to set the next presentation; when to finish testing; and how to estimate 
threshold from the collected data. Threshold search methods work under the assumption that the 
underlying psychometric function is monotonic and continuous. Threshold, slope, FP and FN are 
allowed to vary independently within predefined limits e.g. FP + FN < 1. 
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3.2.1 Non parametric methods  
 
A modification of the method of limits is the truncated method of limits, sometimes referred to as an 
up-down staircase. Here step direction is altered with a change in response (direction - when steps 
from incremented to decrementing or vice versa, this is known as a reversal). Therefore the 
presentations are centred about threshold. This method for threshold search (without the estimation 
of slope), had significant time saving properties over the MOCS or method of limits, by reducing the 
number of necessary presentations by 30-40% (Dixon and Mood, 1948). 
Staircases, truncated staircases, transformed up-down methods (Levitt, 1971), non-parametric up-
down (Derman, 1957), weighted up-down (Kaernbach, 1991), MOBS (Tyrrell and Owens, 1988), 
stochastic approximation (Robbins and Monro, 1951) and PEST (Taylor and Creelman, 1967) (PEST 
uses heuristic rules) are all variants of the methods of limits. In each, the number of reversals, step 
size and/or how the threshold is estimated from the collected data varies. Every psychometric 
threshold search method was developed to answer a particular need in psychometric testing; 
Treutwein offers an elegant overview of each (Treutwein, 1995). 
The advantages of non-parametric threshold search methods are numerous: they are, by design, 
unbiased by priors, can be designed to terminate quicker for patients than parametric threshold 
search methods. The disadvantages being that if they have been designed to terminate quicker for 
patients, then visually healthy subjects will sometimes take longer to test, due to the proportion of 
presentations directed toward the abnormal end of the scale. They are reportedly less precise in 
threshold estimation throughout the whole range in comparison to parametric methods. 
Staircases have formed the backbone of clinical threshold search methods since the 1970’s (Heijl, 
1977, Heijl and Drance, 1980, Heijl, 1985a). For example, Full Threshold (FT) on the HFA is a 
truncated staircase of the 4-2 variety (Heijl et al., 1987). In this case, the first presentation will occur 
on, or near to the average value from normative data (or estimate from seed locations). Then, the 
search method will take a step (ascending or descending; based on the response given) of four 
decibels (dB), steps of size four dB will continue until the reversal occurs. On reversal, step size 
changes and drops to two dB, on the next reversal the threshold search terminates.  
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3.2.2 Parametric threshold search methods 
 
In SAP, the underlying psychometric function is monotonically decreasing and continuous (in the case 
of the MMDT it is monotonically increasing), in parametric methods some prior knowledge of the 
general form of the psychometric function is required. This means that some template such as a 
cumulative Gaussian, is assumed to fit the data, then one or two variables forming this model are 
allowed to vary and are estimated from the collected data. Parametric methods were developed to 
help circumvent heuristic rules used to set intermediate intensity levels. Theoretically the dynamic 
terminating criteria based on “goodness of fit” allowed with parametric methods (rather than 
presentation number or number of reversals) should isolate those cases where further data 
collection would be beneficial (Treutwein, 1997). 
These methods use a range of templates, or mathematical functions, to set a general form of the 
psychometric function (e.g. Gaussian, Beta, Gamma, logistic or more typically Weibull). Data is 
collected to inform the best guess estimate of the prior.  Parametric methods are of two main types: 
maximum likelihood (Pentland, 1980, Lieberman and Pentland, 1982) or Bayesian methods (Watson 
and Pelli, 1979, Watson and Pelli, 1983, King-Smith et al., 1994). In maximum likelihood threshold 
search methods, the search begins with the first presentation (start point) at the best estimate of 
threshold (e.g. population based mean). An estimate of the likelihood of data collected in a given trial 
belonging to a set of population values is maintained. For example, given the set of possible 
threshold values, the likelihood of each threshold is calculated and the most plausible threshold is 
selected. In Bayesian methodology the best guess estimate takes the form of a prior distribution 
rather than estimate for the start point. Bayesian methods advance by multiplying the prior by the 
likelihood function resulting in the updated likelihood function. Based on the prior selected, and 
responses recorded, the step size/stimulus intensities will vary with both methodologies. The 
terminating criteria can be based on number of reversals but can be based on goodness of fit 
(Treutwein, 1997). 
Parametric methods have recently been accepted as alternative quicker clinical threshold search 
methods compared to the standard staircases. For example, the so called zippy estimation with 
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sequential testing (ZEST) on the FDT Matrix is a Bayesian method (Anderson et al., 2005). The prior 
was uniform and thus could not affect the threshold measure. The procedure was terminated after 
four presentations as there was no perceived gain in precision (Anderson, 2003b).   
 
3.2.3  Including spatial information in clinical threshold search methods 
 
The visual field does not consist of a discrete number of locations, but rather of a vast number of 
possible test locations with relationship between test locations defined by the underlying physiology 
of the retinal nerve fibre layer. For example, to extrapolate the sensitivity at locations between test 
locations, an interpolation of sensitivity estimates is performed after the test terminates to form the 
familiar greyscale plot. The loss of retinal ganglion cells in glaucoma and associated sensitivity loss is 
observed to follow the nerve fibre pattern (Hubel and Wiesel, 1960, Caprioli and Miller, 1989, 
Morgan et al., 1998, Weber and Ulrich, 1990). There have been several studies examining the 
structure function relationship in glaucomatous patients (Hood et al., 2007, Garway-Heath et al., 
2002, Harwerth et al., 2004). Whilst the relationship is not as strong as historically expected 
(probably due to measurement noise and poor understanding of the measures as outlined in section 
1.4.3), there is a significant association (Bowd et al., 2006). Therefore, if a low sensitivity is recorded 
at a given location, Tp, it follows that in those locations shown to be associated with Tp, there is an 
increased likelihood these locations will have reduced sensitivity (Heijl et al., 1989, Heijl and Asman, 
1989, Crabb et al., 1997, Gardiner et al., 2004, Spry et al., 2002, Crabb et al., 1995, Chauhan et al., 
1989). 
Sensibly, some clinical threshold search methods have been designed to use this ‘spatial’ information 
to help improve performance. To achieve this, response information from surrounding locations is 
allowed to influence intermediate threshold estimates of Tp. A seed location, for example, as 
implemented in the full threshold methodology of the HFA, is one such example. In this scenario 
there are four seed locations placed at (±09⁰, ±09⁰) and the test procedure begins with examination 
of them. When threshold estimates of these locations are reached, the general height of the HoV is 
set. Depending on whether this estimate is an under or over estimate of the height of HoV, every 
location will require more presentations to cross the point of subjective equivalence, which due to 
the probabilistic nature of the test it is less likely to achieve. Therefore, the bias introduced by the 
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seed locations will remain in the estimate of every threshold.  Considering a patient with high central 
sensitivity and low peripheral sensitivity the increased variability introduced becomes apparent. 
Tendency oriented perimetry (TOP), as implemented in the Octopus perimeter, presents a stimulus 
at each location once, but threshold estimation is adjusted at each location four times. Estimates of 
threshold are updated continuously, using linear interpolation of the neighbours tested, the test 
advances by using a bracketing approach. In this case the bias is clearly apparent as the defects 
recorded have been reported to be shallower, have softer edges and are smaller (Morales et al., 
2000). Another study indicated that the defect may be weighted out completely (Anderson, 2003a). 
SITA offers an attractive alternative to FT. The reduction in test duration is derived from the partial 
Bayesian approach taken, requiring fewer presentations overall, but also significantly from the 
absence of catch trials. Again in SITA the seed locations set the general height of the HoV. An 
empirical Bayesian approach is implemented at each test location. At each location two parameters 
are maintained, threshold estimate and classification (‘defective’ or ‘non-defective’). The eight 
closest neighbours contribute to the classification, while only the four closest neighbours contribute 
to the estimate of threshold.  Neighbours were derived from a “non-homogenous directional 
dependence” between locations from an unpublished map developed by Airaksinen and colleagues 
(Department of Ophthalmology, University of Oulu, Finland). The technique is underpinned by a 
spatial model used in imaging reconstruction. Detail of the SITA algorithm has been published 
(Olsson and Rootzén, 1994) but exact reproduction of the SITA method has not been achieved as 
some of the necessary detail is unclear or missing. However, it is recognised that a Bayesian 
approach is used and that the priors implemented do have a significant influence over threshold 
estimate, in some cases the observer responses have less influence than prior used (Rootzén and 
Olsson, 2006). Turpin and colleagues have investigated their SITA-like threshold extensively and have 
shown that the bias introduced is equivalent (or less) than that in a full threshold methodology 
(Turpin et al., 2003). 
 
3.2.4 Efficiency in clinical threshold search methods 
 
To have an efficient threshold search method the slope of the underlying sensitivity profile should be 
fixed and the search for the position of threshold should be the only unknown. In this case the 
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experimenter supplies not only the template of the psychometric function (general form) but also 
the slope and the other parameters (FN, FP). In this case the possible psychometric functions are 
single parameter translations of one another. However, it is clear that this is not true of the MMDT 
stimulus type and measurement scale, as shown in chapter 2, nor is it true with DLS (Wall et al., 
1996).  To achieve this in practice the x-axis (stimulus intensity) would have to be scaled 
appropriately; as subjects at either end of the scale of sensitivity should then require the same 
number of presentations to go from seen to unseen. In this case, the number of presentations would 
be reduced for glaucomatous patients and the relative difference between intensities would be 
closer to being standardised. Since there are less presentations and migration from seen to unseen is 
quicker, the overall test time should be shorter, response confidence should be elevated and 
together these should reduce the lapse and guess rates. The Dynamic strategy of the Octopus 
perimeter attempts this type of strategy and reports similar results to the FT method with shorter 
test duration (Weber, 1995). However it is not possible to implement this type of strategy correctly 
without extensive FOS data collection in a large cohort of visually healthy subjects and glaucomatous 
patients. It is also likely that there would be variation of the shape of the psychometric function 
between disease types. 
As mentioned, each threshold search method will be affected by prior information used. In some 
cases population based priors can improve efficiency. Seed locations introduce bias, but spatial 
information can improve performance, if applied correctly (Turpin et al., 2003). Ultimately spatial 
information and priors should influence the starting point but should not influence the final estimate 
of threshold. However, each method will be affected to varying degrees by these parameters 
depending on how far the chosen initiation point of the search is from true threshold. Terminating 
criteria will also affect performance, and as such will be different for each different search method. 
Typical terminating criteria include the number of presentations (Anderson et al., 2005), the number 
of reversals (Harvey, 1997) or difference between the prior and posterior mean/mode (Treutwein, 
1997). The terminating criteria will largely decide the amount of data collected at a given test 
location. The more data collected at a given location, the more accurate the estimate of threshold. 
Estimates of threshold can be derived from collected data in several ways, however recording the of 
the average of stimulus intensity at the last two reversal points is commonly used. The mean/median 
of the posterior function is an option with parametric threshold search methods. Considering that 
each perimetric stimulus type has a differently shaped FOS curve which will change with eccentricity 
and glaucomatous damage, it is reasonable to assume that search methods which perform well with 
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one stimulus type may not perform well with another.  By adjusting the step size, start point, 
terminating criterion and process of estimating threshold, the final estimate of threshold will be 
significantly affected. Physical restrictions of the hardware will often influence these parameters (e.g. 
step size or start point) and the measurement scales will differ significantly between stimuli types. 
Therefore, in terms of threshold search strategies, one size does not fit all. 
 
3.3 Threshold testing for the MMDT 
 
As outlined in chapter 2, the MMDT is a perimetry test, restricted by the pixel pitch of the monitor. 
The size of the pixel pitch determines the number of the possible steps that cover the test range. 
Furthermore while pixel pitch is uniform across the screen, the angle subtended is not. Any selected 
test strategy would have to hold this as a consideration. Simple staircases, like 2-1 (step size halved 
on first reversal e.g. 2dB initial step size with 1dB step size on reversal) and 1-1 (same step size 
before and after reversals) were selected as possibilities and these were the original methods used 
with the MMDT (Verdon-Roe, 2006). Strategies like ASA, PEST, MOBS and several other variations 
can also be eliminated because of their demands to half the step size on reversal.  
The aim of the work described in this chapter is to examine the performance of three possible clinical 
search strategies for the MMDT. The strategies investigated included a 1-1 staircase and a 2-1 
staircase which are the current test strategies on the MDT against a new strategy WEBS, details of 
which are described below. 
   
3.3.1 Weight based search (WEBS) 
 
WEBS utilises some of the properties of modified binary search (MOBS)) (Tyrrell and Owens, 1988). 
With MOBS, threshold is filtered using a progressive bisection of the intensity range according to 
responses given. For example, with a negative response the lower half the range is selected, the mid-
point of this range is chosen as the next stimulus presentation intensity etc. The ordered list of 
presentation intensities displayed describes the search path. With the WEBS strategy, threshold is 
filtered similarly; however the partitions are not uniform across the range, in this case divisions are 
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made with respect to the cumulative frequency of normative thresholds (Figure 3-1). With both 
MOBS and WEBS, a recovery or jump back into the previously rejected intensity range is made when 
it is strongly indicated that an error was made earlier in the search path.  Selected presentation 
intensities included in the search path are hereafter referred to as nodes. 
 
Figure 3-1 Methodology for presentation intensity selection of first presentation of WEBS (red) and MOBS (green) 
The difference between successive nodes for WEBS on a stimulus range was adjusted with respect to 
information from the normative MMDT data. The normative data used was collected on visually 
healthy subjects, and as such was treated as a ‘population’ of the frequency of thresholds. Each 
WEBS ‘tree’ of possible search paths, the trunk of the tree is the start point, the placement of the 
branches correspond to the nodes on the range and the leaves the point at which the search 
terminates. By permuting the trunk, branches and leaves through all possible combinations, the “tree 
space” was derived. A recovery, where the presentation intensity is returned up two levels of nodes 
and over one such that it passes to other side of the range occurs only when three nodes are passed 
through without change in direction with the same response given and if only one previous change in 
direction had been made within the search path. Recoveries are only placed within 2 steps of the 
start point and are only allowed to occur once per search path. 
An example WEBS tree is given in Figure 3-2. A starting displacement of six pixels, this can yield a yes 
or no response, depending on which the size of the stimulus displacement will be decreased or 
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increased accordingly. In this example, if an unseen (‘no’) response is given, displacement is 
increased to a 12 pixel displacement. Following the branch, if a subsequent presentation at this 
displacement yields a seen (‘yes’) response, the direction is changed and the displacement of a 
subsequent presentation is reduced to nine pixels. If a seen response continues to be returned from 
this location, a recovery is required to ‘cross back’ onto the other side of the tree. In Figure 3-2, 
possible recoveries are denoted by diamonds with matching symbols giving the set path. In this case, 
the recovery brings the displacement back up three levels and across the trunk of the tree, to a 
displacement of three pixels. Termination occurs when the end of a branch is reached and no 
recovery is possible. Additionally the number of accumulated recoveries or changes in direction 
during data acquisition can be used to limit data acquisition. The length of a search path is restricted 
to 5 nodes including the start point, unless a recovery occurs, search paths may terminate sooner if 
there are no further nodes available. Threshold returned is a) the edge of test range if test range is 
reached and no recovery is available b) the average of last node and the respective end of the range 
(depending on last response given) c) suprathreshold (all unseen responses) are recorded outside the 
test range e.g. 35 minutes of arc and likewise superthreshold (all seen responses) are recorded as 
half the smallest possible presentation. 
 
Figure 3-2  A schematic of one possible WEBS tree. Nodes are represented by ovals, recovery points by diamonds and 
threshold returned given by the number within the rectangles.  Presentation intensity is given by the number in the 
centre of each oval. Responses yes (Y) or no (N) from the previous presentation is given in each oval. All possible search 
paths are contained within this diagram.  
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The shape of the tree determines the possible routes to termination. The product of number of 
presentations to reach termination with the underlying probably density function of normative data 
is averaged (over all simulations) to derive an efficiency coefficient. A comparison of these efficiency 
coefficients for all possible trees is used to optimise the layout of the branches of the tree. This 
provides a systematic a method to select strategy which will produce the most likely outcomes in the 
shortest amount of time (quick for visually healthy subjects). Subsequently the normative data 
distribution was adjusted to include a proportion of glaucomatous eyes to ensure that unseen 
locations would terminate quickly and this optimisation process was repeated.  
The restrictions that will affect the possible shapes (possible positions of the nodes) of the trees are 
different step sizes (screen resolution), start point (corresponding to a set point on the normative 
range e.g. 90% limit of normality), termination criteria and types of recoveries allowed. With the ORS 
approach it is possible investigate the tree space that comprises a set number of increments of each 
of these restrictions and the effect they have on the strategy. In the simulations reported here the 
90% limit of normality was selected as the choice of start point; terminating criteria was as described 
above; step sizes varied from 0.5 minutes of arc up to 2.5minutes of arc. These limits were selected 
to correspond to current screen resolutions, e.g. a step size of 0.5 minutes of arc, corresponds to 
screen resolution that is greater than is currently available (pixel pitch of 0.05mm, at location -
27⁰,+03⁰ at a test distance of 30cm). On the other end of this range a step size of 2.5 minutes of arc 
this would correspond to a typical screen with pixel pitch of 0.22mm (corresponds approximately to a 
15.4” laptop screen with SXGA display). 
 
3.4 Testing the strategies: Patient data approach 
 
Participants in the study detailed in Chapter 2 underwent additional testing on a different date but 
within three months of the FOS data collection. This cohort of subjects consisted of 14 visually 
healthy and 14 glaucomatous patients whom were invited to return for a study examining the 
performance of threshold algorithms. The age range of the patients was 36 to 79 years with an 
average age of 65 years. Average MD was -3.82dB [range -8.24dB to 0.57dB]. The age range of the 
healthy observers was 37 to 79 years with an average age of 65 years. Average MD for the visually 
healthy observers was -0.36dB [range -1.82dB to 1.39dB]. Inclusion and exclusion criteria for the 
* 
Y T=1 
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healthy observers and the glaucomatous patients recruited for this study were as described in 
section 2.3.1. The study was approved by Moorfields ethics committee and conformed to the 
Declaration of Helsinki with all participants giving their informed written consent.  
Each subject undertook one examination with each of the following test strategies, in a randomised 
test order. The first trial algorithm was a 1-1 staircase with second reversal triggering termination, 
threshold returned was the average of the last two reversal points. The second trial algorithm was 
the 2-1 staircase with second reversal triggering termination, threshold returned was the average of 
the last two reversal points. The third method was WEBS as outlined above in section 3.3.  
The reference threshold at seven  locations (namely (-27⁰,+03⁰), (-15⁰,+03⁰), (-9⁰,+03⁰), (+03⁰,+03⁰), 
(-09⁰,-09⁰), (+09⁰, -15⁰), (+15⁰,+15⁰))  calculated from the FOS data collection from 98/98 locations in 
healthy subjects and 75/98 in glaucomatous patients (the reduced number of locations with FOS data 
in glaucomatous patients is due to a test location coinciding with a focal defect). Bias, precision, and 
test duration were calculated for the four different strategies tested in the study outlined above in 
section 3.1.  
 
3.4.1 Results 
 
The summary measures of bias and precision are shown for three clinical threshold search methods 
in visually healthy subjects in Figure 3-2. Precision varies between strategies, the 1-1 staircase was 
significantly more precise than 2-1 or WEBS (p<0.01; Krusal-Wallis test), and 2-1 was significantly 
more precise than WEBS (p=0.05; Krusal-Wallis test). There is a relationship between increase in 
reference threshold and an underestimation of threshold to varying degrees with all strategies, 
however WEBS was least affected. 
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Figure 3-3 Summary of the comparative performance of clinical threshold search methods from eyes of visually healthy 
subjects. Each blue dot represents the difference between estimated thresholds using the respective clinical threshold 
search method against reference thresholds as calculated from the constructed FOS curves in chapter 2. The black line 
represents the bias, the dashed black lines represents the standard deviation, which is inversely proportional to the 
precision; the red lines show the trend of estimated threshold with respect to reference threshold. Summary measures 
are given in the table (test duration is average seconds per location). 
In Figure 3-4 bias and precision summary measures of these three clinical threshold search methods 
was examined in glaucomatous subjects. There was no significant difference observed in precision 
between strategies (Krusal-Wallis test; 1-1 vs 2-1 p=0.43; 1-1 vs WEBS p=0.33; 2-1 vs WEBS p=0.43). 
There was a relationship between increase in reference threshold and an underestimation of 
threshold to varying degrees with the 1-1 staircase, 2-1 staircase and WEBS.  
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Figure 3-4 Summary of the comparative performance of clinical threshold search methods from eyes of glaucomatous 
patients. Each blue dot represents the difference between estimated thresholds using the respective clinical threshold 
search method against reference thresholds as calculated from the constructed FOS curves in chapter 2. The black line 
represents the bias, the dashed black lines represents the standard deviation, which is inversely proportional to the 
precision; the red lines show the trend of estimated threshold with respect to reference threshold. Summary measures 
are given in the table (test duration is average seconds per location). 
In Figure 3-5 the speed of the respective algorithms is shown in both visually healthy subjects and 
glaucomatous patients. Visually healthy subjects returned quicker average tests times when 
compared to patients using WEBS (p=0.04 using a two-sample t-test). However, there was no 
significant difference between healthy subjects and patients with the staircase procedures.  The 
WEBS procedure (for both patients and controls) terminated significantly faster than any other test 
procedure (p<0.01, two sample t-test) (see Figure 3-5). 
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Figure 3-5 Number of presentations required to reach termination in visually healthy subjects and glaucomatous 
patients. The height of the box represents the inter-quartile range. The median is shown by the red horizontal line.  If the 
notches (narrower portion) of one box do not overlap with those of another box this indicates significant difference 
between the number of presentations required. 
 
3.4.2 Conclusion 
 
In glaucoma patients the WEBS procedure offers the best efficiency for glaucomatous patients as it 
requires significantly fewer presentations to reach termination, while precision remains comparable 
between strategies to the other clinical threshold search methods. In healthy subjects the results 
varied more with WEBS having lower precision than either staircase procedure.  However, this is a 
small sample of patients and a large study would be needed to verify these findings. 
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The patient data approach described in this section was collected subsequent to the FOS data. The 
three different test procedures had been developed prior to the FOS data collection. However, since 
the FOS data was now available, the FOS curves were constructed and the ORS implemented. Hence 
further optimisation of the test procedures and the defining parameters of each was then possible.  
 
3.5 Testing the strategies: ORS approach 
 
Optimisation of the clinical search methods requires examination of a range of strategy parameters 
such as intensity of the initial presentation and step size. These must be examined for a range of 
thresholds with varying degrees of variability (e.g. FOS curves ranging from low to high slope). The 
clinical threshold search methods that were examined are the 1-1 staircase, the 2-1 staircase and 
WEBS (as outlined in section Error! Reference source not found.). 
 
3.5.1 Example of the ORS approach and change of parameters 
 
To clarify the approach, one example demonstrating how the ORS and the simulation will derive 
estimates of bias, precision and speed is presented below. For this we return to an example FOS 
curve from chapter 2 (shown again in Figure 3-6). This shows the FOS curve for a subject with 
threshold of 5.5 minutes of arc with the MMDT stimulus. The green values beside the green lines 
represent the number of steps, (increments of pixels) required to reach this stimulus intensity.  These 
steps in minutes of arc are easily interpreted by tracing down the respective green vertical line. The 
blue values are estimated percentage seen at each step (i.e. the point of intersection of the FOS 
curve and the green vertical line to the left of this value). Therefore, while implementing this FOS 
curve during a simulation, if a presentation of two steps or 3.9 minutes of arc is queued, then the 
ORS will return a ‘yes’ responses in 21% of simulations and a ‘no’ response in 79% of simulations. 
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Figure 3-6 The FOS curve for a subject with threshold of 5.5 minutes of arc with the MMDT stimulus. The green values 
represent the number of steps (increments of pixels), required to reach this stimulus intensity.  
Figure 3-7 summarises an example of 1000 simulated threshold searches for a 1-1 (same sized step 
size on reversal) staircase with one reversal, derived from the ORS. Each search starts at the green 
node and terminates at one of several red coloured nodes. When the upper or lower limit of the 
stimulus intensity range is reached without reversal, the strategy terminates at the respective end of 
the range. Since the threshold is likely greater or less than presentation intensities made returning 
the last presentation made as threshold is closest estimate possible. To understand the distribution 
of threshold estimates returned with this method, an example of one search path is given. At the 
start node at step size number four (1.9*4=7.6 minutes of arc) is given as the starting presentation. If 
a seen response is recorded, a step to the left (following the orange bar) is made. According to the 
above FOS curve this will occur with a frequency of 77%, or in 770 cases of the 1000 searches. No 
initial direction (increasing/decreasing stimulus intensity) is predefined there. Choice of initial 
direction to decreasing stimulus intensity is not counted as a reversal. Next a presentation of three 
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step sizes (5.7 minutes of arc) is displayed, again seen response will be recorded 54% of searches 
reaching this point (416/1000). If no response is recorded, this will qualify as the second reversal and 
the staircase terminates which will happen in 354/1000 searches, highlighted here in red. At the 
bottom of Figure 3-7, a summary of the number of searches returning each terminating at each step 
size is shown beneath the tree. With this method a threshold of 4 is never recorded. This procedure 
is quick, terminating in 2.5 presentations on average, precision is also high this is because in this 
example, trials were performed with a highly reliable observer (steep slope) and reference threshold 
was within 2 steps of startpoint, as a result threshold measured is on average within 2 min of arc of 
reference threshold (accuracy). 
If the number of reversals is increased from one (as in Figure 3-7) to two (as in Figure 3-8), the 
number of possible trails or paths to termination expands dramatically (threshold returned is now 
the average of the last two reversals). There is a significant increase in the number of presentations, 
slight increase in bias but large increase in precision.  On calculating efficiency for both examples, the 
1-1 staircase with two reversals (efficiency =0.29) proved less efficient than 1-1 staircase with one 
reversal (efficiency =0.30). 
 
Figure 3-7 Schematic showing outcome of 1000 trials with the 1-1 staircase with one reversal prompting termination and 
threshold recorded as terminating presentation. 
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Figure 3-8 The outcome of 1000 trials using the 1-1 staircase with two reversals prompting termination and threshold 
returned as the last intensity corresponding to the seen response. 
 
3.5.2 Methods 
 
In section 3.3 the WEBS procedure was outlined.  In section 3.4 we examined the performance of this 
threshold search methods against the current methods using the patient data approach. This 
suggested that the WEBS method yielded similar results to those with the established modes of 
threshold estimation (i.e. staircases), but with shorter test duration. In this section parameters of 
each threshold search method were allowed to vary between batches of simulations. Examining the 
relative performance of each, allows further refinement of the threshold search methods.  Here 
follows a brief overview of the parameters varied within the simulations described in this section. 
The most efficient WEBS tree was selected (per eccentricity where the start point varied). 
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The Start point was set at the 90% limit of normality according to the normative database for the 
MDT, the relative effect of start point on each threshold algorithm in terms of bias, precision and test 
duration was examined. 
The Step size which is the minimum possible displacement (in the conventional perimetry this would 
equate to the minimum increment in contrast e.g. in the HFA II it is 2dB) was set to 5 step sizes to 
examine the effect of step size on each threshold algorithm in terms of bias and precision namely: 
0.5 minutes of arc; 1 minute of arc; 1.5minutes of arc; 2 minutes of arc and 2.5 minutes of arc. Step 
size is of particular importance to the MMDT as it is determined absolutely by the pixel pitch of the 
monitor. 
The terminating criteria, staircases employed the number of reversals as the only terminating 
criteria (two reversals was selected as three was too long to be comparable to WEBS).  A WEBS 
search path terminated if there were no further nodes available between end of the range and the 
previous node or alternatively if the search path exceeded four nodes. 
The method used to record threshold, here for staircases strategies the average of the last two 
reversal points or in cases where one end of the range was reached the last seen/unseen 
presentation was returned as threshold.  For WEBS: threshold returned is a) the edge of test range if 
test range is reached and no recovery is available b) the average of last node and the respective 
(depending on last response given)  end of the range. For all strategies the supra-threshold outcomes 
(all unseen responses) are recorded outside the test range e.g. 35 minutes of arc and likewise super-
threshold outcomes (all seen responses) are recorded as half the smallest possible presentation.  
For each FOS curve 1,000 simulations of each combination were performed. Summary measures of 
bias, precision, accuracy, test duration and efficiency were calculated  using the formulae outlined in 
section 3.1. For example in Figure 3-9 the box and whisker plot of the outcomes of 1,000 simulations 
for each of the three strategies for one FOS curve are shown. Bias summarises the distance from 
estimated threshold to reference threshold.  Accuracy is a summary measure of the spread of the 
box and whiskers. 
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Figure 3-9 A box and whisker plot of 1,000 simulations for each strategy (step size of 1 minute of arc) for one subject at 
one location. The red line denotes the mean difference between reference threshold and estimated threshold (bias), the 
lower and upper extremes of the box represent the 25
th
 – 75
th
 centile, and the ends of the whiskers the 5
th
 -95
th
 centiles. 
The spread of the data represents the accuracy of the estimated measure. 
 
3.5.3 Results 
 
Examining the effect of distance from start point to reference threshold 
 
Summary measures for 1,000 simulations for each FOS curve with respect to the difference from 
start point of the search path to reference threshold is shown in Figure 3-10, for each search 
strategy. These results were then grouped with respect size of the difference between start point 
and reference threshold (i.e. <2.5 mintues of arc; <2.5 and >5 minutes of arc; >5 minutes of arc from 
start point). This summary is shown in Figure 3-11. In both Figure 3-10 and Figure 3-10 those subjects 
particularly patients with threshold from start point (> 5 minutes of arc) perform badly in all 
summary measures. 
3 Improving measurements in perimetry for glaucoma 2011 
 
97 
 
 
Figure 3-10 Blue symbols represent outcomes from 1-1 staircase search, green from a 2-1 staircase search and pink from 
a WEBS search. Outcomes derived from glaucomatous patients are denoted with cross and visually healthy subject by a 
diamond. 
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Figure 3-11 Mean summary measures from Figure 3-10, for all data denoted ‘all’ on the x-axis, then for three groupings; 
1) where startpoint is within 2.5 minutes of arc of reference threshold, 2) between 2.5 and 5 minutes of arc, or 3) greater 
than 5 minutes of arc from reference threshold. Blue triangles represent outcomes from 1-1 staircases, green triangles 
outcomes from 2-1 staircases and pink triangles outcomes from WEBS. 
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In Figure 3-10 and Figure 3-11, it is apparent that WEBS is consistently faster than either staircase. 
Bias is also much reduced with WEBS versus either staircase and in particularly for those FOS curves 
where reference threshold is far from start point. Precision appears to be similar between the 
groups, accuracy is low over all. There is a marked difference in accuracy between those with start 
point greater than 5 minutes of arc above threshold and the other groups.  
 
Examining the effect of Step size 
 
In Figure 3-12, the effect of step size on efficiency each of the threshold strategies is examined. The 
mean of all data irrespective of reference  threshold  is reported under grouping labelled ‘all’. Those 
FOS curves with start point within 2.5 minutes of arc of reference threshold are reported under the 
group labelled ‘0-2.5’. Those FOS curves with start point greater than 2.5 minutes of arc but less than 
5 minutes of arc from reference threshold are reported under the group labelled ‘2.5-5’. Lastly those 
FOS curves with start point greater than 5 minutes of arc from reference threshold are reported 
under the group labelled ‘5+’.  With FOS curves yielded from glaucoma patients, these groups 
contained 41, 23 and 11 datasets respectively, and for FOS curves yielded from visually healthy 
subjects, these groups contained 51, 38 and 8 datasets respectively.  In most cases WEBS yields 
higher efficiency especially for glaucomatous patients with start point far from reference threshold. 
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Figure 3-12 Efficiency calculated for all 5 step sizes and reported mean of all estimated thresholds and for mean of each 
group with respect to the distance between startpoint and reference threshold. 1) where startpoint is within 2.5 minutes 
of arc of reference threshold, 2) between 2.5 and 5 minutes of arc, or 3) greater than 5 minutes of arc from reference 
threshold. Blue triangles represent outcomes from 1-1 staircases, green triangles outcomes from 2-1 staircases and pink 
triangles outcomes from WEBS. 
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3.5.4 Conclusion 
 
Distance from start point to reference threshold and step size impact the performance of clinical 
threshold search methods. In the experiment described above, which was designed to meet the 
needs of the MMDT, WEBS has greater test efficiency than either staircase procedure.  Where start 
point is far from reference threshold, there is increased bias and reduced precision, both of which 
negatively impact accuracy, which in turn affect efficiency. With increased step size efficiency is 
lowered for staircases but increased for WEBS. However, with patients with elevated threshold (start 
point far from reference threshold) WEBS always had higher efficiency than staircases, this has 
important implications for clinic based testing. 
 
3.6 Discussion 
 
The results agree well between the patient data approach and ORS approach in both cases the WEBS 
had greater efficiency than either staircase strategy for glaucomatous eyes.  
Each threshold estimation regardless on the distance from start point is important, ideally uniform 
accuracy should be obtained at each possible threshold value. However, with a start point far below 
threshold, particularly with staircases, the demand of a large number of responses to reach the point 
of subjective equivalence introduces bias. For 2-1 staircase with start point set close to the mean of 
the normative data will have much wider confidence intervals than a 1-1 staircase (with the same 
start point )at the normal end of the scale and the converse is true when the start point is far from 
threshold. In terms of perimetry the 4-2 staircase used in full threshold search method in the HVFA 
would have much wider confidence limits in comparison to a 2-2 staircase at the ‘normal’ end of the 
measurement scale, but the 2-2 would have greater bias at the abnormal end of the scale. This is 
reduced with the use of prior information, in the example shown in Figure 3-10 and Figure 3-11, the 
WEBS procedures were less affected by start point in terms of bias. This is of considerable 
importance when assessing threshold in eyes with pathology, since they are likely to have threshold 
values far from the start point set. This, at least  in part, explains the large repeatability issues at the 
lower end of the  scale with the HFVA and the full threshold algorithm (Henson et al., 2000). 
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 While step size is a restriction of all perimetric instruments, step size has a large effect on 
performance of threshold search methods and it has been somewhat overlooked in the published 
literature. The work presented in this chapter may prompt FOS study to address this question in DLS 
standard automated perimetry. 
Most published simulation work uses FOS curves with estimates of threshold and slope derived 
variability limits (Henson et al., 2000, Turpin and McKendrick, 2003, Turpin et al., 2002a, Turpin et al., 
2002b, Turpin et al., 2003, McKendrick and Turpin, 2005a). Since the data reported by Henson and 
colleagues (2000) is derived with a threshold search method (full threshold) this will confound the 
simulation work by introducing variability which originates from the threshold search method rather 
than the patient. The FOS curves used in this work were carefully derived from visually healthy 
subjects and glaucomatous patients at a large number of locations. It rendered the responses 
generated by the ORS to be potentially more representative of real patient responses.  
Additional factors influencing patient data approach, like fatigue and learning effect have not been 
incorporated in the simulations reported in this chapter.  These would be useful to implement, but 
implement would be very difficult to assess properly. 
Highly variable subjects (those with shallow FOS curves) produced low accuracy perimetric exams 
outcomes. This will produce a large degree of noise in the measures confounds detection of 
progression. In these cases regardless of the test strategy used this low signal to noise ratio likely will 
persist and the overall test accuracy will remain low. Identifying these subjects at baseline and 
eliminating them from threshold examination or adapting the test to a suprathreshold test in 
locations of damage may prove a more efficient approach to data collection.
4 Developing and evaluating a case-finding perimetry algorithm 
 
The full-threshold (FT) testing strategy used in automated perimetry has been a standard 
measurement for mapping the extent and depth of visual field defects, especially in a hospital or 
secondary/tertiary care setting.  However, the patient examination time for this clinical test is long 
and measurements yielded are still often unacceptably variable. Over the years attempts have been 
made to develop faster and more efficient test strategies as discussed in chapter three (Turpin and 
McKendrick, 2003, McKendrick and Turpin, 2005b, Turpin et al., 2007, Anderson and Johnson, 2006, 
Morales et al., 2000, Weber and Klimaschka, 1995). There is a need to have a quick visual field test 
while maintaining acceptable specificity and sensitivity, especially for glaucoma detection in primary 
care, screening programmes and large epidemiological studies (Vitale et al., 2000, Quigley, 1998, 
Henson and Artes, 2002, Henson et al., 1998, Quigley et al., 2007). In these settings, perimeters 
employing suprathreshold (ST) testing strategies are typically used. Suprathreshold measurements 
are simple: stimuli are presented to the subject, one at a time, typically at a level above the 
estimated detection threshold of a normal visual field location. Normally, if a presentation at any 
location is recorded as unseen, then later in the test another presentation (trial) is made at that same 
location. If both presentations at a given location are unseen, then that point is classified as a defect. 
ST offers simple pass/fail results to the clinician. Furthermore stimulus presentations are displayed at 
the upper levels of the normal response (bright) and are displayed less frequently at each location: 
for the test subject naïve to perimetry this improves test acceptability and eases understanding 
(Gardiner et al., 2008, Artes et al., 2002a). 
Not all ST testing strategies are limited to two trials and it would seem sensible, especially when the 
aim is to minimise false positive diagnosis of a defective location, to have more trials per location 
(multisampling). Artes and colleagues (Artes et al., 2003, Artes et al., 2002a) examined this idea 
rigorously, concluding that measured VF defect area was less variable and exhibited lower systematic 
error when using multisampling suprathreshold paradigms (3 or even 5 trials at each point). The 
method has been implemented in Henson Pro perimeter (Sheen Instruments, Surrey, UK). Still, the 
benefit of increased sampling at all test points does come at the cost of increased test time 
compared to conventional ST. 
This chapter describes the design of novel method of suprathreshold testing (Enhanced 
Suprathreshold Testing Algorithm (ESTA)), which was developed with the aim of maintaining short 
test duration, without negatively affecting diagnostic precision. This aim was pursued by exploiting 
4 Improving measurements in perimetry for glaucoma 2011 
 
104 
 
the spatial relationship between the measurements at fixed visual field test points as a result of their 
position relative to the RNFL. In this section, ESTA is compared to conventional and multisampling 
suprathreshold algorithms in a group of healthy subjects and patients with early glaucomatous loss. 
The testing methods are compared using the Moorfields Motion Displacement Test (MMDT) as the 
perimetry platform.  
The work described in this chapter is published in part as a granted patent (A Supra-Threshold Test 
for Use in Detecting Sensitivity Loss Across the Field of Vision [UK priority application 1007697.4 and 
US priority application 61/332023] (See ‘List of supporting publications’). The results in this chapter 
have also been presented in part as a read paper at the Association for Research in Vision and 
Ophthalmology Meeting, Fort Lauderdale, Florida, USA in May 2009) and another at the UK & Eire 
Glaucoma Society Meeting, Dublin, Ireland in December 2008 (See ‘List of supporting publications’.) 
 The methods to derive performance related data of the new algorithm will mirror those in the 
previous chapter. Using FOS curves derived in chapter 2 it is possible to estimate performance of 
suprathreshold methods in two ways by taking data from chapter 3 to determine if threshold is 
outside or within normal limits and thus whether the location should pass or fail the exam to set the 
reference standard. The outcome of the reference standard is compared to the results derived using 
suprathreshold test data collected directly from the same cohort. This is referred to as the patient 
data approach. Estimates of concordant and discordant pairs can be derived from this data. 
 
4.1 Suprathreshold methods 
 
What follows is a description of the suprathreshold testing strategies investigated in this study as 
they might apply to standard automated perimetry (SAP). Common to these testing strategies is the 
concept that the stimuli presented to the subject has a ‘fixed’ intensity normally set at some 
percentile level estimated from a sample of healthy subjects for each test location.  
Conventional Suprathreshold (ST) Strategy (C 1/2)  
A single stimulus is presented at each location. If a response is not recorded, the presentation is 
repeated and locations are classified as defective if both presentations were missed (pass criterion 
1/2). Each point is either tested one or two times. 
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Multisampling Suprathreshold (ST) Strategy (MS 1/2) 
At each location, a stimulus is presented twice. The locations are classified as defective if either 
presentation was missed (pass criterion 2/2). Each point is tested twice. 
Multisampling Suprathreshold (ST) Strategy (MS 2/3)  
At each location, a stimulus is presented on two occasions. For those points where the stimulus is 
seen twice (non-defective) or not seen twice (defective) the test strategy stops (terminates). At other 
locations where there has been just one response, another single trial takes place. If there is no 
response on this third trial, then the location is classified as defective. Otherwise it is classified as 
non-defective. Each point is, therefore, either tested two or three times. 
Enhanced Suprathreshold Strategy (ESTA) 
What follows is a description of the novel principles underpinning ESTA and a description of how it 
would be applied to a perimetric device: this serves as an accessible narrative of the method and 
should be read in conjunction with the steps illustrated in the schematic shown in Figure 4-1. 
Additional detail along with the specific heuristics used in the algorithm, are given in the Appendix – . 
ESTA differs from other ST strategies by using the well-established notion that points on a visual field 
grid are spatially related (Brindley and Westheimer, 1965, Enoch et al., 1970, Katz and Sommer, 
1986, Gardiner et al., 2004, Strouthidis et al., 2006b). This relationship can be traced to the 
physiological location of the VF test point relative to the nerve fibre layer (Brindley and Westheimer, 
1965, Garway-Heath et al., 2000). This means that, for example, ‘defects’ that occur in isolation are 
assumed more likely to be false responses than those that present in clusters of points following 
known patterns of glaucomatous loss.  By using this information, ESTA differs from other ST 
strategies in that not all points are tested with a fixed diet of trials; testing at an individual points is 
influenced by the responses at the points in a given neighbourhood or cluster. First a ‘map’ is 
required detailing the neighbourhoods and how each VF location is related. A prescription for this 
can be found from the work relating the VF to the optic disc by Strouthidis and colleagues (2006b). 
The rationale for using this map is that localised defects are more likely to occur in clusters 
determined by the anatomical entry position of nerve fibre bundles into the optic nerve head. In 
short, the map involves two parameters for every VF test location (TL) in order to determine a 
relationship between a primary test location and a secondary test location (representing the other 
TLs in the visual field).  The first parameter is derived by tracking the nerve fibre bundle on which the 
primary TL sits back to the optic nerve head, and likewise by tracking the nerve fibre bundle on which 
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the secondary TL sits back to the optic nerve head.  The first parameter then reflects the angle 
between these two nerve fibre bundles at the ONH.  The second parameter is the Euclidean distance 
between the primary TL and the secondary TL.  Denoting the first parameter as ONHd and the second 
parameter as RETd, then an expression for the so-called functional correlation (FC) between the 
primary TL and the secondary TL is given in Equation 4-1 (Strouthidis 2006b). 
 
Figure 4-1 gives a flowchart of the processes which comprise the ESTA method. PTD denotes the Probability of True 
damage. 
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Equation 4-1 Functional correlation to structural measures of optic nerve head angle and retinal 
distance 
FC= 0.9325-(0.0029)*ONHd – (0.0077)*RETd + 
(0.0001) * ONHd * RETd    
This supra-threshold test starts with an initial 
sweep of every point in the test field. Then based 
on these results, the likelihood of there being a 
defect is established for every location tested. 
Using this score, the points for retesting are 
determined. After the second round of testing 
this score is recalculated and the points for a 
third testing round are determined. A few 
discreet points may require retesting for a fourth 
and final time, after which the test terminates. 
The initial sweep of all the test points is made 
at the presentation intensity level which 
corresponds to the 95% limit of normality. An array of seen and unseen responses is returned, 
considering this set as an array of zeros and ones, with zero recorded if the test point was seen and 
one if the test point was unseen.  This comprises the initial results array (RA) (Figure 4-2). 
Neighbouring ‘defective’ points are more likely to be truly damaged, and to extract this information a 
spatial map was applied (Strouthidis et al 2006a). This spatial filter uses two parameters to 
determine neighbours, namely the angle which the retinal nerve bundle (on which each test location 
sits) leaves the optic nerve head and the Euclidean distance between test locations (in degrees). For 
example for the primary point (-15⁰,+15⁰) the weightings for the neighbouring points according to 
this map are as shown in Figure 4-3 (yellow). This is then normalised to sum to unity. Two examples 
are given in Figure 4-3 (green). Here a further example at location (+03⁰,-09⁰) is also given. 
 
 
 
     0 0 0 0     
   0 0 1 0 0 0   
 0 0 0 0 0 0 1 0 
0 0 1 0 0 0 0  0 
0 0 0 0 0 0 0  0 
 0 0 1 0 0 1 1 0 
   0 0 0 0 1 0   
     0 0 0 0     
Figure 4-2  Example of initial sweep results, displayed in the 
grid like format of the 24-2 test pattern. 
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E.g. (-15⁰,+15⁰) 0.74 0.68 0.60 0.54       E.g. (+03⁰,-09⁰) 0.51 0.51 0.51 0.52     
   0.87 0.75 0.66 0.61 0.56 0.49       0.51 0.49 0.47 0.46 0.46 0.48   
 0.73 0.70 0.66 0.61 0.57 0.54 0.49 0.51    0.51 0.48 0.46 0.45 0.45 0.44 0.42 0.50 
0.62 0.63 0.63 0.60 0.55 0.52 0.51   0.51   0.51 0.49 0.46 0.45 0.46 0.50 0.47   0.46 
0.40 0.38 0.38 0.40 0.45 0.49 0.51   0.50   0.50 0.53 0.59 0.67 0.70 0.64 0.63   0.38 
 0.44 0.44 0.45 0.48 0.51 0.51 0.52 0.50    0.53 0.58 0.66 0.75 0.87 0.74 0.58 0.36 
   0.52 0.52 0.52 0.52 0.52 0.51        0.56 0.60 0.65 0.66 0.60 0.53   
     0.52 0.52 0.51 0.49           0.57 0.57 0.54 0.49     
                                    
     0.13 0.12 0.00 0.00            0.00 0.00 0.00 0.00     
   0.15 0.13 0.11 0.00 0.00 0.00       0.00 0.00 0.00 0.00 0.00 0.00   
 0.13 0.12 0.11 0.00 0.00 0.00 0.00 0.00    0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 
0.00 0.00 0.00 0.00 0.00 0.00 0.00   0.00   0.00 0.00 0.00 0.00 0.00 0.00 0.00   0.00 
0.00 0.00 0.00 0.00 0.00 0.00 0.00   0.00   0.00 0.00 0.00 0.12 0.12 0.00 0.00   0.00 
 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00    0.00 0.00 0.11 0.13 0.15 0.13 0.00 0.00 
   0.00 0.00 0.00 0.00 0.00 0.00        0.00 0.00 0.11 0.12 0.00 0.00   
     0.00 0.00 0.00 0.00           0.00 0.00 0.00 0.00     
                   
Figure 4-3 Two examples of functional coefficients (upper schematics) are shown. The seed locations are marked in 
orange [(-15⁰,15⁰),(+03⁰,-09⁰)], and those correlations greater than 0.65 are marked in yellow, thus the neighbourhood is 
highlighted. Below each is the normalized weightings of neighbours, the seed location is marked in dark green and the 
neighbours in lighter green.  
Calculating this for every location we have a similar map of weightings (WA) for the respective 
surrounding locations, giving us as many maps as test points (i.e. in this example there are 52 maps). 
Summing the point wise multiplication of each map with the corresponding point in the results 
column, derived from the initial sweep, gives us an estimate of which locations are more likely to be 
defective (Figure 4-3). 
We can use the PTD measure as a summary measure for the likelihood of a location being ‘defective’. 
From the PTD it is possible to set appropriate cut offs as to levels which are acceptably low (most 
likely ‘non-defective’), those points with high PTD (most likely defective) and those locations with 
PTD values between these, in which ambiguity remains, and retesting is required. 
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Figure 4-4 Results of the initial sweep (A) are combined with each map of standardised correlations (single map for 
location (+03,-09) shown in B) to derive the probability of true damage. 
To set the lower limit of PTD, single missed points were considered. If a point was recorded as 
unseen on the first sweep, retesting of this location should follow. Considering all possible single 
missed points, if the lowest value assigned to the seed location in any of the maps was for example 
0.19 (for 32 locations of the MMDT), as such it was 0.18 that was selected as the lower bound on 
retest limits. Similarly, inspecting all maps the highest value assigned to a single seed location was 
0.55 (again for the MMDT 32-location test). Since it is required that at least two contiguous locations 
must be unseen to justify not retesting an upper bound on retest limits, in the case of the MMDT an 
upper retest limit of 0.70 was selected. 
 
  RA 0 0 0 0          
      0 0 1 0 0 0        
    0 0 0 0 0 0 1 0      
  0 0 1 0 0 0 0   0      
  0 0 0 0 0 0 0   0      
    0 0 1 0 0 1 1 0      
      0 0 0 0 1 0        
        0 0 0 0          
               
              
  WA of  (3,-9) 0 0 0 0          
     0 0 0 0 0 0        
   0 0 0 0 0 0 0 0      
  0 0 0 0 0 0 0   0      
  0 0 0 0.12 0.12 0 0   0      
   0 0 0.11 0.13 0.15 0.13 0 0      
     0 0 0.11 0.12 0 0        
       0 0 0 0          
               
  PTD= 0.11+0.13 0 0 0 0          
      0 0 0 0 0 0        
    0 0 0 0 0 0  0 0      
  0 0 0 0 0 0 0   0      
  0 0 0 0 0 0 0   0      
    0 0 0.11 0 0 0.13  0 0      
      0 0 0 0  0 0        
        0 0 0 0          
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With those points needing retesting now isolated we begin the second sweep. The intensity level can 
be adjusted at this stage to increase specificity. For example testing twice at the 80% level of 
normality would still equate to a 4% chance of missing a second presentation, in an average normal 
observer. Considering that 32 or 52 locations are being tested in the above description, between 1 
and 3 locations can reasonably be expected to return a defective result, which would increase as the 
normal observer moved towards the upper centiles of the normative distribution. However, 
increasing to an intensity level corresponding to the 95% limit would reduce this to less than 1 
missed location in the average normal test subject. 
 At the locations which have been retested, ESTA uses the 2/3 Henson Pass/Fail criterion, therefore 
to fail this test two points at or over the 95% limit level must be unseen for this location to be 
classified as ‘defective’. Following the second sweep, the result array is updated and the PTD 
recalculated for every location including those that were eliminated on the first sweep. Reapplying 
the limits of acceptability, we isolate those test locations with ambiguous PTD values. These test 
locations undergo a third iterative sweep. The results array (RA) is updated with the quotient of the 
number of seen presentations and the total number of presentations at that location. 
Following the third sweep the PTD is again recalculated. In a few cases there may be a fourth sweep 
to satisfy the terminating criterion. After the test terminates the PTD is calculated again based on the 
final results. 
In short, each location will pass or fail the test based on two criteria: 
 The likelihood of a defect is either below 0.19 or above 0.7 
 Two presentations above the 95% have been missed by the observer 
 
Generalising this, the ESTA algorithm begins with the simple ST strategy. Each TL is tested once with a 
stimulus set at a fixed intensity level (this is an estimated threshold for the TL that would be seen in 
95% of visually healthy subjects). Then each location has a recorded value of seen (beta) or unseen 
(1-beta) in a results array (RA). For the purpose of this explanation beta will be taken as one, so seen 
= 0 and unseen =1. In practice, the probability of the stimuli being seen at a fixed level (0.95) is 
entered for a seen location and 0.05 for an unseen location (see appendix). This concludes the first 
sweep or cycle of testing. Simultaneously, for each TL the WA and RA are convolved (see appendix). 
This gives a value at each TL which represents the probability of the point being a glaucomatous 
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defect dependent on the responses at TLs in the cluster of points that are considered to be 
physiologically contiguous. For example, points missed in isolation are given a low so-called, 
‘probability of true damage’ (PTD) whereas those close to, or at the edge of ‘physiologically likely’ 
clusters of defective points are given higher PTD.  
     ∑   
 
 
   
     
ESTA proceeds, in a novel fashion, to only examine those points without either a very high or very 
low PTD. Thus, locations that have a high estimated PTD (above a first limit, U1) and those locations 
that have a low estimated PTD (below a second limit, U2) are not selected for retesting. The only 
locations selected for retesting have a value such that U1>PTD>U2.  If no locations satisfy this 
criterion, then the test terminates (see Figure 4-1). A stimulus is presented at a new intensity level 
(see appendix) only at those locations selected by the algorithm for retesting. This concludes the 
second sweep of testing.  
The new (retest) results are recorded and combined with the previous results (see appendix) to 
produce an updated version of the RA, and from that an updated set of estimated PTD values. These 
estimated PTD values are now re-examined as before with locations selected for retesting by having 
a value of PTD such that T1>PTD>T2  (where T1 is a lower arbitrary retest limit and T2 the upper 
retest limit) and do not have two or more presentations giving the same result, i.e. both seen or both 
unseen. A decision rule on the number of sweeps is now applied and if this is not satisfied a new 
sweep of testing, using a stimuli set at a slightly different intensity, is carried out. One such set of 
decision rules and termination criteria are given in the appendix. At the conclusion of the test each TL 
has an estimated level of PTD.  TLs that have an estimated PTD estimated above the associated upper 
bound (>T1) are flagged, using standard ST terminology, as failed, and all other TLS are considered to 
have passed the test.  Each point has a PTD value and a simple summary measure of these values is 
the sum of all PTD values. This gives a global index of VF loss as, for example, a mean deviation (MD) 
measure in Humphrey SAP.  
ESTA for the MMDT (Appendix- Matlab code of ESTA) was first developed in Matlab (version 
7.2.0.232 (R2006a)) and then directly programmed into the MMDT software, and details of the ESTA 
program as implemented with the official version of the MMDT are given in Appendix A. Other ST 
testing is also available on the research version of the software. 
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4.2 Patient data approach 
 
The cohort of subjects described in chapter two and three all underwent suprathreshold testing. This 
data was collected on a different and subsequent day to FOS data collection. Data were collected 
equally by CB and RM. Fourteen patients with a clinical diagnosis of primary open angle glaucoma in 
at least one eye were recruited from Moorfields Eye Hospital, London. Patients were purposely 
selected to give a range of VF defect severity. All were experienced in SAP and had prior experience 
with MMDT. 
Inclusion and exclusion criteria for the healthy observers and the glaucoma patients recruited for this 
study were as described in section 2.3.1. The study was approved by the Moorfields Ethics 
Committee and conformed to the Declaration of Helsinki with all participants giving their informed 
written consent. 
 
4.2.1 Methods 
 
For each participant in this study we needed to determine a ‘ground truth’ on whether a TL was 
‘abnormal or ‘normal’. To do this we devised a surrogate value from the threshold testing conducted 
in Chapter 3. From Moosavi and colleagues, the 95th centile normal limit of threshold was defined 
(Moosavi, In submission; MD Thesis). Results of four threshold search trials collected from this cohort 
were available. Examining threshold estimates at each location allowed a classification of whether a 
location was within or outside normal limits. If the result of two or more trials returned threshold 
estimations above the 95th centile then this test location was classified as outside normal limits 
(criterion 1).  An alternative stricter criterion was also examined: if a test location was classified as 
outside normal limits on 3 or more of the threshold estimation examinations, this test location was 
classified as outside normal limits (criterion 2). 
For suprathreshold estimation, the test subjects (visually healthy and glaucomatous patients) 
described in chapter two and three underwent an additional component during their second visit. In 
addition, during the second visit, subsequent to threshold examination described in chapter 3, each 
participant underwent MMDT testing with a customised ST tests strategy. During the ST strategy 
each location was tested three times, such that each TL had 3 trials performed in randomised order. 
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From this data C 1/2, MS 1/2 and MS 2/3 test outcomes were calculated. Each participant also 
underwent ESTA suprathreshold test separately. The order in which the ST and ESTA strategies were 
performed was randomised. 
Each TL, in both the ST strategy and the ESTA strategy was examined in random order with a 
displacement equivalent to that expected to be seen in an estimated 95th centile of visually healthy 
subjects. These values were the current machine norms, being derived from a study of 120 visually 
healthy subjects, where thresholds were established using a staircase algorithm (Moosavi, In 
submission; MD Thesis).  
The agreement and associated concordant/discordant pairs for each suprathreshold method against 
criterion 1 (Table 4-1) and criterion 2 (Table 4-2) were examined. The overall agreement as defined 
by Eqn 4-2 was also calculated, with the associated confidence limits. 
Equation 4-2 
             
                                   
                                   
 
 
4.2.2 Results 
 
Figure 4-5 shows the summary of test duration for each of the suprathreshold methods. C1/2 
suprathreshold method had shorter test duration than any other methodology.  ESTA showed an 
overall average increase of 17% (SD =17%, range = -7% to 73%) in test duration over C 1/2, being 
broken down as a 12% increase for visually healthy eyes (SD=9%, range = 3% to 32%) and 21% for 
glaucomatous eyes (std =22%, range = -7% to 73%).  The increase in number of required 
presentations for visually healthy and glaucomatous patients was significant (p=0.002 and P<0.001 
respectively; two sample t-test). ESTA required significantly less presentations than MS 1/2 or MS 2/3 
(p<0.0001 for all groups and subgroups, two sample t-test).  MS 1/2 took 51% longer than ESTA (SD 
=22%, range 8% to 85%), while MS 2/3 took 69% longer than ESTA (SD 22%, range 14% to 100%). 
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Figure 4-5 Scatter plot of the number of presentations required to reach termination for all 14 visually healthy (green) 
and 14 glaucoma patients (red), for each suprathreshold strategy (ESTA, C1/2, MS 1/2 and MS 2/3). Horizontal jitter has 
been added to help show the distribution of test duration. A box and whisker plot for each group is superimposed on top 
of the data points. The average number of presentations required is stated at the bottom of the graph under the 
corresponding group. 
Using criterion 1 as the reference standard, 31/448 (6.9%) test locations of normal subjects were 
outside normal limits, while 147/448 (32.8%) test locations of glaucomatous patients were outside 
normal limits. Similarly, using criterion 2 as the reference standard, 5/448 (1.1%) test locations of 
normal subjects were outside normal limits, while 94/448 (21.0%) test locations of glaucomatous 
patients were outside normal limits. 
MS 2/3 appears to have the greatest ‘agreement’ with the reference standard (criterion 2).  ESTA has 
the next greatest ‘agreement’, followed by C 1/2 and lastly MS 1/2. No other combination reached 
significance, most likely due to the small number of subjects in this study.  
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Table 4-1 Summary of agreement in classification between each suprathreshold method (ESTA, Conventional, 
Multisampling 1/2 and Multisampling 2/3) and the reference standard of criterion 1. 
Strategy Outcome Pass Fail Agreement
Pass 660 100
Concordant pairs 
(green + red) 717 72.40%
Fail 15 57
Discordant pairs 
(orange) 115 CI ± 2.3%
Pass 662 102
Concordant pairs 
(green + red) 717 72.40%
Fail 13 55
Discordant pairs 
(orange) 115 CI ± 2.3%
Pass 647 87
Concordant pairs 
(green + red) 717 72.40%
Fail 28 70
Discordant pairs 
(orange) 115 CI ± 2.3%
Pass 663 97
Concordant pairs 
(green + red) 723 73.80%
Fail 12 60
Discordant pairs 
(orange) 109 CI ± 2.3%
Multisampling 2/3
Criterion 1
Concordant/ Discordant 
pairs
ESTA
Conventional
Multisampling 1/2
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Table 4-2 Summary of agreement in classification between each suprathreshold method (ESTA, Conventional, 
Multisampling 1/2 and Multisampling 2/3) and the reference standard of criterion 2. 
 
4.2.3 Conclusion 
 
Conventional suprathreshold remains the fastest suprathreshold method.  However, the ESTA 
algorithm is up to 100% faster than MS 2/3. There was no significant difference found between ESTA 
and any other suprathreshold method in terms of ‘agreement’ about defect classification in this 
sample of participants. 
 
4.3 Discussion 
 
Strategy Outcome Pass Fail Agreement
Pass 726 34
Concordant pairs 
(green + red) 773 85.5%
Fail 25 47
Discordant pairs 
(orange) 59 CI ± 1.7%
Pass 727 37
Concordant pairs 
(green + red) 772 85.4%
Fail 24 45
Discordant pairs 
(orange) 61 CI ± 1.8%
Pass 706 28
Concordant pairs 
(green + red) 759 82.5%
Fail 45 53
Discordant pairs 
(orange) 73 CI ±1.9%
Pass 729 31
Concordant pairs 
(green + red) 779 87.3%
Fail 22 50
Discordant pairs 
(orange) 53 CI ± 1.7%
Multisampling 2/3
Criterion 2
Concordant/ Discordant 
pairs
ESTA
Conventional
Multisampling 1/2
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The data presented here is derived from a small sample of glaucomatous patients and visually 
healthy subjects and as such may not be representative of the general population or, indeed, of the 
glaucomatous patient population. However, this data demonstrates that ESTA performs to the 
conventional suprathreshold methods in terms of ‘agreement' against a surrogate reference 
standard determined from threshold testing. ESTA seems quicker than the multi-sampling 
approaches described by Artes et al (Artes et al., 2003) but doesn’t appear to lose diagnostic 
accuracy.  
Time saving is important in the context of getting more reliable perimetric results. According to 
Henson and Emuh the time between test onset and enlarged amplitude of  the ‘fatigue wave’ is less 
than  three minutes (Henson and Emuh, 2010). After three minutes the mid amplitude ‘fatigue wave’ 
can occur, which is associated with a 20% decrease in probability of seeing from 90% to 70% at 3dB 
above reference threshold. This shift in the FOS curve is associated with an ‘increase in amplitude of 
fatigue waves’. In some cases of visually healthy subjects this manifests as an apparent increase in 
lapse rate and corresponds to an increase in unseen presentations.  In a suprathreshold test of 
visually healthy subject the lapse rate is proportional to the number of locations flagged as 
‘defective’.  A quicker test will help keep ‘fatigue’ within acceptable limits, thus helping to maintain a 
low number of ‘defective’ locations in visually healthy naïve subjects. 
A higher presentation intensity level will be more robust to the fatigue effect described by Henson 
and Emuh (2009). However, the ideal presentation intensity level is not obvious. In strategies like 
that of the HEART algorithm, where the local normative value is estimated and a higher intensity 
level (5dB above threshold) is used (Henson and Artes, 2002) the shift in the underlying FOS curve 
associated with the ‘fatigue wave’ is likely to have a greater impact on the number of visually healthy 
subjects flagged as ‘abnormal’ than on those where the presentation intensity level is set at a 
predefined level from the normative database.  
Full field simulation (FFS) becomes particularly difficult when spatial information is being used.  If a 
new test algorithm exploits the spatial connectivity of the retinal sensitivity values, then testing it on 
a patient simulator that doesn’t incorporate the same information will, by experimental design, lead 
to incongruous results. At the same time if both incorporate the same spatial information then the 
results are likely to be unrealistic. To implement a FFS accurately, full field FOS data would be 
required, since this is not available the ORS approach with a full field simulation implemented was 
not attempted within this chapter. 
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Theoretically, the more information gathered on each location the better the probability of correctly 
labelling a location as ‘non- defective’ or ‘defective’ (Artes et al., 2003). Since the FOS curve changes 
considerably with increased test duration, there is an argument that collecting more information in 
suprathreshold testing weakens the ability of the test to correctly classify ‘normal’ and ‘abnormal’. 
Using the spatial information incorporated in the ESTA algorithm, may allow isolation of the test 
locations where further information is required, while minimally increasing test duration. 
It is clear that there is a delicate balance between time and accuracy, and this depends on the testing 
scenario. In the screening or case detection scenario, test duration is paramount to maintain both 
accuracy of suprathreshold test and acceptability of the test for the patient and operator. Put in 
context, a suprathreshold test such as ESTA, takes a little over one quarter of the time that a 
threshold test takes. It is accepted clinical practice that perimetric exams utilising threshold search 
methods are more suitable for secondary or tertiary care, where both the depth and the size of the 
VF defects are monitored. However, it is clear that in the screening or case finding scenario, the 
suprathreshold strategy has many advantages, for example, test results are easily interpretable and 
the test has high presentation intensity levels with short test duration. Combined these make 
suprathreshold testing more suitable for the naïve test subject. However, one question remains: 
does the threshold search method have greater diagnostic accuracy? In section 5.5, this question is 
revisited. 
 
5 Using the new test algorithms (ESTA and WEBS) 
 
One of the main outcomes from the work described in this thesis has been the development of novel 
perimetry test algorithms. To recap, one of these methods is designed to provide a rapid test to be 
used in screening and case finding (ESTA), whilst the other (WEBS, specifically designed for the 
MMDT) is intended for measuring the severity of impairment to a displacement stimuli at the 
different locations in the visual field, thus being equivalent to a ‘threshold’ test. This chapter first 
briefly describes interim results from a multi-centre prospective trial (started in 2009) designed to 
compare the performance of the MMDT, using the algorithms (ESTA and WEBS) as developed in this 
thesis, against other perimetric instruments (This will be referred to as the The Perimetry Instrument 
Comparison Study). A summary of this study will be given in section 5.1. The work reported in other 
parts of the chapter (sections 5.2 and 5.3) formed two posters presented at the Association for 
Research in Vision and Ophthalmology Meeting, Fort Lauderdale, Florida, USA in May 2010 ((Bergin 
et al., 2010a, Sinapis et al., 2010); see ‘List of supporting publications’). The joint authors of this work 
are Ciara Bergin [CB], Dimitrios Sinapis [DS], Angelos Sinapis [AS], Reza Moosavi [RM], Gay Verdon-
Roe [GVR], Richard Russell [RR], David Crabb [DC] and David Garway-Heath [DGH]. The study was 
conceived and designed by DGH, GVR with help from DC. The prospective data was collected from 
patients attending Moorfields Eye Hospital by DS, AS and RM. Other centres in Italy and Canada were 
involved in data collection (see below). Extensive data management across all centres was performed 
and co-ordinated by CB with help from GVR.  All the data and graphical analyses, along with 
development and conception of quantitative techniques, were performed by CB with some help from 
RR. One of the posters was wholly written and first authored by CB (Bergin et al. 2010a) with all other 
authors contributing in part. All the work was supervised by DGH and DC. The final study results are 
due to be reported in 2012. The work reported towards the end of the chapter (section 5.5) formed a 
read paper presentation at the 19th International Symposium of the Imaging and Perimetry Society 
Meeting in Tenerife, Spain in May 2010 ((Bergin et al., 2010b); See ‘List of supporting publications’). 
The joint authors of this work are Ciara Bergin [CB], Gay Verdon-Roe [GVR], Eamon Sharkawi [ES], 
David Crabb [DC] and David Garway-Heath [DGH]. The study was conceived and designed by ES. 
Subject testing and data collection was, in part, done by CB along with other workers at Hôpital 
Ophthalmique Jules-Gonin, Lausanne, Switzerland. Data analysis was performed by CB. The 
presentation was first authored by CB with all other authors contributing in part. 
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5.1 The perimetry instrument comparison study 
 
This study was conducted a four centres: Moorfields Eye Hospital, London, UK; Bietti Foundation, 
Rome, Italy; Dalhousie University, Halifax, Nova Scotia, Canada; and Waterloo University, Toronto, 
Canada. The study aimed to collect 160 visually healthy subjects and 160 glaucomatous patients. 
There are different aspects to this study: relative comparative diagnostic accuracy of three different 
perimeters with suprathreshold and four different perimeters with threshold testing strategies, and 
comparing the repeatability of these perimeters in threshold estimation. The overall study did not 
aim to assess the performance of the devices in routine clinical use. The index tests are all the 
different perimeters investigated in the study. In this way, the index tests (the different perimetric 
instruments) may be compared with each other and against a common reference standard. The 
reference standard is not taken as the ‘gold standard’ (as there is no gold standard for the diagnosis 
of glaucoma), so that the diagnostic accuracies determined in this study are relative, not absolute. 
The primary research objective of the The Perimetry Instrument Comparison Study (PICS) is to 
compare the sensitivity of the Humphrey visual field perimeter, Frequency Doubling Technology, 
Moorfields Motion Displacement Test (SAP, FDT, and MMDT respectively) and The Heidelberg Edge 
Perimeter (HEP using FDF perimetry) to detect glaucomatous RNFL loss. The study followed the 
guidelines of the STARD steering committee (Standards for Reporting of Diagnostic Accuracy) 
http://www.stard-statement.org/ (Bossuyt et al., 2003a, Bossuyt et al., 2003b).  The design of the 
experiment and sample calculations was primarily based on examining the performance of the 
different instruments in terms of sensitivity of each device at a fixed specificity of 95%. The study is 
powered (n=320) to give a 95% confidence interval (CI) of 90.4 to 97.4% for this fixed specificity 
(95%).  
All subjects underwent HRT imaging and IOP assessment (GAT). Visually healthy subjects were 
required to be “within normal limits” on the global and each sector of the Moorfields Classification 
with IOP≤21mmHg.  Glaucomatous patients were classified based as those subjects “Outside normal 
limits” for at least one sector of the Moorfields Classification with IOP>21mmHg at least once during 
follow-up before treatment, but not during the PICS data collection period. It was also required that 
both cohorts have no history of ocular surgery (apart from uncomplicated phacoemulsification) or 
other ocular pathology (eg cataract) or systemic disease which may affect visual performance.  Prior 
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to participation all subjects provided written informed consent in accordance with a protocol 
approved by NHS foundation trust, and in accordance to the tenets of the Declaration of Helsinki. 
 
 
5.2 Comparing the ‘screening’ strategies of three perimetry devices to 
discriminate between healthy and ‘glaucomatous’ eyes (interim results) 
 
5.2.1 Background and purpose 
 
Screening or case-finding perimetric tests demand higher specificity and shorter test duration than 
those in secondary or tertiary care, making suprathreshold testing a favoured choice. Furthermore, 
the ease of understanding and lower fatigue effect associated with ST tests is of added benefit in 
naïve subjects. A comprehensive review of the published literature pertaining to screening tools for 
glaucoma, including standard and newer types of perimetric devices, indicated that the FDT1 was a 
perimetric device with potential as a glaucoma screening tool (Mowatt et al., 2008). MMDT and FDF, 
however, were not included in that meta-analysis because these devices are not currently 
commercially available. SAP was included in the meta-analysis, as both a threshold test and a 
suprathreshold test. 
 
There were three perimetric instruments involved in this aspect of the perimetry comparison study, 
namely namely FDT1 (see section 1.7.3.2), MMDT (see section 1.7.3.3) and SAP (see section 1.7.2). 
The FDF screening test was still in development at the start point of this study.  
 
The FDT1 was selected over the FDT MATRIX as the screening tool, as it is reportedly the more widely 
used clinical tool in the UK (Myint et al., 2010, Myint et al., 2011). The format of the FDT1 C-20 test is 
of 17 test locations (see Figure 1-7 (C)). To the best of our knowledge details of the test strategy are 
not published. The C-20 format was selected as it was previously reported to have good 
discriminatory power (Cioffi et al., 2000, Nehmad and Madonna, 2008, Zwarts and Stoutenbeek, 
2010), with low learning and fatigue effects (Brush and Chen, 2004), and has been included in several 
comparative studies previously (De Tarso Ponte Pierre Filho et al., 2006, Iester et al., 2000).   
Approximately 20% of eyes fail the initial test and repeat testing has been recommended to increase 
specificity (Mansberger et al., 2007).  
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The MMDT 32-location format (see Figure 1-8 (B)) using the ESTA strategy (see section 4.1) was 
selected. This strategy had undergone the pilot study outlined in section 4.2, and also been included 
in a multi-instrument screening scenario in St. Kitts (Artes et al., 2009), where it reportedly had 
higher sensitivity than FDT MATRIX 24-2-1 and SAP 76-point screen 3 zone test at fixed levels of 
specificity.  
 
The SAP 64-point screener test format (see 1-5 (C)) with the C1/2 suprathreshold test is outlined in 
chapter 4. According to the manufacturers’ guidelines it is the standard screening ST test available on 
the HFA instrument (personal communication: John Hood October 2009). Suprathreshold testing in 
the HFA device have been largely neglected with little or no development in recent years.  
 
The aim of this aspect of the study was to consider interim study results of the relative diagnostic 
precision and test duration of the screening strategies of three perimetry devices (including MMDT 
using ESTA) to discriminate between healthy and ‘glaucomatous’ eyes, defined by neuroretinal rim 
loss and intraocular pressure (IOP) level (Bergin et al., 2010a). 
 
5.2.2 Methods 
  
The results from the first test session were examined. Visually healthy subjects and glaucomatous 
subjects were defined as outlined in section 5.1. One eye from each subject was selected for 
inclusion in the study; if both eyes met the study criteria then one eye was selected randomly. The 
order of the instruments was randomised between test subjects. Each subject underwent the 
training demonstration program for each instrument. If the reliability indices did not meet the 
criteria (SAP (FP<15%, FN<15%); FDT (FP<15%, FN<15%); MMDT (FP<15%)), the suprathreshold 
program was repeated once. If on repeat test results were not within the criteria specified, the 
subject was excluded from further testing and all data from this subject were excluded from analysis. 
 
5.2.3 Results 
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Two-hundred and sixty two (262) participants of the total 320 recruited subjects had completed 
suprathreshold testing when this data was analysed (interim results). This included 130 
‘glaucomatous’ eyes and 132 age-matched visually healthy subjects. The mean age of the subjects 
was 59.4 years with a range of 20 to 83 years. 
Using the classifications ‘glaucomatous’ and ‘healthy’, as described above, a receiver operator 
characteristic (ROC) curve and a partial ROC curve were constructed for the three techniques (Figure 
5-1 and Figure 5-2). A comparison of these curves showed an almost complete overlap indicating 
little, if any, difference in diagnostic accuracies (Figure 5-2). Sample sensitivity was calculated for 
each device at fixed specificities of 95% and 90% (Table 5-1). The sensitivity at these fixed levels of 
specificity was indistinguishable for SAP and MMDT. SAP and MMDT had better sensitivity than FDT 1 
at 95% specificity but this was not statistically significant. Interestingly, the cut-off criteria for FDT 1 
was 5 missed points (30% of points tested) at the 95% specificity level. In contrast, SAP and MMDT 
required less than 10% of points in the tested VF to be flagged as ‘defective’ to distinguish visually 
healthy subjects from ‘glaucomatous’ patients. 
 
Figure 5-1 Receiver operator characteristic curve for suprathreshold tests on SAP (red line), MDT (blue line) and FDT 
(green line). 
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Figure 5-2 The partial receiver operator curve (85%-100% specificity) analysis for each instrument, highlighting sensitivity 
at important high levels of specificty. The blue shaded area represents the 95% confidence interval for 95% specificity, 
while the lighter orange shaded area represents the 95% confidence interval for 90% specificity.  Within both intervals 
the measures for SAP, MMDT and FDT overlap to a large extent. 
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Instrument Sensitivity  @              
Specificity 95%  CI [92%, 
98%] 
Sensitivity  @                               
Specificity 90%  CI [84% ,95%] 
FDT 35% [26%,43%] 50%  [42%,59%] 
MMDT 46% [38%,54%] 50%  [42%,59%] 
SAP 46% [38%,54%] 55%  [46%,64%] 
Table 5-1 Summary of the sensitivity and specificity values of the three screening perimetric devices. 
Test duration for the three tests are summarised in Figure 5-3. The FDT C-20 is the fastest test, 
followed by MMDT ESTA with SAP 64-point suprathreshold test being the slowest. For healthy 
subjects the mean test time was 41s (SD=8s), 93s (SD=7s), 153s (SD=16s) for FDT, MMDT and SAP 
respectively. For ‘glaucomatous’ subjects the mean test time was 63s (SD=28s), 102s (SD=17s), 171s 
(SD=32s) for FDT, MMDT and SAP respectively. There FDT 1 was significantly faster than MDT ESTA 
and SAP 64point (p<0.001, two sample t-test). The visually healthy subjects had significantly shorter 
test duration than the glaucomatous patients for each of the instruments (p<0.001, two sample t-
test). 
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Figure 5-3  Summary of test duration of the three screening perimetric devices. 
 
5.2.4 Conclusion 
 
This interim analysis suggests that the relative diagnostic precision of the screening strategies for SAP 
(64-point screening), FDT1 (C20), MMDT (ESTA) in the clinic-based population of early glaucoma 
patients are equivalent. FDT1 (17 test points) and MMDT (32 test points) are quicker to perform than 
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the SAP screening strategy.  It is most likely related to the number of test locations with the test 
procedures having a lesser contribution.  
The large proportion of ‘defective’ test locations isolated by the FDT1 C-20 in order to achieve similar 
levels of specificity as MMDT and SAP, suggests that the referral criterion (2 ‘defective’ locations) is 
not at present set to the correct level. This is likely to be a significant contributor to the large 
proportion of tests failing the first screening (Mansberger et al., 2007). An adjustment to the referral 
criterion may remove the need for repeat testing.  
 
5.3 Comparing the diagnostic performance of four threshold perimetry tests to 
discriminate between healthy and ‘glaucomatous’ eyes (interim analysis) 
 
 
5.3.1 Background and purpose 
 
Agreement between instruments and in particular agreement between structural and functional 
measures aids clinical confirmation of glaucoma diagnosis and detection of glaucomatous 
progression. In this part of the perimetric comparison study we are comparing the relative diagnostic 
precision of each perimetric instrument, when diagnosis has been made independently of visual 
function measures. There were four perimetric instruments involved in this aspect of the perimetry 
comparison study, namely SAP (see section 1.7.2 ), FDT MATRIX (see section 1.7.3.2), HEP (with FDF 
stimulus type; see section 1.7.3.4) and MMDT (see section Figure 1.7.3.3). 
With SAP the standard 24-2 test pattern was selected (see Figure 1-5(B)). The SITA standard 
threshold algorithm was used. This is the most commonly reported testing format in the literature, 
therefore it is useful to continue to report on this format to allow comparison between this and 
other previously reported studies. The agreement between SAP and structural measures has been 
repeatedly examined; the outcomes have considerable variation dependent on disease severity of 
the study population (Bowd et al., 2008, Bowd et al., 2006, Bowd et al., 2001, Bowd et al., 2000, Shah 
et al., 2006).  
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The FDT 24-2 test pattern (see Figure 1-7 (B)) with a ZEST algorithm (Anderson, 2003b, Anderson and 
Johnson, 2006)(see section 3.2) was used. All threshold tests on the FDT MATRIX use the ZEST 
algorithm (Zeppieri and Johnson, 2008). The 24-2 format closely matches the test format of the HFA 
24-2 format, in terms of location placement, but it is not exact (see Figure 1-5 (B) and Figure 1-7 (B)). 
In the literature this test format has been used previously to compare the diagnostic accuracy to that 
of SAP SITA (Clement et al., 2009, Artes et al., 2005, Spry et al., 2005, Racette et al., 2008).  
The test pattern on the HEP with the FDF stimulus type was also the 24-2. The test locations of this 
format have been matched exactly to the stimulus locations reportedly used in the HFA SAP 24-2. 
The so-called “Standard Adaptive Staircase Thresholding Algorithm” (ASTA-Std) has been 
implemented on this instrument. There is no real detail about this algorithm in the literature and it 
has simply been described as using up/down staircase procedure that is modified relative to the 
expected normal database. This test format has recently been used to compare threshold and 
deficits estimates of FDF to those of HFA SAP SITA (Calvo Perez et al., 2011, Gil, 2011). 
The test format of the MMDT is different from the standard 52 point 24-2 test format. In this case a 
subset, 32 of the 52 points, were selected for testing. These 32 test locations correspond directly to 
32 of the 52 test locations tested in FDF and SAP. The test algorithm used in this scenario was WEBS 
as documented in section 3.3.1. Until this time the multi-locational MMDT has not been included in 
any large comparative studies.  
The purpose of this aspect of the study was to  consider interim results of the relative diagnostic 
performance of four threshold tests, including MMDT using WEBS,  to discriminate between healthy 
and ‘glaucomatous’ eyes, defined by neuroretinal rim loss and intraocular pressure (IOP) level 
(Sinapis et al., 2010). 
5.3.2 Methods  
 
For this aspect of the perimetry instrument comparison study, between the four test centres 274 of 
the 320 test subjects were recruited and tested. Of these 136 were classified as ‘glaucomatous’ 
based on outside normal limits HRT MRA analysis and elevated IOP (>21mmHg), while 138 age 
matched healthy controls were also examined. Test subjects were divided into visually healthy 
(green) and ‘glaucomatous’ patients (orange) based on OHN appearance and IOP.  
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Each subject underwent the training demonstration program and suprathreshold test for each 
instrument, prior to undergoing the threshold examination. If the reliability indices did not meet the 
criteria (SAP (FP<15%, FN<15%); FDT (FP<15%, FN<15%); MMDT (FP<15%)) on either the 
suprathreshold or threshold test, the examination was repeated once. If on repeat test results were 
not within the criteria specified, the subject was excluded from further testing. The order of 
instruments was randomised. The threshold tests examined were SAP 24-2 SITA, FDT 24-2 ZEST, HEP 
24-2 ASTA-Std and MMDT 32 point WEBS. 
Those locations outside normal limits or ‘defective’ were selected for analysis. In a visually healthy 
subject, due to the probabilistic nature of the exam, we would expect two locations to be outside 
normal limits, we would not expect, however, that these locations would be neighbours. Therefore 
the size of the largest cluster of neighbouring defective locations was calculated. For example in 
Figure 5-4 there are two clusters of defective locations marked A and B, plus a single defective 
location C. A contains eight neighbouring defective locations; whereas B contains a cluster of five, 
therefore, eight is the size of the largest cluster of defective locations. The result of relative 
diagnostic precision in terms of sensitivity and specificity were calculated for each instrument. 
 
Figure 5-4 example of clusters of defective locations for cluster size analysis 
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5.3.3 Results 
 
The ROC curves shown display the sensitivity of an instrument on the y-axis against 1- specificity 
(false-positive rate) on the x-axis (Figure 5-5). This figure shows the comparison of the ROC curves of 
each perimeter. Numbered points indicate the size of the largest depressed cluster. The total number 
of points tested varied for each instrument (see Table 5-2). For approximately 95% specificity, the 
corresponding sensitivity and maximum size of depressed cluster per instrument are shown. 
 
Table 5-2 Diagnostic characteristics for each instrument. 
 
Figure 5-5 ROC curves of HEP, SAP, FDT and MMDT are shown in purple, green, blue and red, respectively. Numbered 
points indicate the size of the largest depressed cluster and the corresponding sensitivity and specificity. 
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5.3.4 Conclusion 
 
Diagnostic precision as estimated by ROC analysis suggest there is little difference between the perimeters, 
there was no significant difference in the sensitivities of all four perimetry instruments at 95% specificity. Since 
patients with early glaucoma were tested, a structure/function agreement is reportedly low at this stage. 
  
5.4 Discussion of Perimetry Instrument Comparison Study 
 
The results reported in section 5.3 and 5.4 are interim results and before any firm conclusions are 
drawn the full dataset will have to be examined. The study is powered for a larger sample size 
(n=320), with the current number (n≈260) the width of the confidence interval is slightly larger 
(n=260 gives a 95% confidence interval (CI) of 89.8 to 97.8% for this fixed specificity (95%)). So, the 
final results of the study are not expected to vary greatly from those reported here. 
Unlike previous perimetric comparison studies, the definition of the presence of glaucoma was made 
independent of functional measures. In this manner the large selection bias present in previously 
reported studies was significantly reduced. This study has placed these perimetric devices on a 
relatively level ‘playing-field’ for comparison. The key point is that the reference standard is 
independent of the index tests following the recommendations of STARD (Bossuyt et al., 2003b). 
Agreement between structural measures from images of the ONH on classifications (of disease 
presence/progression) and that with functional measures has been examined (Wollstein et al., 2000, 
Harwerth and Quigley, 2006, Shah et al., 2006). Reported agreement in classification of disease 
presence is low in early glaucoma. As outlined in section 1.4.2, this is likely due in part to varying 
sources of measurement error.  Regardless of the cause, while examining relative diagnostic accuracy 
of perimetric devices with diagnosis of glaucoma based on structural measures, this low level of 
agreement between structure and function will cause relative sensitivity of all perimetric devices to 
be low. Other approaches to the problem of comparing instruments could include that suggested by 
Artes and colleagues (2009), using a technique that exposes the signal to noise ratio of a test.   
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All test subjects included in this study underwent training and were prone to strict reliability 
requirements with respect to false positive rates and false negative rates. Therefore learning effects 
and highly variable subjects should not be a confounder of this study. 
When comparing the ROC curves reported in section 5.3 and 5.4 it is interesting to find that at 95% 
specificity there was no significant difference between the sensitivity reported with threshold or 
suprathreshold testing methodologies. Therefore with respect to diagnostic accuracy there is no 
discernable difference between threshold or suprathreshold methods. This is an important 
observation, because this suggests that for glaucoma detection the suprathreshold tests would 
perform as well as the threshold tests. 
The results from sections 5.2 and 5.3 illustrate an important discussion point. In both the 
suprathreshold test and the threshold test, a larger proportion than expected of test locations were 
flagged as ‘defective’ to achieve high levels of specificity. In the FDT1 suprathreshold test, to achieve 
specificity of 95% or greater, five out of 17 test locations must have been ‘defective’. In the MMDT 
and SAP this remained at two/three missed locations. This suggests that the diagnostic accuracy of 
the FDT1 may be undermined by its referral criterion. In threshold perimetry, the FDF stimulus 
requires the largest sized cluster of missed locations, SAP the next, followed by FDT MATRIX and 
finally the MDT, suggesting that the normative cut offs vary considerable between instruments. This 
information is invaluable when considering the diagnostic precision of these methods.  
The perimetry instrument comparison study demonstrates the utility of the testing algorithms 
developed from the work of this thesis. The interim results suggest that both WEBS and ESTA, as 
used on the MMDT platform, are at least ‘reliable’ and operational. Indeed, they appear to produce 
results that are at least equivalent to those testing strategies that are used on other commercially 
available perimeters. This is important evidence for the utility of these methods. This is recently 
supported by another independent study where MMDT ESTA was used in a small screening study 
(Artes et al., 2009). 
 
5.5 Performance of MMDT ESTA in a ‘screening’ event for glaucoma 
 
On World Glaucoma Day (WGD), the 12th of March 2009, citizens of Lausanne Switzerland and the 
surrounding area were invited to attend a free glaucoma screening day at the Jules-Gonin ophthalmic 
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hospital. Advertisements about glaucoma awareness had been made on the radio and in the local 
newspapers in the preceding weeks, in preparation for the event. Details of risk factors for glaucoma 
were stressed in these advertisements; in particular age and family history of glaucoma. 
One of the purposes of this study (reported here) was to assess the acceptability of the MDT ESTA 
device in the screening scenario and a comparison of performance with the reference standard of 
ophthalmologist based follow-up. Retrospective ethical approval was granted by the ethical 
committee of the Canton of Vaud, Switzerland for this study. 
 
5.5.1 The event and demographics of attendees 
 
In total 312 people attended this screening event. The age of the attendees was skewed towards the 
older age groups as shown in Figure 5-6. Family history of glaucoma was reported by approximately 
21% of this cohort. The median age for a subject with family history of glaucoma in attendance was 
56 years, whereas the median age for all other subjects in attendance was 64.5 years. This suggests 
that this risk factor was a consideration of those in attendance. 
 
Figure 5-6 Histogram of the age demographics of subjects attending WGD 2009. 
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5.5.2 Methods 
 
Due to unanticipated demand, only 167 of 312 attendees completed visual function assessment on 
the day. The visual function assessment included MMDT testing using the ESTA testing strategy. The 
referral criterion for this device was if two or more visual field points with the ESTA algorithm (see 
section 4.1) were flagged as defective. 
Each subject was subsequently assessed by one of 14 general ophthalmologists. Assessments were 
approximately 15-25 minutes in duration and comprised of slit lamp assessment of the disc, IOP 
(GAT), gonioscopy assessment of the iridocorneal angles and Van Herick assessment. Suspicious 
clinical exam would entail one or more of the following: cup-disc ratio ≥0.7, IOP ≥ 21mmHg, 
gonioscopy ≤10 degrees in two or more quadrants, Van Herick <1/4. 
If a test subject on WGD failed the ‘clinical’ examination or had an ‘abnormal’ MMDT result, they 
were requested to return for a second appointment with a glaucoma specialist. However, some of 
those attending WGD were already in the care of an ophthalmologist and requested to be allowed to 
return to their own practitioner for follow-up appointments. This meant that 40 subjects were lost to 
follow-up.  
 
5.5.3 Results 
 
Test acceptability 
The test duration was relatively quick, with a median of 99 seconds, the distribution of the test 
durations for left eye, right eye and average per patient is shown in Figure 5-7.  
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Figure 5-7  Histogram of the distribution of test duration. 
Workflow of the MMDT, using the ESTA algorithm, made it possible to see as many as nine test 
subjects in a single hour, with a single instrument, equating to 6 minutes 40 seconds per test subject 
(Figure 5-8). 
 
Figure 5-8 Bar chart of number of test sessions per instrument throughout the day. 
With the MMDT ESTA program the number of location missed, directly contributes to the PTD value 
as described in chapter 4. The distribution of the total PTD values of those subjects examined at the 
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WGD event is show in Figure 5-9. Over seventy per cent of the subjects had a PTD value less than 1.5 
in the worse eye, which equates to less than 2 points recorded as ‘defective’.  
 
Figure 5-9 The distribution of MMDT PTD for attendees of WGD 2009, for Left, Right and max of Right and Left. 
The flow chart shown in  
Figure 5-10 gives the breakdown of the process for referral, second visit and diagnosis. This is 
followed by an examination of the relative sensitivity and specificity of the MMDT device in the 
screening scenario. 
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HRT
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Clinical Exam Glaucoma Specialist
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Visual field Damage
&
Structural damage
N=8
Diagnosed Suspicious
Visual field Damage
Or
Structural damage
N=10
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No measurable visual field 
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Or 
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With Risk Factors 
(IOP/ Narrow angles)
N=14
Without Risk factors
N=37
MDT PTD<2
&
Normal IOP, Disc & 
angles & GQL-15
N=41
NO second visit
 
Figure 5-10 Flow chart of referrals from WGD 2009. 
The MMDT was performed on 48% of the participants, between 86% and 95% of all other indices 
were recorded for all subjects. 43% of participants had all data recorded (150 subjects). This group 
will be the core group for analysis. For both referral criteria approximately 61% of those whom were 
referred for a second visit attended a second visit at the JGOH (40 subjects lost to follow-up). Nine 
subjects were referred due to non-glaucoma related pathology e.g. cataract or age-related macular 
degeneration. 
The classification criterion of MDT PTD result >2.0, detected 88% of the test positive cases, while 
with this criterion only 4% of the test negative without risk factors were wrongly classified as 
“abnormal” (Figure 5-11). In a comparison of diagnostic accuracy between the MMDT and IOP, 
MMDT was significantly better at detecting the test positive from the test negative than IOP (Table 
5-3). 
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Figure 5-11 Bar chart of the assessment of the performance of the MMDT following phenotyping with the cut-off 
criterion PTD of 2.0. 
 
 
 
 
 
 
 
 
Table 5-3 Summary of each of positive predictive values and negative predictive values of IOP and MMDT ESTA. 
 
 
Instrument Cohort Cut-off Positive predictive 
power 95% CI 
Negative predictive 
power 95% CI 
MMDT         
  
Test positive PTD=3.5 47% [21%,72%] 100% [92%, 100%] 
Test suspicious PTD=3.5 48% [31%,66%] 52% [35%,69%] 
IOP  Test positive 23mmHg 33% [0%,87%] 54%[27%, 81%] 
Test suspicious 21 mmHg 50% [24%,76%] 51%[37%,65%] 
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5.5.4 Discussion 
 
The speed of the ESTA MMDT in the screening scenario is clearly demonstrated in this study. In 
Figure 5-8 the number of sessions achieved with one ESTA MMDT device is reported. At peak flow, 
nine patients were tested on the same instrument in one hour. It follows that at this time point, 
other eye occlusion, test explanation and testing both eyes including any required repeated fields 
was taking on average 6.5 minutes. With this type of perimetric screening test, visual field 
assessment cannot be labelled as “unfeasible”. This is an important observation for MMDT ESTA. 
The results from this study illustrate the utility of the ESTA algorithm on the MMDT, in particular the 
usefulness of a quick test that appears to produce ‘reliable’ results. In this study, MMDT ESTA 
detected close to 90% of the glaucomatous patients (test positive), while only 4% of visually healthy 
subject (test negative without risk factors) were recalled. However, it is very important to note, the 
small number of participants and the large proportion lost to follow-up restricts the strength of this 
study. 
Patient acceptability and clinical practicability of perimetric devices are often undervalued when 
determining the quality of visual function assessment. In a recent assessment of patient acceptability 
the less patient dependent tests were rated with higher patient acceptability e.g.  IOP has higher 
patient acceptability than functional tests (Gardiner and Demirel, 2008). In the comparison of these 
perimetric tests the FDT MATRIX rated higher than the SWAP despite having the longer test duration 
(Gardiner and Demirel, 2008). This difference was attributed to ‘increased mental fatigue and 
frustration caused by uncertainty about whether they saw the stimulus or not’. If the test is easier to 
understand, for example is on a familiar platform like a laptop, and is of a short duration, then it 
follows that both the patient and the clinician will be more willing to repeat the exam if there is a 
doubtful result. Repeated fields will reduce the number of abnormal results, for example a reduction 
of 30% was reported with the FDT1 in the screening scenario (Mansberger et al., 2007).  
 
 
6 The effect of induced intraocular stray light on perimetric tests 
 
As outlined in the introduction to this thesis perimetry has become a well-established and valuable 
tool for the detection and monitoring of sensitivity loss that accompanies various diseases of the 
visual pathway, especially glaucoma. While the structure/function debate continues, no consensus 
has been reached on why, in some individuals, structural loss is observed at a retinal level before 
functional loss is identified with standard automated (contrast) perimetry (SAP) using a white-on-
white stimulus (Quigley et al., 1982, Harwerth et al., 1999, Fraser and Manvikar, 2005). This has 
prompted a search for newer perimetric techniques designed to detect functional changes earlier, 
however these newer stimuli type may prove more robust to factors that affect the measurement of 
retinal function. The seemingly reduced diagnostic sensitivity of perimetry is due, to a large degree, 
to inherent variability within the normative data and measurement noise (Artes et al., 2002b). With 
age being an important risk factor for glaucoma, it is imperative that other causes of age-related 
losses of vision (particularly optical deficits) are accounted for when quantifying neural loss due to 
pathology. 
There have been many studies demonstrating the effect of cataract on visual field sensitivity, mainly 
by comparing visual function before and after cataract extraction and intraocular lens implantation. 
In several studies, Standard Automated Perimetry (SAP)(Lam et al., 1991, Hayashi et al., 2001, 
Membrey and Fitzke, 2001) and Frequency Doubling Technology (FDT)(Tanna et al., 2004, Membrey 
and Fitzke, 2001, Siddiqui et al., 2005) mean deviation was significantly reduced in the presence of 
cataract. Although it is recognised that cataract can significantly affect perimetric thresholds, the 
degree and nature of lens opacity or cataract was often poorly quantified or characterised in these 
studies. In addition, it is not immediately clear which particular aspects of optics confound the 
quantification of neural vision loss to the greatest degree. The ageing lens displays changes in general 
light absorption (Werner, 1982, Pokorny et al., 1987) forward and backward light scatter (Van den 
Berg et al., 2007) and spectral transmission characteristics (Said and Weale, 1959, Ruddock, 1965, 
Sample et al., 1988). The relative contribution of each of these to perimetric threshold increase is not 
clearly understood. 
One result of ageing in general, and cataract formation in particular, is an increase in intraocular 
stray light (IOS), arising from increased forward light scatter (de Waard et al., 1992, Van den Berg and 
Od, 1995, Van den Berg et al., 2007). Increases in IOS cause a shortening and widening of the point-
spread function of the eye, resulting in reduced contrast sensitivity. Although IOS varies between 
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individuals, even in the young healthy eye, largely as a result of differing ocular pigmentation 
(Franssen et al., 2007, Van den Berg and Od, 1995), IOS values associated with cataract are greater 
(de Wit et al., 2006, Ijspreet et al., 1990). It is reasonable to expect that some perimetric stimuli 
might be more susceptible to the influence of additional IOS than others (as some are being 
modulated in contrast while others are being modulated along a spatial scale). It follows that of the 
various forms of commercially available perimeters (which often employ different stimulus types 
with different configurations) some may be affected more than others with additional IOS. 
Several studies have used white diffusing filters during perimetry to simulate the effects of cataract 
(de Wit et al., 2006, Wood et al., 1987, Membrey et al., 1999, Budenz et al., 1993). These studies 
have shown a general depression of the hill of vision with SAP (on both the Humphrey Field Analyzer 
and the Octopus perimeter) and FDT perimetry; there were significant reductions in sensitivity after 
the introduction in front of the eye of diffusing filters consisting of photographic filter foils (Membrey 
et al., 1999), 500nm latex beads (Wood et al., 1987) or ground glass (Budenz et al., 1993). The results 
found with these cataract simulations were consistent with those reported in patient cases of pre- 
and post-operative cataract removal, although the degree of simulated cataract was not quantified in 
a way that could be correlated with physiological or pathological states of the eye’s optical quality. 
Membrey et al (1998) carried out a study to investigate the effects of simulated cataract (using one 
white diffusing filter) on the FDT (FDT1, 24-2), SAP (HFA II, Full Threshold) and a prototype Motion 
Discrimination Test (MMDT) (using single line presentation) and comparisons were made between 
these three instruments using standardised values for the thresholds. They concluded that the 
MMDT stimulus was more resilient to this form of simulated cataract compared to the stimuli used in 
SAP and FDT. Significant modifications have been made to the test strategies, formats and stimuli 
used in these clinical devices since this study was conducted and the relationship between the 
properties of the diffusing filter and the various forms of lens opacity is not well defined.  
Diffusing filters used for cataract simulation have traditionally been characterised either nominally or 
by their optical density.  However, a recent study by de Wit et al has considered the use of diffusing 
filters as a simulation of cataract (de Wit et al., 2006) by comparing the light scattering properties of 
the filters with those of cataract. Anderson et al, recently investigated the effects of intraocular stray 
light, induced by white opacity filters (WOFs; LEE Filters, Andover, UK) of different grades on various 
forms of perimetry (SAP, FDT1, short-wavelength automated perimetry (SWAP) and peripheral 
grating resolution perimetry (GRP))(Anderson et al., 2009). The WOFs contain light-scattering 
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particles within the matrix of the polymer rather than etchings on the surface, resulting in wide angle 
scatter similar to that caused by cataract (Anderson et al., 2009, de Wit et al., 2006, Franssen et al., 
2007). A particular strength of the study by Anderson and colleagues (Anderson et al., 2009) was that 
the magnitude of intraocular stray light induced by each filter was quantified using the Oculus C-
Quant cataract quantifier (Oculus, Wetzlar, Germany) as described by Franssen and colleagues 
(Franssen et al., 2006).  
The aim of this study is to examine the effect of IOS, using similar methodology to Anderson and 
colleagues (Anderson et al., 2009) on threshold measurements for stimuli employed in four 
perimeters: namely HFA SAP SITA, FDT MATRIX ZEST, MDT WEBS and HEP FDF ASTA-Std. 
The work reported in this chapter has formed a paper published by Investigative Ophthalmology and 
Visual Science ((Bergin et al., 2011); See ‘List of supporting publications’). The joint authors of this 
work are Ciara Bergin [CB], Tony Redmond [TR], Neil Nathwani [NN], Gay Verdon-Roe [GVR], David 
Crabb [DC], Roger Anderson [RA] and David Garway-Heath [DGH]. The experiments were conducted 
by CB, TR and NN.  The experiment was conceived jointly by all the authors. CB performed all the 
data analysis and wrote the manuscript with contributions from all the authors and the work was 
supervised by DC and DGH. The results in this chapter have also in part been presented as a poster 
presentation at the Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, 
Florida, USA in May 2009 ((Verdon-Roe et al., 2009); See ‘List of supporting publications’). 
 
6.1 Method to detect difference in measurements with additional stray light 
 
Six healthy, psychophysically experienced volunteers (aged 21-29 [mean 26] years) participated in 
this study. None had a history of ocular pathology or systemic disease that may affect visual 
performance and none had previous ocular surgery. Inclusion criteria included optic disc rim area 
classified as “within normal limits” by Moorfields Regression Analysis of the Heidelberg Retina 
Tomograph (HRT II; Heidelberg Engineering, Heidelberg, Germany) and intraocular pressure 
<21mmHg. The right eye was tested for all subjects and each wore appropriate near correction, 
refractive error ranged from 0 to -4.25 [mean -2.10] dioptres sphere. Subjects had negligible 
astigmatism (≤0.50 dioptres cylinder). Best-corrected visual acuity for each observer was 20/17 (6/5) 
or better. All subjects were reliable (false positives <20%, false negatives <33% and fixation losses 
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<33%) in two initial practice sessions on each perimeter. The study had local ethical approval from 
City University, London with recruitment and experimentation adhering to the tenets of the 
Declaration of Helsinki. 
 
6.1.1 Perimetric Stimuli 
 
Four types of perimetry were employed namely HFA II; SITA-Standard 24-2 program,  FDT Matrix; 
24-2 ZEST program, HEP; 24-2 ASTA, MMDT; 32 WEBS. As mentioned previously, each perimeter has 
a different stimulus, detection task and thus scale on which threshold is measured. SAP is measured 
on an inverse log scale of Michelson contrast, the dynamic range of the instrument is 0dB to 40dB 
(which in terms of contrast >99% contrast to <1% contrast). FDT also has a contrast modulated 
stimulus, Michelson contrast varies between 100% and 1%, and thresholds are measured on a log 
scale ranging from 0dB to 38dB.  FDF on the Heidelberg Edge Perimeter (HEP) is also a contrast 
modulated stimulus, Michelson contrast varies between 100% and 1%, and is measured on a log 
scale ranging from 0dB to 22dB. Within the software there is a default scale has been transformed to 
match the dynamic range to that of the HFA clinical instrument. For this study we used the non-
transformed version of threshold measures from the HEP. Finally, the stimulus of the MMDT is 
modulated in magnitude of displacement; displacements vary between 2min of arc and 40 min of 
arc. 
 
6.1.2  White Opacity Filters (WOF) 
 
Five white resin opacity-containing filters were used (Fog 1 to 5). These WOFs had mean light 
transmittance spectra ranging from 0.86 (Fog 1) to 0.42 (Fog 5) as measured against an achromatic 
CRT screen (luminance: 10cd/m2; x = 0.218, y = 0.328) For ease of use, these filters were cut and 
edged into spectacle frames with large aperture lens. Blenderm tape over a blank lens was used to 
occlude the non-test eye in order to eliminate the detection of form or movement.  
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6.1.3 Psychophysical measurements 
 
The C-Quant stray light meter (Oculus, Wetzlar, Germany) was used to determine IOS (log(s)) values 
using the ‘compensation comparison’ method (Franssen et al., 2006). A baseline (no WOF) IOS was 
recorded and an IOS value with each of the filters, for each subject. The order of measurements was 
randomised between subjects. 
To characterise the subjects, IOS for each subject under each condition are shown in Figure 6-1 (a). 
The C-quant software provides an estimation of the typical age equivalent IOS that is simulated using 
each WOF. For example, an average 25 year old has an IOS value of ~0.85log(s) and an increase in IOS 
of 40% (to 1.2log(s)) renders the subject similar to an average 70 year old. The WOFs yielded an 
increase in IOS of 10%-200% from baseline, resulting in IOS values seen in normal ageing to those 
obtained from patients with considerable cataract. Figure 6-1(b) shows approximate mean age as 
estimated by the C-quant normative database with respect to the filters (Ijspreet et al., 1990, Van 
den Berg and Od, 1995). 
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Figure 6-1(A) The measured change in IOS for each subject at baseline (no WOF) and fog filters 1-5. (B) the age equivalent 
induced by each WOF across subjects, according to the C- Quant normative database. This normative database gives the 
mean and the limits of normality, which have been translated here into mean predicted age 
SAP, FDT perimetry, FDF perimetry and the MMDT were performed once by each subject with each 
of the 5 WOFs and once without a filter. The order of the tests and filters was randomized to avoid 
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bias or possible learning effects. Each subject underwent 6 sessions, each session consisting of 1 trial 
with each perimeter with one (or no) WOF, resulting in a total of 24 trials. After each trial there was a 
rest period of five minutes, no more than 2 sessions were performed in one day.  
 
6.2 Analysis of the different effects of IOS 
 
Direct comparison of average threshold values is of limited value because each instrument uses a 
different stimulus type measured on scales unique to that stimulus. Comparative threshold values 
were determined by relating each test value to a normative distribution for each instrument. For 
example, if a measured threshold on SAP lies on or outside the 95% limit of normality and, at the 
same location, the measured threshold at the FDF lies on or outside the 95% limit of normality, then 
it would be reasonable to assume that the two thresholds are equivalent. However, a comparison of 
all possible levels on the probability scale of normality is required, i.e. 0%-100%, not just at the 
discrete levels of 95%, 98% etc. In order to achieve this we employed previously-generated 
normative database information for each of the perimeters involved in this study.  
The normative database information used here for both the FDF and the MMDT were made directly 
available to us from the developers. For SAP, a normative database of 120 right eyes was formed 
from retrospective data collected at Moorfields Eye Hospital for a separate study. For FDT, estimates 
were made from published material (Anderson et al., 2005, Van den Berg and Od, 1995). Thresholds 
were then transformed to z-scores (Hill, 1966, Van den Berg and Od, 1995).Using normative data we 
can establish the position of each TMS on the normal ranges, i.e. near the mean, 1 standard 
deviation away, 1.96 standard deviations (this corresponds to the 95% limit of normality shown on 
the TD maps) or outside normal limits. 
Thresholds were compiled for all 192 trials (8 × 24 trials). For FDF, FDT and SAP, sensitivity values 
were transferred manually to a computerised database. The MMDT allowed for automatic transfer. 
All data were then analysed using the statistics package within Matlab (version 7.2.0.232 (R2006a)). 
Points were analysed at all locations, then 32 matched locations, then, centrally [4 matched 
locations: (+/-3, +/-3), mid periphery [8 matched locations (+/-9,+/-3),(-9,+/-9),(+3,+/-9)] and 
peripherally [16 matched locations: (-27,+/-3), (+/-21,+/-3), (+/-21,+/-9), (+/-15,+/-15), (+9,+/-15)]. 
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Since the results of this study were consistent throughout only those results from “all locations” are 
reported below  
 
6.3 Degree of the effect of IOS 
 
Examining the change in Mean Deviation (MD), from baseline to WOF5 is clinically significant in SAP 
FDT and FDF (SAP=-4.4dB; FDT=-6.5dB; MDT=+0.7Min of Arc and FDF=10.1dB). Since each instrument 
measures along a different scale, we cannot compare one instrument with another; however we can 
examine how each instrument behaves with increases in IOS. A two-way ANOVA with  subjects acting 
as blocks in the experiment and the main factor being each grade of WOF indicated that MD as 
measured with FDT, SAP and FDF worsens across the different WOF (P<0.0001). Conversely, there 
was no evidence of a difference in MD values for MMDT across the different WOFs (P=0.18). 
Threshold Mean Sensitivity (TMS) is the average measured sensitivity; we examined the relationship 
between TMS and grade of WOF used. We found that with WOF greater than grade 4, SAP (p<.001), 
FDT (p=0.003) and FDF (p<0.001) were highly significantly affected and MMDT TMS values did not 
have a significant association with the density of FOG filter used (p=0.73) (ANOVA).  
All subjects had different stray light values for each of the WOF filters used. To reduce the spread of 
the data points, TMS values were plotted against the respective C-Quant log(s) values; this is 
represented in Figure 6-2, here the shaded area represents the approximate normative range for 
each instrument. Using linear regression, the dB (or minutes of arc for MMDT) loss per log(s) for each 
perimeter is estimated; the FDF, SAP and FDT are all significantly associated (p<.001) by IOS; MMDT 
does not have significant slope (p=.34). The estimated slopes were: SAP=-1.6dB/log(s), FDT=-
1.7dB/log(s), FDF=-3.1dB/log(s) and MMDT=-0.1minutes of arc/log(s)). 
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Figure 6-2 Shows the Threshold Mean Sensitivity with respect to the (1-4) grade of White Opacity Filter, where the grey 
area represents the normative range. It is clear that despite the negative trend in Frequency Defined Form, Standard 
Automated Perimetry and Frequency Doubling Technology, they mainly remain with the normative range of measured 
values. 
A direct comparison between instruments, with respect to the changes in TMS values due to 
increases in stray light can be achieved using z-scores. Here we derived the z-scores using our 
independent normative databases. To calculate the z-score we compute the difference between the 
age corrected mean of the normative database at a location and TMS value at the matched location. 
The resultant value is divided by the spread of the respective (age corrected) normative database for 
the matched location. Figure 6-3(a) summarises the calculated z-scores (for each subject with each 
grade of the WOF) against the respective C-Quant log(s) values.  
We grouped these results into 3 bands with respect to the measured IOS, these bands were chosen 
to correspond loosely with Franssen et al classifications within normal limits, outside normal limits 
and significant cataract (Franssen et al., 2006, Franssen et al., 2007). Pointwise z-scores were derived 
and the distribution of these values is summarised using a box and whisker plot.  This allows us to see 
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the overall trend (the median is represented by the solid line within the box) as well as the IQR (size 
of the box) and the range of the data points (length of the line). Comparing the measurement noise 
between instruments, would suggest that MMDT has the least amount of measurement noise and 
FDF the most. The average threshold for all perimeters did not lie on the average normal line for the 
band of 10-50% in IOS, therefore we derived the standardised z-scores. 
In Figure 6-3(b) the standardised z-scores are plotted against the percentage increase in stray light. 
The 3 bands for grouping in this case were with respect to the percentage change from baseline of 
IOS namely; 10-50%, 50%-100%, 100%-200%. The associated p-values are displayed at the base of 
the graphs (ANOVA). MMDT was not significantly affected and SAP was not significantly affected with 
IOS increases of less than 50%, FDT and FDF were highly significantly affected at all stages and SAP 
with increases in IOS of greater than 50%.  
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Figure 6-3 (A) Box and whisker plot of the z-scores against the respective increase in stray light, 3 subgroups 0-1.2dB, 
1.2dB-1.6dB and 1.6-2.0dB (B) Box and whisker plot of the distribution of TMS values for each instrument for 3 degress of 
increases in IOS; 10-50%, 50-100% and 100-200%. The grey line bisecting each box is representative of the median z-
score. The heavy black lines across the graph show the confidence limits for the normative range corresponding to the 
75% cut-off and 95% cut-off. (* denotes a significant difference p<0.01, ** p<0.0001, ANOVA two way test)  
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The mean standardised z-score against the change in stray light was plotted Figure 6-4. Each symbol 
here represents the mean of the standardised z-scores for one subject with one filter, of which there 
will be four means, one for each instrument (four different symbols). The calculated slopes using 
linear regression give an estimated order to the robustness of each of the instruments to increases in 
IOS. MMDT shows little to no association with IOS (slope=-0.00), SAP shows weak association with 
IOS (slope=-1.21), followed closely by FDT (slope=-1.57), and finally FDF with a considerably stronger 
association (slope=-2.56). 
 
Figure 6-4 Scatterplot of standardised z-scores with respect to the change in stray light. Each symbol represents a 
different instrument. Each marker shows a mean standardised z-score for one subject, with one instrument and one 
filter. 
On examining the differences of the effect of IOS on threshold with eccentricity as an explanatory 
variable, SAP and FDF were uniformly affected by stray light with no significant differences between 
the central, mid or periphery groups. For the MMDT, there was no significant difference between the 
central and peripheral groups, however there were significant differences (p<.02) between the mid 
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and central and the mid and peripheral groups. For FDT mildly significant differences (p<.05) were 
found between the central and mid-range groups. This may have be effect by the reduced Michelson 
contrast and change in length of line stimuli (energy) see discussion. 
 
6.4 Discussion 
 
Perimetry has two purposes, for monitoring disease and for case-detection. For both roles, it is 
important that the test result is not confounded by eye conditions other than the ‘target’ condition 
(in this case glaucoma). For monitoring, progressive cataract in glaucomatous patients or suspects 
may result in a change in thresholds that may mimic progressive glaucoma. For case-detection, 
considering IOP level is a risk factor for glaucoma, but does not define the disease (Weinreb, 2007), 
and sophisticated imaging devices are expensive for primary care settings, therefore many clinicians 
rely on perimetric tests for diagnosis. It is unsurprising then that often false positive results may arise 
from cataract.  Thus, it would be advantageous to have a perimetric test that is robust to the effects 
of cataract. 
An analysis developed to compensate for the effects of loss of optical quality is the addition of 
Pattern Deviation (PD) maps (as in STATPAC for the Humphrey Field Analyser). PD measures partly 
account for diffuse (typically optical) loss by subtracting from the total deviation plot (deviation from 
the sensitivity of age-matched normals), the value corresponding to the 85th centile of the TD 
measures thus amplifying focal loss in the pattern deviation plot. However, this diffuse loss is not 
individualised with respect to expected reduction in sensitivity due to loss of optical quality. For this 
reason when diffuse loss is accounted for with summary measures such as PSD in the HFA, diffuse 
glaucomatous loss is hidden. Thus, although pattern deviation plots are useful in that they help 
identify sites of focal loss, they remain of limited value.  
In this study we have created IOS environments ranging from those associated with normal ageing to 
those encountered with significant cataract. This has allowed us to demonstrate the effect of various 
levels of intraocular stray light on perimetric thresholds and give measure of the robustness of each 
instrument to such ocular imperfections. Throughout the range of IOS levels, the MMDT stimulus 
remained relatively robust while each of the other perimeters suffered greater loss in sensitivity with 
markedly increased IOS. 
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Using these WOFs we have attempted to demonstrate not only the effects on modern perimetry of 
the additional IOS equivalent to those due to ageing but also with significant cataract. Real cataracts 
have typically been graded in four different categories depending on location, colour, density and 
shape of the opacity within the lens (Chylack et al, 1993). The WOFs used in this study are uniform 
density filters and, as such, are simulations of only one form of cataract.  
The spatial characteristics of the test stimuli may account for the notable difference in robustness to 
the effects of IOS between the tests. Stimuli employed in SAP, FDT and FDF are contrast-modulated, 
whereas the MMDT stimulus remains at constant contrast and the magnitude of displacement is 
modulated. So while the MMDT suffers an approximate 10-20% decrease in Michelson contrast at 
displacements at reference threshold, alternative contrast modulated methods may suffer 70-80% 
decrease in contrast at respective reference thresholds. This result is therefore not surprising given 
that contrast suffers at the hands of optical imperfections arising from conditions such as cataract.   
Further to this we measured luminance for the MMDT stimuli with the densest of these WOF (FOG 5) 
we calculated resultant energy where energy is a composite of area and change in luminance 
between the stimulus and the background as described by Verdon-Roe et al. Using the relationship 
between energy and MMDT threshold, we calculated the expected threshold with and without FOG 5 
. We found that for stimuli of length greater than about 40 min of arc the estimated drop in 
threshold according to this relationship should be less than 5 mins of arc, which is less than 2 
standard deviations of the normative database, and so may not reach significance.  
Anderson et al found a similar result for robustness with their peripheral grating resolution perimetry 
(GRP) test; notably it is also a less contrast dependent test (Anderson et al., 1995, Anderson et al., 
2002, Anderson, 1996). 
The effect of IOS on SAP thresholds is similar but less marked in this study compared to that of 
Anderson et al (4.9dB/log(s) versus 3.5dB/log(s), respectively (Anderson et al., 2009). The difference 
may be accounted for by the greater number of test locations in the present (52) as opposed to only 
4 central test locations used in the analysis of Anderson et al (Anderson et al., 2009). On examining 
the differences between central and peripheral locations with SAP and FDT from this study we found 
that peripheral locations were weakly significantly more affected with IOS (p<.05). Also we compared 
FDT1 from Anderson et al with FDT Matrix result from this study. However, we are conscious that the 
stimulus size and testing procedures, screen resolution and appearance of each of these instruments 
differ somewhat. The size of the effect in terms of z-scores is slightly greater (1.3/log(s) with FDT1 
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versus 1.6/log(S) with FDT Matrix) and this may be due to the additional peripheral locations and also 
the reduced stimulus size of the Matrix FDT (5 degree patch versus 10 degree patch of FDT1).  
 There is a need for further clarification of the role of IOS log(s) in baseline values in perimetry. Here, 
we demonstrate measurable effects of increases in IOS, equivalent to those related to age, on SAP, 
FDT and FDF (Figure 6-3 and Figure 6-4. The correlation of stray light with spread of normative values 
may lead to tightening of normative ranges, or an improvement to standard normative databases as 
suggested by Anderson et al(Anderson et al., 2009). This may lead to a methodology to correct for 
the current issue with diffuse glaucomatous loss and clinical contrast modulated standard perimetric 
measures. Tighter normal ranges would facilitate the identification of subtle sensitivity loss and 
provide greater confidence for diagnostic decisions. Therefore further exploration of the influence of 
individual IOS measures on the normative databases is required.  
The main conclusion to be drawn from the study reported in this chapter has important ramifications 
for the practical use of perimetric instruments. There was little difference in the performance of FDT 
and SAP with respect to increases in IOS, both were significantly affected. FDF appears to be quite 
sensitive to increases in IOS in comparison to SAP and FDT. There was little to no appreciable effect 
of IOS on MMDT thresholds. 
 
7 Conclusions 
 
Glaucoma is the leading cause of preventable blindness worldwide. Automated perimetry currently 
offers the best measure of functional impairment from the condition. However, the high level of 
noise in automated perimetry erodes the value of these measurements. Reduction in this noise, 
whether it comes in the form of better performing testing algorithms, or greater resilience of 
perimetric stimuli to forms of optical blur or media opacity, is a welcome advance. 
 
7.1 Summary of thesis 
 
In chapter 2, the effect of eccentricity and threshold on the MMDT stimulus type was explored in 
patients and visually healthy control subjects using a FOS analysis; this had not been done previously. 
The primary outcome of this chapter was a sample of carefully collected FOS data collected in 
patients and controls that could be used to develop reference standards and models for testing the 
perimetric algorithms developed in subsequent chapters. 
In chapter 3, a review of the types of clinical threshold search methods currently available was made. 
A best parametric type algorithm and best non-parametric type algorithm (WEBS and NEST) were 
modified and applied to the MMDT stimulus.  The performance of these two algorithms was 
compared against standard staircases that were initially implemented in the MMDT. Analyses of the 
patient data approach and ORS approach were reported. The newer methods showed significant 
improvements over the staircases. The ORS approach in particular showed that WEBS and ZEST were 
less affected by start point and step size than staircases.  
 
In chapter 4, a novel suprathreshold testing algorithm, ESTA, was developed. As in chapter 3, the 
performance of this algorithm was then compared with alternative suprathreshold algorithms using 
only the patient data approach. In the patient data approach the significant reduction in test 
duration in comparison to multisampling suprathreshold perimetry was shown, while agreement 
with the reference standard remained at a similar level for all suprathreshold methods. The 
investigation into the diagnostic performance of the algorithm was limited by the sample size. Still, 
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the ESTA algorithm provides a novel promising rapid perimetric strategy for glaucoma detection and 
it has been patented (see ‘List of supporting publications’). 
 
In chapter 5, studies using the test algorithms developed in the work described in this thesis (MMDT 
WEBS and MMDT ESTA) were reported. In the main, these interim results suggest there is no 
significant difference in the diagnostic accuracy of either MMDT WEBS or MMDT ESTA with any of 
the compared devices. For example, the interim analysis suggests that the relative diagnostic 
precision of the screening strategies for SAP (64-point screening), FDT1 (C20), MMDT (ESTA) in the 
clinic-based population of early glaucomatous patients are equivalent. FDT1 (17 test points) and MDT 
(32 test points) are quicker to perform than the SAP screening strategy.  A further study reported in 
this chapter indicated how the MMDT, running the ESTA algorithm in a ‘screening event, gives 
evidence of the utility of this technique, suggesting that the device is truly portable and quick, 
without losing accuracy for detection. 
 
Chapter 6 reported a study examining the effect of intraocular stray light (IOS) on threshold 
measurements made by four types of perimetry: Standard Automated Perimetry (SAP), Frequency 
Doubling Technology Perimetry (FDT), the Frequency Defined Form (FDF) and the Moorfields Motion 
Displacement Test (MMDT). Average response to SAP, FDT and FDF were highly affected by 
moderate to large increases in IOS while MDT remained largely unaffected over the same range of 
stray light levels. This work, being the first of its kind, indicates that MMDT has greater resilience to 
simulated effects of media opacity compared with other clinically used devices. The practical 
ramifications of this finding suggest that the MMDT stimulus could be preferred over other devices 
when case finding glaucoma in the elderly population where media degradation in eyes will abound. 
 
In summary, the key contributions, in order of importance, of the work described in this thesis to the 
field of perimetry in glaucoma are: 
 Production of the novel suprathreshold testing method ESTA, which has been implemented 
on the MMDT device. This work has title of a US and UK patent (see ‘List of supporting 
publications’). 
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 Demonstration of the resilience of the MMDT to optical media opacity when compared to 
other perimetric instruments. 
 Production of a clinical threshold search method (test algorithm) which is less variant with 
respect to step size and starting point as compared to current used methods on the MMDT. 
 Providing interim results on the performance of the MMDT against other perimetric devices 
in an instrument comparison study. 
 Providing frequency of seeing data in glaucomatous patients with the multi-locational 
MMDT. 
 
 
7.2 Future work 
 
Several projects originating from outcomes of this thesis have already begun: 
 Examine additional perimetric devices to determine the effect of intraocular stray light. 
 Examining the resilience of the MMDT in comparison to alternative perimetric devices  to 
media opacity in pre and post cataract extraction patients. 
  Matching the dynamic ranges of SAP and MMDT using FOS data collection.  
  A search for a clinically acceptable FOS data collection algorithm to identify and eliminate 
highly variable subjects/areas of loss from threshold data acquisition. 
 Development of a clinical threshold test which is a hybrid of FOS data collection and 
suprathreshold assessment. 
 
In conclusion, the MMDT appears to have some advantages over alternative perimetric methods, 
such as robustness to increases in IOS (as demonstrated in chapter 6). Combined with the short test 
duration delivered with the suprathreshold test ESTA (described in chapter 4), the test appears to 
perform well in the screening environment (section 5.5). When compared to alternative perimetric 
instruments, MMDT ESTA does not perform significantly differently in terms of diagnostic accuracy 
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(section 5.1-5.4). Therefore, these results would suggest that the MMDT ESTA instrument would be 
clinically useful as a case finding test for the community optometrist. Several studies are currently 
investigating this. 
 
Robustness to moderate levels of optical blur has been reported with the MMDT (-6.00DS: +4.00DS 
Moosavi 2011; In submission), which removes the need for optical correction in the majority of 
cases. Furthermore, the MMDT has reportedly low learning effects (Moosavi 2011; In submission) 
which is likely to be related to the familiar hardware used, which will should reduce the need for 
repeat testing and reduce the number of false referrals. Robustness to learning and optical blur will 
also have significant implications for speed in the screening environment. 
 
Screen characteristics play a large role in the development of the threshold monitoring version of the 
MMDT. The MDT stimulus is set at 85% Michelson contrast however, with LCD screens and with 
laptop LCD screens in particular, uniform contrast is difficult to maintain throughout the screen. 
Currently each piece of hardware has to be calibrated manually. Moreover due to the restrictions of 
pixel pitch with current screen technology, the threshold version of the MMDT has proved more 
difficult to develop. However with the speed of technological advancement and introduction of 
organic screens in particular, this restriction should soon be insignificant. The selection of 
measurement scale that is calibrated to functional loss, such that uniformity between degree of 
functional loss and MMDT measures is the next point of research (see 1.4.3). Since the relative step 
size on the end of the measurement scale corresponding to functional loss would be increased (e.g. 
the log scale of SAP does this in part) this should increase relative precision with threshold 
estimation. 
 
The construction of an ORS similar to that reported in this thesis which is robust enough for spatial 
simulation would be useful but very difficult to achieve. Intense data collection at a large number of 
locations throughout the field in a larger cohort of subjects (visually healthy and glaucomatous) 
would be required. The incorporation of fatigue and learning would also be required to form an ORS 
robust enough to simulated ESTA like procedures, in search procedures which are as short as ESTA 
the learning effect will have a highly variable impact, which will be difficult to simulate correctly. 
 
The development of ‘better’ threshold algorithms has long been attempted. There is no easy answer 
to whether further investigation will yield significant results, and the low signal to noise ratio 
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associated with perimetric testing suggest that improvements will always be difficult to make. The 
construction of the WEBS procedure reported in this thesis outperformed the current methods used 
for threshold assessment in the MMDT, however the implementation of individualised tests, where 
either previous perimetric tests result are utilised in retesting (e.g.  REMU (Turpin et al., 2007)) or 
structural measures are used to inform and focus perimetric testing (Turpin et al, 2009) may provide 
more reliable perimetric results. What was apparent from this work is that the slope of the frequency 
of seeing curve has a significant impact on precision, notably subjects with shallow slopes or low 
response confidence will always provide highly variable results. These subjects would likely perform 
better with suprathreshold testing, where the size of the defect is monitored rather than the depth.  
A method to identify these subjects early and eliminate from further threshold testing may prove 
useful.  
 
Baseline FOS data on all subjects could provide a method to identify these subjects. Clinical FOS data 
collection at a large number locations would be unfeasible, however a suprathreshold threshold 
method which migrated into intense sampling at one location in each disc quadrant (as defined by a 
given map e.g. Garway-Heath 2000), may provide the relevant information for structure/function 
assessment, broad functional information on size of defects and the necessary information on 
reliability. This information on reliability of each of the quadrants could then be used to estimate 
interpretation error (King-Smith 1994), the larger the interpretation error the more noise in 
measures and the more difficult it will be to detect change (signal). Pre-set limits on signal to noise 
ratios could then be used to determine whether it would be useful to any threshold information in 
this quadrant. The additional benefit of this method is that the baseline could be repeated at any 
stage and the FOS curves compared allowing disease progression to monitored with respect to 
changes in threshold and changes in slope. 
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Appendix – Summary description of the Enhanced Suprathreshold Algorithm 
(ESTA) as applied to the Moorfields Motion Displacement Test (MMDT) 
 
Graphical Output (Figure A.1) 
 
The graphical output of the MMDT ESTA program is composed of three plots.  
(i)  Pass/Fail plot which is determined by a combination of the spatial filter and  
      multi-sampling (clear box = pass; solid box = fail).  
(ii) Probability plot which is determined by the ESTA spatial filter. The values in  
      the probability plot give an estimate of the “probability of true damage” (PTD), which is  
      calculated according to the weighted relationship between each field location and the  
                number of unseen responses. The weighted value is adjusted according to the centile  
                estimate of the displacement size. The higher the PTD, the greater the probability that  
                the location is damaged.  
(iii) Grey scale plot which relates the field defect to the optic nerve head (ONH)  
      by applying the Garway-Heath anatomical map.
2  
Each letter on the graphical  
      output of the field corresponds to the anatomically related sector of the ONH,  
      which is displayed on the adjacent diagram. 
 
 
Global PTD  
The global index of the probability of true damage (PTD) represents the sum of the PTD for each location. The 
higher the value of the PTD, the higher the probability of “true damage”. 
 
ESTA 95: displacements are presented at the 95
th
 centile of the normal population and, when required, 
confirmatory presentations are made at 98
th
, 92
nd
, and 95
th
 centiles (in this order) 
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Figure A-1 Example of ESTA MMDT graphical output showing an upper hemifield defect (right eye). 
General rules 
 All stimulus displacements (3 oscillations at 200 ms per cycle) are presented in randomised order 
 The rules of the Pandora response algorithm are applied. Where a false response occurs the 
displacement is represented within the randomised order of the test sequence. 
 
Rules of the MMDT ESTA Spatial Filter 
 A spatial filter is applied to estimate the weighting array (WA) between each test location (TL). 
 The ESTA spatial filter is static and the weightings are therefore only calculated once. 
 Locations are clustered according to the anatomical entry of nerve fibre bundles into the optic nerve 
head (ONH). The distance of each location to the ONH is traced.
 
The angle between each primary test 
TL relative to each of the secondary 31 TLs is calculated (ONHd). These values are integrated into the 
software through referencing a ready prepared look-up table which is derived from Figure A-2 (from 
Garway-Heath et al 2000). 
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Figure. A- 2 The Optic nerve head location, in degrees, for each visual field point of the Standard Automated 
Perimetry 24-2 program  
 
 The Euclidean distance between each primary TL and secondary TL x,y coordinates (retd) are auto-
calculated within the MMDT software code and verified through a check facility written to a CSV file. 
 The correlation coefficient for each test location is then derived from the best fit model described by 
Strouthidis et al
1
:            
            R Square = The Square Of ( 0.9325 - 0.0029*nONHd - 0.0077*nRETd + 0.0001*nONHd*nRETd)   
 The “correlation array” is defined by the primary TL and related secondary TL(s) where the R-Square 
correlation coefficient is >0.65 (Figure A-3) note: The correlation coefficient used by Strouthidis et al 
was 0.70. The correlation coefficient was decreased to 0.65 for the purpose of the MMDT 32 location 
test to ensure that each location had at least one neighbour.  
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Figure A-3. Schematic Diagram illustrating an example of the correlation array for location -15,+15 (right 
eye). The Correlation array is indicated in yellow, with the primary location -15,+15 in bold. 
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 The weightings of correlated locations are re-normalised so that the weightings total 1.0  
(Figure A-4) 
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Figure  A-4. Schematic Diagram illustrating example of normalised correlation values for location (-15⁰,+15⁰) 
(right eye). The normalised Correlation array is indicated in green, with the primary location (-15⁰,+15⁰). 
 
Rules for the Calculation of Probability of True Damage [PTD] for each location 
The PTD for each primary test location is the sum of (TL)= [Sweeps results array (seen/unseen adjusted for 
centile estimate for displacement*)  x normalised correlation coefficient array) for each location within the 
correlation array (e.g. [primary TL + secondary TL1+ secondary TL2 etc]).  
Rules for ESTA “95
” 
test version (ref Figure A-5) 
Rules ESTA 95: 
1. Sweep 1: all locations are presented with displacements at 95
th
 normative centile in randomised order 
In the response array: 
Seen=0.05 
Unseen=0.95 
After the end of sweep 1 the following will be calculated: 
Sweeps results array = response array in this sweep 
PTD calculated as described above 
 Possible outcomes: 
a) All locations seen – action: test terminates. All locations passed on pass-fail plot; PTD 
entered on probability map 
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b) > 10 locations unseen – action test terminates. Unseen locations failed on pass fail plot. 
PTD entered on probability map 
c) ≥1 ≤9 locations are missed: locations will be retested if they fall within the range L1 (lower 
bound for sweep 1) to U1 (Upper bound for sweep 1) as specified in ini file. 
 
Once a decision is taken not to test a location again, that decision is final. However the PTD for that 
location will continue to be updated for subsequent sweeps. The location will not be re-tested even 
if the updated PTD is within the boundaries for re-testing.  
 
2. Sweeps 2 presents locations identified in 1c) with displacements at 98
th
 centile 
In the response array: 
Seen=0.02 
Unseen=0.98 
After the end of sweep 2 the following will be calculated: 
Sweeps results array = (response array1 + response array2)/n, where n is the number of 
presentations made at that location 
PTD calculated as described above 
 
Actions:  
If any of the following applies, the testing at that location terminates: 
a) if both unseen 
b) if both seen 
c) if PTD >U2 (as specified in ini file) 
d if PTD <L2 (as specified in ini file) 
 
For each location, once a decision to not test it again has been made, that decision is final 
 
 
 
3. Sweep 3 presents displacements at 92
nd
 centile 
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In the response array: 
Seen=0.08 
Unseen=0.92 
After the end of sweep 3 the following will be calculated: 
Sweeps results array = (response array1 + response array2 + response array3)/n, where n is the 
number of presentations made at that location 
PTD calculated as described above 
 
Actions:  
If any of the following applies, the testing at that location terminates: 
a) if seen in sweep 1, unseen in sweep 2 
a. seen in sweep 3 (the pass/fail plot will record it as pass) 
b) if unseen in sweep 2, seen in sweep 2 
a. unseen in sweep 3 (the pass/fail plot will record it as fail) 
c) if PTD >U3 (as specified in ini file) 
d) if PTD <L3 (as specified in ini file) 
 
For each location, once a decision to not test it again has been made, that decision is final 
4. sweep  4 presents displacements at 95
th
 centile  
 In the response array: 
Seen=0.05 
Unseen=0.95 
After the end of sweep 4 the following will be calculated: 
Sweeps results array = (response array1 + response array2  + response array3 + response 
array4)/n, where n is the number of presentations made at that location 
PTD calculated as described above 
 
Rules for the Pass-Fail graphical output for each location – 95 centile 
Pass-Fail Rules (examples in the table below): 
1. A location will be recorded as FAIL if one or all applies: 
a) PTD>U 
b) sweep 1 AND sweep 2 unseen  
c) two unseen in sweep 1, 3 or 4 
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2. A location will be recorded as PASS if one or all applies: 
a) PTD<L  
b) sweep 1 AND sweep 2 seen  
c) two seen in sweep 1, 2 or 4 
d) sweep 1 AND  sweep 3 seen 
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Figure A-5 Detailed flow chart of ESTA, PTD denotes the probability of true damage, RA the results array, WA the 
weighting array,   the presentation intensity level on that sweep and   
 
       
 
the upper and lower limits for retesting 
at the j the location. 
 
Table 1: Possible outcomes in the pass-fail graphical output. 
Scenario Sweep 1 Sweep 2 Sweep 3 Sweep 4 Outcome 
 95% 98% 92% 95%  
1 Seen (PTD<L1)    Pass 
2 
Unseen 
(PTD >U1) 
   Fail 
3 
Unseen 
(L1<PTD<U1) 
Unseen   Fail 
4 
Seen 
(L1<PTD<U1) 
Seen   Pass 
5 (a) 
Unseen 
(L1<PTD<U1) 
Seen 
(PTD>U2) 
  Fail 
5 (b) 
Unseen 
(L1<PTD<U1) 
Seen 
(PTD<L2) 
  Pass 
5 (c) 
Unseen 
(L1<PTD<U1) 
Seen 
(PTD>U2) 
Unseen  Fail 
6 (a) 
Seen 
(L1<PTD<U1) 
Unseen 
(PTD>U2) 
  Fail 
6 (b) 
Seen 
(L1<PTD<U1) 
Unseen 
(PTD<L2) 
  Pass 
6 (c) 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Seen  Pass 
7 
Unseen 
(L1<PTD<U1) 
Seen 
(L2<PTD<U2) 
Seen 
(PTD>U3) 
 Fail 
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7 
Unseen 
(L1<PTD<U1) 
Seen 
(L2<PTD<U2) 
Seen 
(PTD<L3) 
 Pass 
7 
Unseen 
(L1<PTD<U1) 
Seen 
(L2<PTD<U2) 
Seen 
(L3<PTD<U3) 
Unseen Fail 
8 
Unseen 
(L1<PTD<U1) 
Seen 
(L2<PTD<U2) 
Seen 
(PTD>U3) 
 Fail 
8 
Unseen 
(L1<PTD<U1) 
Seen 
(L2<PTD<U2) 
Seen 
(PTD<L3) 
 Pass 
8 
Unseen 
(L1<PTD<U1) 
Seen 
(L2<PTD<U2) 
Seen 
(L3<PTD<U3) 
Seen Pass 
9 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Unseen 
(PTD>U3) 
 Fail 
9 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Unseen 
(PTD<L3) 
 Pass 
9 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Unseen 
(L3<PTD<U3) 
Unseen Fail 
10 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Unseen 
(PTD>U3) 
 Fail 
10 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Unseen 
(PTD<L3) 
 Pass 
10 
Seen 
(L1<PTD<U1) 
Unseen 
(L2<PTD<U2) 
Unseen 
(L3<PTD<U3) 
Seen Pass 
 
 
Appendix- Matlab code of ESTA 
 
Function 1:  To calculate the weighting array using the Strouthidis spatial filter 
function WA=SF(x) 
load('sp_data.mat') % contains ONHd data from Garway-Heath and colleagues 
(2000) 
                    % with corresponding (x,y) locations in Matrix A 
for i=1:52 
    for j=1:52 
     % computes distance between test locations 
     RETd(i,j)=sqrt((A(i,2)-A(j,2))^2+(A(i,3)-A(j,3))^2);  
      
     % computes angle between test locations 
     b=abs(A(i,4)-A(j,4)); 
     if b<180 
        ONHd(i,j)=b; 
     else 
        ONHd(i,j)=(360-b); 
     end 
      
    end 
end 
count=0; 
%computes the FC for location x from Strouthidis and colleagues (2006) 
  
for j=1:52 
    Rsq(j)=(.9325-(0.0029*ONHd(x,j))-
(0.0077*RETd(x,j))+(0.0001*ONHd(x,j)*RETd(x,j)))^2; 
        if Rsq(j)>.65 
        count=count+Rsq(j); 
        end 
end 
  
% Computes the Weightings array for location x 
  
for i=1:52 
   
    if Rsq(i)>.65 
        WA(i)=Rsq(i)/count; 
    else 
        WA(i)=0; 
    end 
end  
 
Function 2: ESTA 
function [count,PTD,PF]=ESTA(G1, G2, age) 
count(1:14,1:1000)=0;  %counts the  
load('lims.mat') % look-up table of normative limits 
load('weights.mat') % look-up table of WA's 
  
R1(1:32)=0; % Results array (RA) sweep 1 
R2(1:32)=0; % Results array (RA) sweep 2 
R3(1:32)=0; % Results array (RA) sweep 3 
10 Improving measurements in perimetry for glaucoma 2011 
 
172 
 
R4(1:32)=0; % Results array (RA) sweep 4 
  
S(1:14)=0;      % initate results matrix 
PF(1:32)=-1;    % initate pass/fail matrix 
A(1:32)=0;      % initate sweep results matrix 
Pres(1:32)=0;   % initate presentation matrix 
beta1=0.95;     % intial presentation intensity level 
beta2=0.80;     % second presentation intensity level 
beta3=0.95;     % third presentation intensity level 
beta4=0.94;     % fourth presentation intensity level 
u1(1:32)=.7;    % upper retest bound 
u2(1:32)=.18;   % lower retest bound 
  
a(1,1:32*5)=rand([1 32*5]); % for use with the ORS random number generator 
presintensity=lims(1:32,1)+norminv(beta1,0,1)*lims(1:32,2)+age*.1; 
%% Sweep 1 
  
        for i=1:32 
            g(1)=(G1(i,j)); % threshold of the given patient/subject at 
location i 
            g(2)=(G2(i,j)); % slope 
            A(i)=ORS(presintensity(i),a,i,g); %provides the response  
        end 
        R1=A; %the results of the first round 
        R=R1; %set as overall results at this point     
        Pres(1:32)=1; % presentation counter 
        PTD=(R*weights);% calculates the PTD for use in sweep 2 
        A(1:32)=0; %resets the sweep results array 
             
        if sum(R1)>10 % if more than ten locations are missed - stop the 
test and fail. 
                PF=R1; % The Pass fail result (PF) is given as the results 
of the first round. 
                Pres(1:32)=1; % only one presentation at each location                 
        end 
%% Sweep 2 
        for i=1:32   
          presintensity=lims(i,1)+norminv(beta2,0,1)*lims(i,2)+age*.1; % 
moved up one increment 
          if PTD(i)>u1(i) % High PTD no need to retest. 
             PF(i)=1; 
          elseif PTD(i)<u2(i) % Low PTD no need to retest 
             PF(i)=0; 
          elseif (PTD(i)<=u1(i) && PTD(i)>=u2(i)) %select points for 
retesting in the middle on PTD values 
             A(i)=ORS(presintensity,a,i+32,g); %Subject/Patient response     
             Pres(i)=Pres(i)+1; % individual location presentation counter 
          end 
        end 
       R2=A; % the results of the second sweep 
       R=(R1+R2)./Pres; %overall response-  
                        %the average* of the number of responses given 
       PTD=(R*weights); % Calculates the PTD for sweep 3 
       A(1:32)=0; %resets the sweep array 
         
%% Sweep 3 
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       for i=1:32 
          presintensity=lims(i,1)+norminv(beta3,0,1)*lims(i,2); % moved 
down one increment 
          if Pres(i)==2 
            if R1(i)+R2(i)==0 % Henson 2/3 pass/fail criterion 
               PF(i)=0; 
            elseif PF(i)<0                   
               if (PTD(i)<=u1(i) && PTD(i)>=u2(i) ) %select points for 
retesting 
                   A(i)=ORS(presintensity,a,i+64,g); 
                   Pres(i)=Pres(i)+1; 
               end 
            end 
          end 
       end 
       R3=A; 
       R=(R1+R2+R3)./Pres; 
       PTD=(R*weights); 
       A(1:32)=0; 
%% Sweep4 
       for i=1:32 
           presintensity=lims(i,1)+norminv(beta4,0,1)*lims(i,2)+age*0.1; 
           if Pres(i)==3 
              if R1(i)+R2(i)+R3(i)>=1.9 % Henson 2/3 pass/fail criterion 
                   PF(i)=1; 
              elseif R1(i)+R2(i)+R3(i)<1 % Henson 2/3 pass/fail criterion 
                   PF(i)=0; 
              elseif PF(i)<0 
                if (PTD(i)<u1(i) && PTD(i)>u2(i)) %select points for 
retesting 
                    A=ORS(presintensity,a,i+96,g); 
                    Pres(i)=Pres(i)+1; 
                    PF(i)=A(i);           
                end 
              end 
           end 
       end 
       for i=1:32 
           if PF(i)<0 
             if PTD(i)<.2 
                 PF(i)=0; 
             else 
                 PF(i)=1; 
             end 
           end 
       end 
        
  
%% Outcomes 
  
            PTD=PF*weights; 
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